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Chronic Open-angle Glaucoma (COAG) is a disease affecting the optic nerve, 
which can cause slow and irreversible sight loss. Once diagnosed, COAG 
requires lifelong monitoring in a hospital setting. The four studies presented 
within this thesis aimed to explore the experience of living with COAG through 
investigating some of the cognitive and emotional processes of patients and 
their informal caregivers (ICG). In the first study (cross-sectional) illness 
representations in 58 newly diagnosed patients with COAG were similar to 58 
peers who had been diagnosed for > 2 years. The main outcome was the Brief 
Illness Perception Questionnaire (BIPQ). Analysis correcting for personality 
type (DS14) and general health (EQ-5D) indicated newly diagnosed patients to 
have marginally better illness representations on individual BIPQ items 
quantifying impact on life in general, experience of symptoms and 
‘understanding’ of their condition (all p<0.01). In contrast, patients with COAG 
with a diagnosis >2 years understood better their condition to be long-term 
(p<0.01). The second study (longitudinal feasibility) tested the hypothesis that 
patients could self-monitor their COAG using a web-based diary tool. Ten 
volunteers were prompted to monitor symptoms every three days and 
complete a diary about their vision during daily life using a web-based diary 
tool over an 8-week period. Completion rate to items was excellent (96%). 
Themes from a qualitative synthesis of the diary entries related to behavioural 
aspects of glaucoma. Patients reported a variety of important life changes due to 
their COAG, such as increased frustration and cessation of activities as well the 
importance of social support and clinician trust as protective factors for their 
wellbeing. The third study (cross-sectional) investigated the factors which may 
lead to an increased reliance on ICG. A modified version of the Caregiver Strain 
Index (MCSI) was used to investigate ICG strain. In the patients with an ICG, 
87% (33/38) self-reported they were married or in a committed relationship as 
opposed to being single, divorced, widowed or separated; 60% (40/67) in the 
patients who did not have an ICG (p=0.004). Percentage of patients with an ICG 
was also much higher in patients with advanced VF loss (82%; 9/11) when 
compared to those with non-advanced VF loss (31%; 29/94; p=0.001). Mean 
(standard deviation) MCSI was considerably inflated in the advanced patients 
(5.6 [4.9] vs 1.5 [2.2] for non-advanced; p=0.040). Worsening VF and poorer 
self-reported EQ-5D were associated with worsening MCSI. The final study 
(focus groups) used interpretative phenomenological analysis (IPA) to 
investigate experiences of ICG. Experiences of patients with ICG and patients 
without ICG were compared. Participants without an ICG feared a loss of 
independence more than those with an ICG. Those with an ICG stressed the 
importance of their ICG being involved in communicating with care teams and 
administering medications. ICGs felt a sense of obligation toward the patient, 
but this was not generally associated with negative emotions. To conclude, 
these studies demonstrate new knowledge on the complexities of the cognitive 
and emotional processes involved in living with COAG, including the importance 
of both the patient and their support network in forming and maintaining 
positive attitudes toward health and illness. Results from this thesis 
may inform a more integrated approach to COAG clinical practice, 
encompassing both the patient and their ICG.   
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Chapter One - Introduction  
“I am not what has happened to me, I am what I choose to become.”  
- Carl Gustav Jung  
The aim of this PhD thesis is to explore the experience of living with Chronic 
Open-angle Glaucoma (COAG). Specifically, to investigate the cognitive and 
emotional processes involved in adaptation to COAG as a chronic illness from 
the perspective of both the patient and their immediate social support network 
(informal caregivers). In order to clarify the aims of this work, this chapter gives 
a summary of relevant background literature. Further details on the specific 
aims of the thesis are outlined at the end of Chapter One.  
1.1 Glaucoma Definition and Background  
Glaucoma is the name given to a group of chronic diseases whereby the optic 
nerve sustains damage over time, affecting a patient’s visual function. Damage 
caused by glaucoma is irreversible; indeed, it is the second most common cause 
of irreversible blindness in the developed world (Bourne, et al., 2018). An 
estimated 60.5 million people have experienced a loss of vision caused by 
glaucoma, with 4.5 million people developing bilateral blindness (blindness in 
both eyes) as a result (Quigley & Broman, 2006). Glaucoma has no cure, 
although appropriate long-term treatment and monitoring can halt or slow 
disease progression (Lee & Higginbotham, 2005). In the UK, Chronic Open-angle 
Glaucoma (COAG), which is the most common subtype, affects around 2% of 
people over the age of 40, with prevalence rising to 10% of people over the age 
of 70 (King, Azuara-Blanco, & Tuulonen, 2013). Due to the increase in life 
expectancy in developed countries and the number of people with glaucoma is 
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expected to reach ~80 million by 2020 (Quigley & Broman, 2006). COAG is 
sometimes referred to as the ‘silent thief of sight’ because it is usually 
asymptomatic in its early stages. This means that as many as 22-25% of 
patients already have advanced vision loss when they present to eye services 
for the first time (Crabb, Saunders, & Edwards, 2017). Visual impairment from 
COAG (measured by loss in the visual field, [VF]) has been linked to restricted 
mobility and activities of daily living, falls and a reduction in Quality of Life 
([QoL] Crabb, 2016). A rise in the number of COAG cases, many of whom may 
already have advanced vision loss and impacted QoL on presentation, is likely 
to lead to increased demands on already strained hospital eye care services. The 
increase of cases could potentially cause detrimental effects on patient 
wellbeing. 
1.1.1 Glaucoma Subtypes and Risk Factors 
The term ‘glaucoma’ is often used synonymously with COAG, but glaucoma is 
actually a group of neurodegenerative diseases, each with different 
characteristics. Glaucomas are classed as ‘primary’ or ‘secondary’, with the 
latter term referring to cases where optic nerve damage has occurred as a result 
of other ocular disease. The primary risk factors for glaucoma are age (King, 
Azuara-Blanco, & Tuulonen, 2013), ethnicity (Quigley & Broman, 2006), family 
history of the disease, thinner central corneal thickness and higher intraocular 
pressure (Coleman & Miglior, 2008). 
Primary glaucomas, including COAG, affect around 60.5 million people 
worldwide (Quigley & Broman, 2006). This means that COAG affects around 2-
3% of adults over 40, increasing exponentially to between 10-20% of adults 
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over 70, with African and Latin American populations being disproportionately 
affected(Quigley & Broman, 2006). COAG typically occurs because of a gradual 
or sustained increase in intraocular pressure (IOP), which causes progressive 
damage to the optic nerve head (ONH). This in turn causes the patient to lose 
vision in their visual field (VF). Estimates of the average rate of VF loss in COAG 
vary but typically progression of more than -1.5dB a year is considered 
problematic (Saunders, Medeiros, Weinreb, & Zangwill, 2016). Once a patient 
has been diagnosed with COAG, they require lifelong monitoring of their 
condition.  
Some patients will sustain ONH damage and VF loss similar to COAG patients, 
but whilst their IOP measurements remain within normal range. This variant is 
called normal tension glaucoma (NTG). It is not known how damage occurs in 
people with NTG (Bell & O'Brien, 1997). The data collected and utilised in this 
thesis relate to COAG and NTG, with no distinction made between the two since 
the treatment and monitoring are identical. 
Angle closure glaucoma (ACG) is another form of primary glaucoma which 
generally progresses faster than COAG and often constitutes a medical 
emergency. Around a third of primary glaucoma cases are ACG (Quigley, 1996). 
ACG affects around 0.5% of the worldwide population over the age of 40 and 
whilst ACG prevalence remains relatively stable in Caucasian and African 
populations, it increases to around 2-5% of over 70’s in South East Asian 
populations (Quigley & Broman, 2006). The process of harm in ACG can happen 
in two ways. It may occur as a sudden attack (acute angle closure), which 
manifests as a sharp pain in the eyes, accompanied by blurred vision, nausea 
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and a headache, or as a progressive disease, similar to COAG, but with patients 
typically progressing at a rate of around -2dB per year (Lee, Kim, & Hong, 
2004). Most ACG patients will be offered laser or surgical interventions, 
although acute angle closure requires emergency surgical treatment to open the 
drainage angle. 
There are also several secondary glaucoma’s, which occur because of other 
ocular or systemic disease. Examples of these include exfoliative glaucoma, 
neovascular glaucoma and some forms of glaucoma which occur in babies and 
are caused by malformation of the anterior segment in utero, these forms of 
glaucoma are often visible to the naked eye or on inspection of the anterior 
chamber (see Figure 1.1) 
 
Figure 1.1: Left: A new-born with secondary congenital glaucoma due to 
incomplete formation of the anterior segment (source: author’s own image). 
Right: A patient with neovascular glaucoma where new blood vessels develop in 




1.1.2 Biological Basis of Glaucoma 
The exact pathophysiology of glaucoma remains speculative but it is thought 
that damage to the optic nerve head (ONH) occurs through the loss or death of 
retinal ganglion cells (RGC), which leads to a reduction in light sensitivity in the 
VF (Casson, Chidlow, Wood, Crowston, & Goldberg, 2012). To understand how 
RGC loss relates to a reduction in light sensitivity, it is necessary to understand 
how light is processed by the human eye. In short, light waves enter the eye 
through the cornea and are projected on to the retina. The retina is a thin band 
of tissue consisting of layers of cells which lines the back of the eye (see Figure 
1.2). 
 
Figure 1.2: The key landmarks of the human eye (left) and retina (right) (source: 
https://www.oercommons.org/courseware/module/15125/student/?task=3).  
RGC’s are responsible for receiving light signals from the rod and cone cells 
(collectively known as the photoreceptors) and transmitting them down the 
ONH where the information can be processed in the visual cortex (Masland, 
2012). The layer of RGC axons responsible for transmitting light signals is called 
the retinal nerve fibre layer (RNFL). In glaucoma, the axons in the RNFL are 
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damaged which leaves them unable to process or communicate the signals, 
resulting in a reduction of sensitivity.  
The reason that the RNFL is affected in glaucoma is not fully understood but it is 
thought that increases in RGC death and subsequent visual damage may occur 
because of high intraocular pressure (IOP) (Guo, Moss, Alexander, Ali, Fitzke, & 
Cordeiro, 2008). In the eye, pressure is controlled by the balance of aqueous 
humour, which is a clear watery fluid that circulates through the anterior 
chamber (the front section of the eye), next to the iris and cornea (see Figure 
1.2). The aqueous humour is drained away through a series of small channels, 
which are called the trabecular meshwork. Sometimes there is a disturbance 
between the inflow and outflow of the aqueous humour, causing an elevation in 
IOP.  Elevated IOP (defined clinically as more than or equal to 24mmHg) is a key 
criterion for referral from primary care services (community optometrists) to 
secondary care services (hospital clinics) for suspected glaucoma (National 
Institute for Health and Care Excellence, 2017). Around 10% of patients 
referred to glaucoma services in the UK will be diagnosed with ocular 
hypertension (OHT) (Chan, et al., 2017), defined as sustained IOP more than or 
equal to 24mmHg but without damage to the VF. Around 4% of patients 
diagnosed and on treatment for OHT go on to develop COAG (Gordon, Beiser, & 
Brandt, 2002), compared with around 10% of those who are untreated.  
The resulting damage to RGCs leads to areas of the retina becoming less 
sensitive to light. These patches of poor vision are referred to as a ‘scotoma’ 
(plural; scotomata). Patients with COAG usually do not lose light perception in 
the areas of their vision that are affected, and so do not view these patches as 
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blackness but rather as blurred or missing patches in their vision (Crabb, Smith, 
Glen, Burton, & Garway-Heath, 2013). This is particularly important for our 
understanding of why more than 50% of COAG remains undiagnosed in the 
developed world (Quigley, 1996). COAG is often unilateral to begin with, 
meaning that it affects one eye before the other in around 66% of new cases 
(Heijl, Bengtsson, & Oskarsdottir, 2013). Human vision however, is binocular, 
meaning that both eyes work together and the least affected/unaffected eye 
compensates for the scotoma in the affected eye, making the vision loss 




1.2  Diagnosing and Monitoring Glaucoma 
Due to the progressive nature of COAG and the likelihood that the patient does 
not notice their early VF loss, most new COAG patients are identified during 
routine optometric examinations (Lawrenson, 2013). Patients who have 
suspected COAG are referred to hospital eye care services, where around 10% 
will be diagnosed with OHT (Chan, et al., 2017) and ~40-50% will be diagnosed 
with COAG (Salmon, Terry, Farmery, & Salmon, 2007). The most common 
causes for referral to secondary care are abnormalities in ONH images (~30%), 
elevated IOP (~26%) or a combination of these two parameters (~17%) 
(Salmon, Terry, Farmery, & Salmon, 2007). In a secondary care (hospital) 
setting, COAG is diagnosed using a combination of gonioscopy, which allows 
examination of the anterior chamber angle, measurement of IOP through 
tonometry, imaging of the ONH using slit lamp bio microscopy or optical 
coherence tomography (OCT) and tests of visual function, including VF and 
visual acuity (VA). Once diagnosed, patients will attend a m..onitoring visit 
approximately once every six to twelve months for the remainder of their 
lifetime (National Institute for Health and Care Excellence, 2017). 
1.2.1 Gonioscopy 
 
Gonioscopy is used to evaluate the internal drainage system of the eye. This 
internal drainage system is called the ‘anterior chamber angle’ and it contains 
the trabecular meshwork, a series of channels which the aqueous humour 
drains from.  A special lens prism is placed onto the cornea and allows the 
clinician to look at the drainage angle and assess its functionality (Boyd, 2019). 
The appearance of the drainage angle is used to determine the type of glaucoma 
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that the patient may have. An open drainage angle may be indicative of COAG, 
whereas an angle that appears closed or narrow is indicative of ACG.  
1.2.2 Tonometry 
Although an elevated IOP can occur in isolation and may not be indicative of the 
presence of VF damage, it is the only modifiable risk factor for COAG 
progression and a useful clinical measurement in glaucoma clinics. The IOP 
value is measured during a procedure called tonometry. Tonometry measures 
the level of force in grams (which is then converted to millimetres of mercury 
(mmHg), which is required to flatten the cornea. Pressure is applied either 
indirectly using an air pulse (non-contact) or directly using a probe on the 
cornea (contact). The reference standard in ophthalmology is Goldmann 
applanation tonometry (GAT), a form of contact tonometry. In GAT, the clinician 
uses small probe to flatten an area of the central cornea.  
GAT measurements may be biased by the structure of the eye. For example, 
patients with thin corneas often have artificially lower IOP readings (Medeiros 
& Weinreb, 2012). There are also many patients who have NTG, where there is 
the presence of glaucomatous damage without elevated IOP(Bell & O'Brien, 
1997). For these reasons, IOP measurement, although a useful predictive tool, 
cannot be used as the sole tool for establishing the presence of glaucoma or 
monitoring progression.  
1.2.3 Measurement of structural change 
The health of the ONH and RGCs are key diagnostic criteria for COAG, as well as 
a useful indicator of progression.  This is because changes can occur to the ONH 
long before any changes in vision can be observed (Weinreb & Khaw, 2004). 
24 
 
The health of the ONH is analysed in two ways. Clinicians may use a slit lamp to 
look at the ONH directly or use optical coherence tomography (OCT) to create 
images of the ONH and RNFL(National Institute for Health and Care Excellence, 
2017). When using a slit lamp, clinicians primarily look for changes to the ONH, 
including its colour and the pattern of blood vessels within the eye. The ONH 
has a small ‘cup’ at the centre, which is surrounded by a rim of RNFL tissue (the 
neuro-retinal rim). Clinicians measure changes to the ONH using the cup-to-disc 
ratio (CDR). A good analogy for the CDR is the size of a doughnut hole. If the 
hole occupies 2/10 of the entire diameter of the doughnut, the CDR would be 
0.2 whereas, if the hole occupies 7/10 of the doughnut, the CDR would be 0.7. A 
typical non-glaucomatous CDR is less than 0.4, however there is individual 
variation. A CDR of >0.8 indicates that a disc should be treated as glaucomatous 
until proven otherwise (Tsai, 2005). In addition to calculating CDR, clinicians 
look for changes to the colour of the optic disc and changes to the RNFL, which 






Figure 1.3 A comparison of a healthy optic nerve head (left) and a glaucomatous 
optic nerve head (right). Severe optic disc cupping and disc pallor can be seen in the 




Due to the high intra-observer and inter-observer variation in assessment of the 
ONH when assessing the health using a slit lamp (Gaasterland, et al., 2001), the 
clinician will also take images of the ONH and RNFL using OCT. OCT is a non-
invasive procedure which provides three-dimensional, high resolution images 
of the ONH and RNFL, and provides cross sections so that the thickness of the 
RNFL can be assessed. OCT machines compare the scanned eye to other eyes in 
an in-built normative database in order to provide the clinician with an 
estimate of whether the eye is glaucomatous. RNFL and ONH imaging using OCT 
provides high quality reproducible images and is highly sensitive for detecting 
changes in the CDR and RNFL thickness (Kotowski, Wollstein, Ishikawa, & 
Schuman, 2014).   
1.2.4 Visual Fields 
Understanding of physiological damage in glaucoma is very valuable, however 
measures of visual function are also important for understanding the impact of 
COAG on the patients’ ability to see well in their day to day lives. Perhaps the 
most important method of assessing visual function in COAG is measurement of 
the VF. VF testing is the method used to detect scotomata and thus is a vital 
component for the diagnosis and monitoring of COAG.  
The visual field can be defined as the entire space a person or animal is able to 
see when the eye is fixed in a central position. A ‘normal’ VF usually covers an 
area of approximately 60° down and 70° up and 90° temporally and 60° nasally 
from the point of fixation (Henson, Chaudry, Artes, Faragher & Ansons, 2000). 
The VF test looks at light sensitivity at different points on the retina. Light 
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sensitivity can be described using a ‘hill of vision’ analogy. Sensitivity is highest 
at the point of fixation and gradually decreases as the light reaches the more 
peripheral points of the VF (see Figure 1.4). The functionality of the VF is 
assessed using a procedure called perimetry. 
 
 
Figure 1.4: A 2-dimensional representation of the hill of vision. The 0° point 
represents the point of fixation. We can see that sensitivity decreases in the 
peripheral retina (source: https://entokey.com/the-visual-field/) 
Standard automated perimetry (SAP) is regarded as the gold standard for 
diagnosis of COAG(National Institute for Health and Care Excellence, 2017). 
Two of the most common standard automated perimeters are the Octopus 
(Interzeag AG, Schlieren-Zurich, Switzerland) and the Humphrey Field Analyzer 
(HFA, Carl Zeiss Meditec Inc., USA).  
The HFA (see Figure 1.5) is the most commonly used in the UK and was the 
perimetry method used for the studies described within this thesis. During HFA 
examination, the patient places their head on the chin/forehead rest at a fixed 
distance of 33cm and looks into the ‘bowl’, which has a luminance of 10cd/m². 
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Light stimuli from 0.025 to 3183cd/m² are projected onto different areas of the 
retina according to the algorithm chosen by the clinician. The patient is 
required to fixate at a central point and press a button each time they detect a 
light stimulus. The lowest luminance level, measured in decibels (dB), which is 




Figure 1.5: A Humphrey Field Analyzer (source: The Melbourne Eye Centre: 
http://melbourneeyecentre.com.au/glaucoma/diagnosing-glaucoma/). 
 
Generally, clinicians use a standard 24-2 Swedish Interactive Threshold 
Algorithm (SITA standard 24-2) to detect and monitor glaucoma.  This test 
measures 24° temporally, and 30° nasally of the fixation point. The HFA 
compares the patient’s responses to white-on-white light stimuli with an age-
matched normative database and any reductions in sensitivity indicate a VF 
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defect in that location.  A mean sensitivity of 30-35dB is generally considered 
normal. Information generated during VF testing is summarised using a series 
of metrics, which are reported on the output generated by the machine (see 
Figure 1.7). The HFA produces a greyscale image of the entire field where 
darker spots indicate less light perception. This greyscale image is useful for 
observing patterns of loss, and can be used to differentiate between conditions 
like COAG (where patches of the field will be progressively darker) and 
neurological disease (where entire quadrants of the field will appear black) 
(Yaqub, 2012). Additionally, the greyscale can be used by clinicians to explain 
glaucomatous loss to the patient and has been incorporated into patient 
education materials (Crabb, 2016, see Figure 1.6). 
 
Figure 1.6: Screenshots of the ‘Glaucoma in Perspective’ app (Glaucoma in 
Perspective UK on the App Store, 2019), which incorporates the HFA greyscale in 
order to demonstrate the subtle effects of COAG vision loss to patients (source: 
Crabb, 2016).  
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The HFA subsequently produces a pattern deviation plot, used to calculate 
pattern standard deviation (PSD). The symbols on the bottom pattern deviation 
plot show point by point information which identifies if the value falls outside 
normative limits, / for example, a value of <1% demonstrates that less than 1% 
of the ‘normal’ population would display a value worse than the test eye. PSD is 
the standard deviation (SD) of the difference between the measured threshold 
and the threshold value in the normative database. PSD helps account for 
reduced vision due to cataract or uncorrected refractive error. 
The total deviation plot shows the difference in sensitivity (in dB) between the 
patient and the ‘normal’ values from age-matched controls. A value of 0 
indicates no deviation from the norm, whereas a minus value indicates that the 
light sensitivity in that location is poorer than expected. The total deviation plot 
is used to calculate the mean deviation (MD). The MD value represents the 
average variation across the field from a normative database, for example, an 
MD of -9.74dB for this patient represents a VF defect that is 9.74dB below that 
of age-matched controls. MD is perhaps the most important of the global indices 
produced by the HFA. MD in the better eye is strongly linked to visual function, 
QoL and limitations in activity at all stages of the COAG disease process (Crabb, 
Fitzke, & Hitchings, 2004; Alqudah, Mansberger, Gardiner, & Demirel, 2016; 
Saunders, Russell, & Kirwan, 2014) and is therefore considered to be a reliable 
indicator of disease severity in COAG patients. Older criterion for staging the 
severity of COAG, often categorise severity of COAG vision loss using a mixture 
of MD and PSD data but recent studies demonstrate that MD is a better 
predictor of vision-related QoL and visual function (Alqudah, Mansberger, 
Gardiner, & Demirel, 2016) and is also correlated to actual levels of RGC loss 
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(Medeiros, Zangwill, Bowd, Mansouri, & Weinreb, 2012). The studies in this 
thesis use MD as a surrogate measure of visual function. 
 
Figure 1.7: An anonymised HFA output portraying a visual field from a left eye 
using the SITA standard 24-2 algorithm. The greyscale image is outlined in red. 
The total deviation and pattern deviation plots are outlined in yellow. The MD and 






1.2.5 Visual Acuity 
 
Visual acuity (VA) is another commonly used method of assessing visual 
function in clinical practice (McClure et al, 2000). VA is an assessment of a 
person’s ability to perceive detail at high contrast (black stimuli on a white 
background). Typically, to test VA, the patient is placed at a fixed distance of 6 
metres from a chart and asked to read lines of letters which decrease in size. 
The smallest line which a person successfully reads is used to estimate their VA.  
The most commonly used form of assessing VA is the Snellen chart (see Figure 
1.8) which uses lines of letters which decrease in size. The patient is asked to sit 
6 metres from the chart and the smallest line of letters they are able to read is 
used as the denominator in the VA. The numerator represents the distance that 
the patient is at. A VA of 6/6 represents that the patient can see, at 6 metres, 
what the average eye can see at 6 metres. The denominator increases as the 
patient’s distance vision gets worse, so for example, a VA of 6/9 means that the 
patient can see, at 6 metres, what the average eye can see at 9 metres.  
The Snellen VA chart has several important limitations, such as crowding effects 
due to the proximity of the letters at the top of the chart being wider than the 
narrower spacing between letters at the bottom of the chart. LogMAR VA is 
more commonly used in research, and is the method used in the studies within 
this thesis. LogMAR VA is commonly measured using charts (see Figure 1.8) 
developed as part of the Early Treatment Diabetic Retinopathy Study (ETDRS) 
(Ferris et al, 1982). ETDRS charts, in comparison to Snellen, have equal 
numbers of letters per line, equal steps and spacing between lines and equal 
spacing between letters across the chart.  
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Although many patients with glaucoma have preserved VA, those with 
advanced COAG or a scotoma in a more central location often have decreased 
VA(Asoaka, 2013). Decreases in VA in COAG are associated with loss of 
functionality, such as when reading signs or using the telephone (Richman, 
Lorenzana, & Lankaranian, 2010). Decreased VA in COAG has also been linked 
with worse psychological functioning, including a deterioration in positive self-




Figure 1.8: Examples of an ETDRS chart (left) and a Snellen chart (right) used for 
measuring visual acuity. (source: left, https://www.precision-






1.3 Treating Glaucoma 
 
As IOP is the only modifiable risk factor for COAG (Crabb, 2016), treatment 
focuses largely on decreasing IOP relative to baseline measurements. In COAG 
patients, reducing IOP by 20-40% generally reduces the average rate of VF loss 
over the lifetime of the patient by half (Weinreb & Khaw, 2004). Most patients 
will start with self-administered eye drops which are designed to lower IOP. If 
eye drops are ineffective or not appropriate, laser treatments to the trabecular 
meshwork or surgical intervention may be offered instead(National Institute for 
Health and Care Excellence, 2017).  
1.3.1 Eye Drops 
 
The first line therapy for COAG is generally self-administered topical drops. The 
most common drops for COAG are prostaglandin analogue drops, which are 
designed to increase the outflow of aqueous humour, thus lowering IOP. 
Commonly prescribed prostaglandin analogues include latanoprost, 
bimatoprost and travaprost. Prostaglandins are the preferred treatment by 
doctors due to their high efficacy and remarkably good safety profile (Sambhara 
& Aref, 2014). They are generally also the preferred method of treatment for 
patients as they are not accompanied by systemic side effects and need only be 
administered once daily (Li, Chen, Zhou, Wei, & Yao, 2006). Localised side 
effects of prostaglandin drops include hyperaemia (excess blood vessels in the 
eye), lash changes and colour change in the iris.  
Beta-adrenergic agonists (beta-blockers), such as timolol, were once the first line 
therapy for COAG but are now often prescribed only as an adjunct to 
prostaglandins. Beta-blockers are generally administered twice daily and work 
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by decreasing the production of aqueous humour. Unlike prostaglandins, beta-
blockers come with systemic side effects such as decreased heart rate, dizziness 
and headaches. Psychological symptomology, such as depression, confusion, 
decreased libido and alterations in mood are also associated with beta-blockers. 
Moreover, these psychological symptoms are less likely to be reported to a 
healthcare professional and less likely to be recognised as a medication side 
effect by the patient, leading to possible underreporting of prevalence (Stamper, 
Wigginton, & Higginbotham, 2002). Beta blockers may also cause redness or 
stinging locally when administered.  
Alpha-2 adrenergic agonists, such as brimonidine, are generally administered 
twice daily but may sometimes be used three times a day. They attempt to 
lower the IOP through a combination of restricting aqueous production and 
promoting aqueous outflow. Alpha agonists are associated with many of the 
same systemic issues as beta-blockers, including fatigue, dizziness and a 
decreased heart rate. They may also be associated with worse localised 
symptoms, such as an increased risk of conjunctivitis and blepharitis (Sambhara 
& Aref, 2014).  
Carbonic anhydrase inhibitors (CAIs) are a class of hypotensive drop, which 
work by decreasing the production of aqueous humour. Examples of topical 
CAIs are brinzolamide and dorzolamide but sometimes oral CAIs such as 
acetazolamide are used. CAIs are generally administered three times a day and 
are associated with several side effects such as eye irritation, lethargy and 
depression. CAIs have also been associated with several very serious side 
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effects, such as Stevens - Johnson syndrome (a rare and often fatal skin 
condition) and choroidal detachment (Sambhara & Aref, 2014).  
Several newer classes of medicine such as rho-kinase inhibitors and fixed 
combination therapies have been trialled along with gene therapies and 
neuroprotective treatments, but these are infrequently used in clinical practice 
(Sambhara & Aref, 2014). The aim of these therapies is to reduce unwanted side 
effects in an effort to improve medication adherence. Estimates of non-
adherence to COAG therapy vary from 5-80% (Olthoff, Schouten, van de Borne, 
& Webers, 2005) but it is generally thought that ~30-50% of patients do not 
take their medication as prescribed (Wolfram, Stahlberg, & Pfeiffer, 2019; 
Newman-Casey, et al., 2015). The reasons why COAG patients do not take their 
medications are multifactorial and complex with researchers suggesting that 
side effects, difficulties with schedule, difficulties instilling drops, forgetfulness 
and decreased self-efficacy play major roles in non-adherence (Wolfram, 
Stahlberg, & Pfeiffer, 2019; Newman-Casey, et al., 2015). The possible reasons 
for non-adherence and factors which may improve adherence are discussed in 
more detail later in Chapter One. 
1.3.2 Laser Treatment 
A number of laser treatment options are available for COAG patients, and these 
are becoming increasingly popular. Selective laser trabeculoplasty (SLT) involves 
a small laser which is directed at the trabecular meshwork. SLT is slightly 
preferable to the previously widespread Argon laser trabeculoplasty (ALT) due 
to its ability to target only cells in need of treatment (melanin pigment in the 
trabecular meshwork). The aim of both SLT and ALT is to increase aqueous 
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outflow, and both have been shown to be equally effective at lowering IOP at 1-
year follow-up (Damji, et al., 2006). Due to its safety and long-term efficacy, as 
well as the low risk of side effects, SLT is becoming a popular treatment option 
for COAG. SLT benefits from often being a one-time intervention, which reduces 
the need for patients to be reliant on drop therapies. A large multi-centre 
randomised control trial (the LiGHT trial) has recently suggested that SLT 
should be offered as first line treatment for COAG, as it may be more cost 
effective in the long term and would lead to a reduction in the problem of non-
adherence (Gazzard, et al., 2019). Although there is currently no evidence on 
long-term visual function from the LiGHT trial, studies in other neurological 
illnesses have argued that offering more aggressive measures earlier in the 
disease process may improve patients’ functional outcomes (Batcheller & 
Baker, 2019).   
1.3.3 Surgical Intervention 
Surgical interventions for COAG are usually offered as the last line of treatment 
for COAG after laser and drop therapies have not achieved the desired reduction 
in IOP. They are occasionally offered to patients with severe glaucomatous 
damage on presentation as a form of emergency treatment (National Institute 
for Health and Care Excellence, 2017). The most common surgical intervention 
for COAG is a trabeculectomy, where a small incision is made in the trabecular 
meshwork to create an artificial drainage route for the aqueous humour. 
Trabeculectomy has a high long-term success rate, with around 80% of 
surgeries deemed successful at 5-year follow-up (Wilensky & Chen, 1996). 
However, as is the case with most incisive surgeries, trabeculectomy patients 
may suffer post-operative scarring which reduces the efficacy of the artificial 
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outflow system and may lead to the need for the surgery to be repeated. In 
order to avoid this complication, anti-scarring agents such as Mitomycin C and 
antivascular endothelial growth factor (anti-VEGF) may be used during or after 
surgery (Khaw, et al., 1992; Pozarowska & Pozarowski, 2016). However, it has 
been demonstrated that the repeated use of anti-VEGF therapies post-
trabeculectomy may lead to an increase in IOP and the long-term implications 
of anti-VEGF therapies are yet to be established (Slabaugh & Salim, 2017). 
There are several minimally invasive glaucoma surgeries (MIGS) which attempt 
to perform the same role as a trabeculectomy using a less aggressive approach. 
These methods include trabecular micro-bypass stent insertion, canalicular 
scaffolding and gel and tube implantation. However, MIGS are relatively new 
and the long-term efficacy, cost effectiveness and impact on patient QoL are yet 
to be established (Kerr, Wang, & Barton, 2017). 
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1.4  Understanding Visual Disability in Glaucoma 
 
In health psychological literature, the terms ‘chronic disease’ and ‘chronic 
illness’ have distinct definitions despite being used interchangeably in generic 
discussions (Martin, 2007). The term chronic disease refers to the clinical 
aspects of long-term disease, such as the aetiology (cause or set of causes), 
pathophysiology (the process of harm of the disease), signs, symptoms and 
treatment. This term may refer to communicable diseases such as HIV/AIDS 
and non-communicable diseases, such as diabetes or heart disease (Bernell & 
Howard, 2016). Chronic illness, on the other hand, refers to the lived 
experience of long-term disease. For example, the experience of taking a 
treatment daily and having routine appointments at the hospital. It is often the 
case that this lived experience is not recognised by healthcare systems, perhaps 
because lived experiences are harder to quantify than disease progression 
(Martin, 2007). This is generally the case in ophthalmic clinical practice, allying 
the healthcare system with an outdated medical model of disability. The patient 
is viewed only in terms of their medical status and the disability caused by that 
medical status is something a medical professional must treat and make normal 
(Brisenden, 1986). Due to this approach, a considerable portion of the 
assessment of the impact of COAG is based on ‘visual disability. This is how 
clinical measurements such as VF translate to the performance of everyday 
tasks, which are guided by vision (Crabb, 2016). 
1.4.1 Aspects of Visual Disability in Glaucoma 
It is, of course, important to study the extent of physical impairment in COAG, 
and studies are numerous. COAG has been shown to affect many vision-related 
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activities of daily living, such as mobility, driving, searching for items, 
recognising faces, and reading.  
Mobility 
Mobility is often viewed as the most important aspect of visual disability since it 
is an essential component in maintaining an independent lifestyle. Reduction in 
mobility can have very serious consequences for patients, such as a reduced 
QoL and an increased reliance on others (Fenwick, et al., 2016). Mobility 
problems in COAG may manifest as slower walking speed, an increased 
incidence of bumping into things/problems with orientation or an increase in 
falls (Ramulu, 2009; Turano, Rubin, & Quigley, 1999). Mobility problems are 
more common in those who have bilateral VF loss.  
Due to the increased mobility problems in COAG, a higher level of mental effort 
for patients to retain normal mobility is required, particularly as loss in the VF 
increases. It has been demonstrated that higher mental effort was exuded by 
COAG patients when they were faced with situations such as an area with high 
pedestrian traffic or a narrow hallway when compared with tasks such as 
climbing a staircase (Geruschat & Turano, 2007). This is supported by work 
from Goldberg et al. (2009) which showed that patients feel significantly more 
compromised when performing outdoor activities than activities within the 
home (Goldberg, et al., 2009). Perhaps for this reason, patients with COAG may 
be less likely to engage in physical activities, such as walking, especially patients 
with more severe VF loss (Ramulu, et al., 2012). This has implications for a 
patients overall health, as limitations in physical activity and a sedentary 
lifestyle have been linked to the development of conditions such as heart 
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disease, obesity and Type 2 diabetes (Carnethon, 2009; Hu, 2003). In other 
chronic disease, sedentary behaviour and limitations of physical activity are 
also associated with reductions in QoL (Hartman, et al., 2017). 
Recognising objects and faces 
There is a great deal of evidence that patients with COAG have difficulty with 
recognising objects in their environment such as faces, and particular objects 
when performing visual search tasks (Nelson, Aspinall, Papasouliotis, Worton, & 
O'Brien, 2003; Glen, Smith, & Crabb, 2013). Recognising faces and performing 
visual search tasks are done regularly, perhaps the most regular stimuli that a 
patient may encounter in their environment.   
Patients with COAG are likely to find visual search tasks harder, and spend more 
time searching for an object. There is a strong relationship between the severity 
of VF loss and performance on visual search tasks (Altangerel, Spaeth, & 
Steinmann, 2006; Smith, Crabb, & Garway-Heath, 2011). There is also evidence 
that patients with worse vision fare worse when recognising faces (Glen, Crabb, 
Smith, Burton, & Garway-Heath, 2012), and they tend to make more frequent 
and larger eye movements (Glen, Smith, & Crabb, 2013). Difficulty recognising 
faces can cause distress in patients with COAG (Glen & Crabb, 2015) and has 
been linked to reductions in lifestyle and wellbeing in other eye disease 
(Tejeria, Harper, Artes, & Dickinson, 2002; Hassell, Lamoureux, & Keeffe, 2006; 





In addition to impaired face and object recognition and mobility problems, 
patients with COAG are likely to lose their driving license as their vision loss 
progresses. In fact, around a third of COAG patients with binocular VF loss 
would fail the fitness to drive test (Crabb, Fitzke, & Hitchings, 2004). Drivers 
with COAG who have not lost their license have been shown to be less safe 
(make more errors), despite rating themselves as safe as a control group 
(Wood, Black, Mallon, Thomas, & Owsley, 2016). Patients with COAG who are 
unable to drive have a worse vision-related Quality of Life, and this may be due 
to a loss of independence and a reliance on family members/friends in order to 
get around (Medeiros, et al., 2015). Assessments of Quality of Life in COAG are 
increasing in popularity but are still minimal in comparison to other eye 
diseases or other chronic disease in general (Glen, Crabb, & Garway-Heath, 
2011). 
1.4.2 Quality of Life in Glaucoma 
Quality of Life (QoL) has been ill-defined in the literature, but the World Health 
Organisation (WHO) defines it as the difference between a person’s goals, 
expectations, standards and concerns and their position in life in relation to the 
context and value system in which they live (Division of Mental Health and 
Prevention of Substance Abuse, 1997). Measures of QoL often fall short of this 
holistic definition and are generally designed to be specific to the illness or 
setting in which they will be administered. For example, QoL evaluations for 
patients with breast cancer often include mostly assessments of sexuality and 
42 
 
body image, whereas assessments of QoL in COAG focus more on how satisfied 
an individual is with their visual ability (Aaronson, 1988; Asaoka, et al., 2011) 
Vision-specific or glaucoma-specific QoL measures are widely used in 
ophthalmic research and provide a good assessment of ocular symptoms and 
specific difficulties with vision-related tasks. An example of a widely used 
vision-specific QoL measure is the National Eye Institute visual functioning 
questionnaire (NEI VFQ-25). The NEI VFQ-25 is a useful measure for 
determining vision-related QoL as it encompasses questions about role 
limitations (Are you limited in the kinds of things you can do because of your 
vision?) and wellbeing (I am often irritable because of my eyesight) as well as 
assessing the patient’s ability to complete vision-specific tasks (because of your 
eyesight, how much difficulty do you have recognising people you know from 
across the room?). Research has shown that the NEI VFQ-25 is a reliable 
measure for assessing change in vision-related QoL with worsening VF 
(Medeiros, et al., 2015).  
However, it has been demonstrated that ophthalmologists in clinical practice 
frequently underestimate the extent to which vision loss impacts the patient’s 
wellbeing (Brown, Brown, & Sharma, 2000). This may be due to an over-
reliance on vision specific QoL measures which largely fail to account for 
emotional response to the illness and individual adaptation and coping 
strategies. Clinicians may also rely heavily on how clinical measurements such 
as VF relate to the patient’s ability to perform certain daily activities. However, 
people with similar levels of vision loss and similar vision-related QoL may 
experience their COAG very differently, particularly when we consider the full 
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definition of QoL, which posits that the individuals ’position in life’ as well as the 
context and value system which they are a part of must be considered. This is 
thought to be based on differing expectations of health and of life (Carr, Gibson, 
& Robinson, 2001).    
Perhaps then it would be more appropriate to utilise a more generic measure of 
QoL in relation to COAG in order to capture non vision-related aspects of the 
illness. This may be useful in older patients where poor vision is unlikely to be 
the sole illness impacting QoL (Banerjee, 2015). One example of a generic QoL 
measure is the EQ-5D-3L, which is a commonly used general health PROM and 
is approved in the United Kingdom (UK) by the National Institute for Health and 
Care Excellence (NICE) as a general health measure for health economic 
analysis. Five items are scored either 1 (no problems), 2 (some problems) or 3 
(severe problems) on the domains of mobility, self-care, usual activities, 
pain/discomfort and anxiety/depression. The scores are then translated into an 
index score ranging from 1 (perfect health state) to -0.624 (worst health state) 
using an existing scoring system  (Devlin & Brooks, 2017). The EQ-5D-5L uses 
the same domains but is scored on a five point, rather than a three-point Likert 
scale. Index scores on the EQ-5D-5L range from a perfect health state of 1 to a 
worst health state of -0.594 (van Hout & Janssen, 2012). The EQ-5D may be a 
particularly useful instrument in assessing QoL in older people. In glaucoma, it 
is sensitive enough to distinguish between groups of patients with different 
disease severities and it has been demonstrated that index scores decrease with 
worsening disease. Decreased VA in glaucoma is also associated with EQ-5D 
score and this is particularly pronounced on the domains of mobility, self-care 
and anxiety/depression (Longworth, et al., 2014). In other neurological disease, 
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EQ-5D index scores have also been used to distinguish between patients with 
and without depression, falls and postural instability (Schrag, Selai, Jahanshahi, 
& Quinn, 2000). Using generic QoL measures means that although we may ‘lose 
out’ on some of the nuances which can be identified through vision specific QoL 
measures, we may be capturing a fuller picture of impairment on an individual 
level. The studies presented within this thesis therefore utilise the EQ-5D as a 




1.5 Cognitive, Emotional and Behavioural Response to 
Glaucoma 
 
Quality of Life is one way to measure the experience of illness but it is unlikely 
that we can fully capture the experience of chronic illness without accounting 
for the cognitive, emotional and behavioural processes that take place in 
adapting to and maintaining ill health. These processes inform patient 
behaviour and individual goals, expectations, standards, and concerns, which 
may develop and change over course of the illness. The most meaningful way to 
capture these processes may be by investigating COAG through the lens of 
health psychological models of chronic illness.  
1.5.1 Health Psychological Models of Chronic Illness 
 
When considering which model to use as a theoretical research framework, it is 
important to consider the validity of the constructs (the extent to which they 
correspond to the real world), and the reliability of the model (the extent to 
which results from previous studies yield consistent results), as well as the 
comprehensiveness of the constructs themselves in terms of explaining health.  
The Health Belief Model (HBM) consists of six interrelated constructs: 
perceived susceptibility, severity, benefits, barriers, cues to action and self-
efficacy (a person’s belief in their abilities to succeed in a specific situation or 
task (Bandura & Adams, 1977)). These constructs are used to predict the 
likelihood of health behaviours, such as uptake of screening programmes  
(Marmarà, Maramarà, & Hubbard, 2017). The HBM has been useful in 
attempting to explain certain health behaviours in COAG, such as medication 
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adherence (Newman-Casey, Weizer, Heisler, Lee, & Stein, 2013). In fact, the 
HBM was used as a theoretical framework in the creation of the Glaucoma 
Treatment Compliance and Assessment Tool (GTCAT). The GTCAT aims to 
measure perceived severity, perceived benefits, medication and control self-
efficacy, perceived barriers and knowledge about glaucoma and has good 
internal reliability (Barker, Cook, Kahook, Kammer, & Mansberger, 2013). 
However, subsequent research with the GTCAT found that only some factors 
(white race, older age and being married) were actually predictive of adherence 
to medication (Barker, et al., 2015). suggesting limited usefulness of this model 
in explaining adaptation to COAG. One reason for this is that the HBM was 
proposed solely to explain the uptake of preventative health behaviours 
(Laranjo, 2016). Patients with COAG already have a diagnosis, so it can be 
argued that health behaviours in COAG are dictated more by maintenance of the 
condition, rather than being a preventative action.   
Other models of health behaviour consider illness as a more dynamic 
experience, where there is a process of adaptation involving biological, 
psychological and societal factors. For example, the transactional model of 
stress and coping suggests that health behaviours are determined by a constant 
appraisal process, which is split into two systems  (Hale, Treharne, & Kitas, 
2007). The first is the primary appraisal system, responsible for processing the 
initial stress/threat level (for example, the diagnosis of disease). Furthermore, 
it determins whether the level is negative, neutral or positive, based on its 
perceived severity and cause and the person’s motivation to act. (Figure 1.9). 
The secondary appraisal system involves a self-evaluation of coping abilities 
and resources for dealing with the stress/threat, such as the person’s perceived 
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control over their emotions and their self-efficacy. The model suggests that 
coping behaviours are formed as a reaction to the perceived seriousness of the 
threat. These coping behaviours can be moderated by societal factors, such as 
social support, and emotional factors, such as emotional regulation. The coping 
behaviours in turn inform the outcomes experienced (the level of positive 
adaptation), including socioemotional outcomes, such as emotional wellbeing. 
The patient is then able to revise their goals based on these outcomes.   
 
Figure 1.9: The Transactional Model of Stress (source: http://www.med-
upenn.edu/hbhe4/part3-ch10-theory-overview-shtml).  
The transactional model has the advantage of accounting for individual 
differences, such as a person’s cultural and socioeconomic background but it 
does not sufficiently account for the development of affective responses to the 
illness, suggesting that emotional factors only play a mediating role in 
behaviours  (Hale, Treharne, & Kitas, 2007).   
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The Common Sense Model of Illness Representations (CSM), in contrast, 
provides an explanation of how cognitive and emotional factors influence 
adaptation to chronic illness (Leventhal, Brissette, Leventhal, Cameron, & 
Leventhal, 2003; Leventhal, Meyer, Nerenz, & Rachman, 1980). The CSM 
suggests that patients use an appraisal system to constantly re-frame their 
illness representations and behaviours based on both internal feedback (e.g. 
emotional outcomes) and external feedback (e.g. health outcomes) (see Figure 
1.10).  
 
Figure 1.10: The common-sense model of illness representations (Source: 
Heffernan, Coulson, Henshaw, & Barry, 2016). 
According to the CSM, individuals with a chronic illness form a set of cognitive 
representations surrounding their illness. These representations are formed 
along the domains of identity, consequences, cause, timeline and control/cure 
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(Leventhal, Brissette, Leventhal, Cameron, & Leventhal, 2003). In a parallel 
process, individuals also form emotional representations of their illness, which 
are affective reactions to their illness. These reactions may include depression, 
anxiety, fear or worry (Moss-Morris, et al., 2002). The cognitive and emotional 
representations that are formed dictate the coping mechanisms or strategies 
that are adopted by the patient. Coping strategies can be adaptive (seeking 
support, cognitive restructuring, problem-focused coping) or maladaptive 
(emotional numbing, escape, intrusive thoughts, rumination) (Thompson, et al., 
2010). These coping strategies influence both clinical and emotional outcomes. 
The resulting outcomes lead to an individual’s appraisal of the efficacy of their 
coping mechanisms, which in turn leads to a change in the cognitive and 
emotional representations held by the patient (Hagger & Orbell, 2003). 
The aim of the following literature review is to provide a narrative account of 
studies related to the CSM to allow for a deeper understanding of the concepts 
discussed in the chapters of this thesis. For further systematic evaluations of 
CSM, please refer to the systematic reviews discussed within this section. 
Specifically, Weinman, Petrie, Moss-Morris, and Horne (1996), Moss-Morris, et 
al. (2002) and Broadbent, Petrie, and Main (2006) have systematically 
evaluated the CSM in terms of its validity and reliability.  
1.5.2 Cognitive response 
 
Cognitive representations of illness have been shown to be important to overall 
acceptance of the diagnosis and the development of adaptive coping strategies 
(Clare, Quinn, Jones, & Woods, 2016). Positive appraisal of illness 
representations has been linked to better long term outcomes, such as 
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improvements in self-care and patient engagement with healthcare services 
(Baker & Stern, 1993; Lorig & Holman, 2003). The opposite also appears to be 
true. negative framing of illness representations and poor adaptation can lead 
to worse outcomes in patients with chronic illness (Frostholm, et al., 2007). A 
recent review of 31 studies on illness representations found that the majority 
showed positive or favourable illness representations were associated with 
better health outcomes. It also found that negative or unfavourable 
representations were associated with worse outcomes, highlighting the 
reliability of the CSM domains in predicting outcomes across a range of health 
conditions (Sawyer, Harris, & Koening, 2019). Furthermore, research evidence 
has demonstrated consistent findings across five important interrelating 
dimensions.  
Identity 
Illness identity is the label or name given to an illness and the symptoms that 
are attributed to it. A strong illness identity can help the patient to legitimise the 
illness and make sense of it (Hale, Treharne, & Kitas, 2007). Identity becomes 
particularly important in diseases where the symptoms are not ‘stable’ because 
there is a chance that diverse symptoms which are unrelated to the illness may 
also be attributed to it (Meyer, Leventhal, & Gutmann, 1985). In a relatively 
asymptomatic disease like COAG, patients may attribute side effects of eye drop 
medications (such as redness) as side effects of their COAG (Nordmann, 
Auzanneau, Ricard, & Berdeaux, 2003). Patients who have variable symptoms 
may not engage with treatment opportunities as well as those who have a 
concrete illness identity (Hemphill, Stephens, Rook, Franks, & Salem, 2013). 
Recent qualitative investigations of illness representations in COAG patients 
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have revealed that those without strong illness identity are more likely to have 
poor medication adherence (McDonald, Ferguson, Hagger, Foss, & King, 2019). 
Cause 
Perception of the cause of an illness may play an important role in shaping a 
patient’s engagement with healthcare professionals and their self-identity. It 
has been suggested that patients who feel their illness is a consequence of their 
own behaviours are less likely to report to healthcare professionals, but will 
show more effective self-management behaviours than those who attribute 
their illness to something external (Turnquist, Harvey, & Andersen, 1988). 
Research in patients with depression has also demonstrated that those who 
hold religious causal beliefs were less likely to engage with treatment 
effectively (Caplan & Whittemore, 2013). The causes of COAG are not well 
understood, and whilst high intraocular pressure provides an explanation for 
some patients, up to 50% of glaucoma is idiopathic (meaning it does not have an 
obvious cause) (Bell & O'Brien, 1997). In other disease where the origin is 
unclear, causal beliefs are important for determining outcomes. For example, 
idiopathic Parkinson’s disease patients who held externalised causal beliefs 
(medication, other disease) perceived their illness to be more controllable than 
those who felt their disease was a random occurrence and displayed more 
adaptive coping strategies (Delaney, Simpson, & Leroi, 2011). 
Timeline  
Timeline beliefs, or the expected duration of the illness or its symptoms are key 
to determining illness behaviours and outcomes. Quantitative studies on illness 
representations have highlighted that patients who believe their illness to be an 
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acute condition, for example, are more likely to abandon their treatment 
programmes earlier than those who view their illness as chronic (Petrie & 
Weinman, 2006). The relationship between timeline beliefs and engagement 
with healthcare services is also mediated by the symptom timeline. Those with 
variable symptoms, despite viewing their illness as long-term, are more likely to 
disengage with treatment opportunities (Hemphill, Stephens, Rook, Franks, & 
Salem, 2013). It has been demonstrated that patients often have difficulties 
comprehending the long-term nature of chronic illness, leading to the 
development of maladaptive coping strategies, such as only believing they had 
the illness when exhibiting symptoms (Halm, Mora, & Leventhal, 2006). This 
has been coined the ‘no symptoms, no asthma’ belief, and may be particularly 
relevant for patients with COAG, where the condition is usually asymptomatic. 
This may explain that as many as 22-25% of patients already have advanced 
vision loss when they see an eye specialist for the first time (Crabb, Saunders, & 
Edwards, 2017). It is likely that the ‘no symptoms, no asthma’ belief is a 
maladaptive coping mechanism meant to shield the patient from negative 
emotional representations such as anxiety and depression, which can be 
associated with the belief that an illness will last a long time (Scharloo, et al., 
1999; Llewellyn, McGurk, & Weinman, 2007).  
Consequences 
Consequence beliefs refer to the perceived impact of the disease, both 
physically and psychosocially. Previous qualitative research on illness 
representations in COAG has demonstrated that consequence beliefs may be 
thought of along these two axes (McDonald, Ferguson, Hagger, Foss, & King, 
2019). Patients identified that practical (physical) consequences of COAG 
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included a reduced ability to go out/travel, see friends, tend to their garden, 
read or drive. These beliefs closely reflect what we know of the actual 
consequences of COAG (Crabb, 2016). Emotional (psychosocial) consequences 
that were identified included depression, concern/worry and loss of confidence, 
however, more than half of the patients in the study reported no emotional 
consequences from their COAG (McDonald, Ferguson, Hagger, Foss, & King, 
2019). Fear of blindness is a well-documented consequential belief in COAG 
patients, with around 34% of newly diagnosed patients reporting a fear of 
blindness falling to 11% of patients at a five-year follow up (Janz, et al., 2007). 
This is further supported by qualitative evidence that suggests initial fear of 
blindness is replaced by a more reasoned perspective over time (Glen & Crabb, 
2015). The aforementioned research does not look specifically at illness 
representations but does highlight the relative importance of understanding the 
patient’s cognitive and emotional reaction to illness. The patient must view 
their illness as serious enough to warrant intervention or treatment, as those 
who have unfavourable consequence beliefs (e.g. the consequences of my illness 
are not serious) may not engage with treatment opportunities (Seamark, Blake, 
& Seamark, 2004; Mann, Ponieman, Leventhal, & Halm, 2009). 
Control  
Control beliefs have been identified by several studies as one of the strongest 
predictors of illness behaviour. Patients who feel that they can exert control 
over their illness more effectively are more likely to have a strong illness 
identity (Pierce, Kostova, & Dirks, 2003). Patients who hold unfavourable 
control beliefs, such as having no control over their illness and their illness 
being incurable tend to fare worst on dimensions of both physical and 
54 
 
psychological (Heijmans, 1998; Falvo, 2005). These patients are the ones that 
tend to employ more passive or maladaptive coping strategies. It has been 
suggested that patients with chronic illnesses may revert to a more dependent 
and passive state if they are unable to exert control as limitations in 
independence occur (Falvo, 2005). In addition, patients who do not feel that 
medication provides them with control over their illness are less likely to follow 
treatment regimens, especially if they also feel that their condition is not long 
term  (Horne & Weinman, 2002; Rees, et al., 2014). This may be particularly 
important in COAG since it is incurable, and treatments may not halt disease 
progression entirely. There have been numerous studies which have indicated 
that beliefs about medicines, particularly that medicines will not help halt 
progression, are important for overall engagement with treatment regimens 
(Friedman, Hahn, & Gelb, 2008; Lacey, Cate, & Broadway, 2009; Tsai, McClure, 
Ramos, & Schlundt, 2003). One study demonstrated that improvements to 
control beliefs can be made through the use of individualised care planning for 
non-adherers in COAG patients (Gray, et al., 2012). 
Research has demonstrated that illness representations may be closely linked 
with the long-term risk of disability. A study in osteoarthritis patients 
demonstrated that illness representations at baseline were associated with 
higher self-reported functional impairment at 2-year follow-up. This study also 
demonstrated that most domains of illness representation changed over the 
study period, including more favourable timeline and identity beliefs, but less 
favourable control beliefs (Damman, et al., 2018),  
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The advantage of using the CSM to investigate the cognitive response to illness 
is that most studies have used a version of the Illness Perception Questionnaire 
The Illness Perception Questionnaire (IPQ) (Weinman, Petrie, Moss-Morris, & 
Horne, 1996), the Revised Illness Perception Questionnaire (Moss-Morris, et al., 
2002) and the Brief Illness Perception Questionnaire (Broadbent, Petrie, & 
Main, 2006) have been systematically evaluated in terms of their validity and 
reliability. It has been demonstrated that these measures have good predictive 
validity, the ability to predict scores on other measures and/or real life 
outcomes and good test-retest reliability, meaning that they yield consistent 
results across studies (Basu & Poole, 2016; Parfeni, Nistor, & Covic, 2013; 
Broadbent, Wilkes, & Koschwanez, 2015). There are a few studies which have 
considered illness representations in COAG as a predictor of medication 
adherence (Rees, Leong, Crowston, & Lamoureux, 2010; McDonald, Ferguson, 
Hagger, Foss, & King, 2019). Rees, Leong, Crowston and Lamoureux (2010), for 
example, found that scores on the Revised Illness Perception Questionnaire 
significantly predicted adherence to ocular hypotensive drugs in COAG patients. 
However, little is known about the formation of illness representations in COAG 
and how these may differ in patients in different stages of their illness. The 
measurement of cognitive illness representations in COAG using these tools is 
the main idea of the work presented in Chapter Two of this thesis.  
1.5.3 Emotional response 
The emotional response to chronic illness is often a complex process, and 
therefore may be commonly overlooked during routine clinical appointments 
(Turner & Kelly, 2000). However, it is important to consider because emotional 
responses influence coping strategies and subsequent clinical outcomes (Moss-
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Morris, et al., 2002). It is widely acknowledged that a diagnosis of chronic 
illness has a profound impact on the patient’s wellbeing, with a large number of 
patients developing anxiety and depression, amongst other negative emotions 
(Taylor & Aspinwall, 1996). The emotional response to chronic illness has been 
described along a spectrum of adaptive (expression and acknowledgement of 
emotions) and maladaptive (inhibition of emotions and avoidance) responses 
(de Ridder, Geenen, Kuijer, & van Middendorp, 2008). Previous research has 
demonstrated that the use of maladaptive coping strategies has been strongly 
linked to the latter. In patients with heart disease, the inhibition of emotions led 
to delays in health seeking behaviour (for example, going to the doctor when 
symptoms worsened), lower treatment adherence and poorer communication 
with healthcare providers (Wiebe & Korbel, 2003).  
The acknowledgement of negative emotions may lead to the development of 
more adaptive coping mechanisms because this provides the opportunity to 
focus on threat, which in turn elicits action, a process known as problem-
focused coping (Lutgendorf & Ullrich, 2002). It is thought that 
acknowledgement of negative emotions also contributes to habituation, 
whereby through writing, thinking or talking about the emotions, these 
emotions become a less intense and invasive experience (de Ridder, Geenen, 
Kuijer, & van Middendorp, 2008). In terms of illness behaviours, expression of 
emotions has been shown to contribute to lower levels of emotional distress, 
improvements to self-management behaviours and the creation of 
opportunities to engage with social support (Mann, et al., 2004; Austenfeld & 
Stanton, 2004).   
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A systematic literature review on older adults with visual impairments 
suggested that the emotional response to vision loss is often negative, 
particularly at the point of diagnosis (Nyman, Dibb, Victor, & Gosney, 2012). 
These findings are supported by evidence that COAG patients, in particular, 
have higher than normal levels of anxiety and depression (Mabuchi, et al., 
2008). Some interesting qualitative observations about emotional 
representations at the point of diagnosis in COAG have been revealed in 
research involving interviews with patients (Hartmann & Rhee, 2006; Lacey, 
Cate, & Broadway, 2009; Odberg, Jakobsen, Hultgren, & Halseide, 2001). For 
example, patients describe being ‘stunned’ by their diagnosis or feeling that it 
was, ‘an absolute blow’ (Hartmann & Rhee, 2006; Lacey, Cate, & Broadway, 
2009). Negative emotional responses in patients with poor vision have been 
shown to be associated with maladaptive coping responses, such as withdrawal 
from society or cessation of activities (Burmedi, Becker, Heyl, Wahl, & 
Himmselsbach, 2009; Glen & Crabb, 2015). However, COAG patients may also 
employ problem-focused coping strategies to deal with the potential emotional 
impact of their impairment, such as adjusting lighting or moving their heads in 
order to cope with their vision loss (Glen & Crabb, 2015).  
There is evidence that patients with sight loss may not always receive 
appropriate support to address or express the emotions associated with their 
condition (Gillespie-Gallery, Subramanian, & Conway, 2013). This could be 
associated with the perceived cost associated with provision of what is termed 
Eye Clinic Liaison Officers (ECLOs). ECLOs play a key role in ensuring that newly 
diagnosed patients understand their diagnosis and are provided with the 
appropriate emotional and practical support. They are also able to provide 
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ongoing support with emotional wellbeing and can act as an advocate for the 
patient should they need to access social care provisions. It is estimated that 
43% of ophthalmology services in England have no accredited ECLO service in 
place (RNIB, 2020). 
However, face to face support with emotional responses may not be necessary, 
as there is evidence that other methods such as the internet and telephone may 
also provide an effective method of expressing and receiving support for 
negative emotions (Brown, et al., 1999). This idea is explored further in 
Chapter Three. 
1.5.4 Behavioural response  
As it has been previously demonstrated, behavioural responses to chronic 
illness are influenced by the cognitive and emotional representations that a 
patient forms and holds about their illness. Behavioural responses are also a 
very strong predictor of clinical outcomes in chronic illness (Heijmans, 1998). 
In short, behavioural responses to chronic illness, much like the representations 
that form them, can be adaptive or maladaptive.  
Adaptive behavioural responses include searching for information about the 
illness, cognitive restructuring, engaging with social support and healthcare 
opportunities, and problem-focused coping strategies. Maladaptive responses 
include escapism, emotional numbing, intrusive thoughts, illicit substance use 
and rumination (Thompson, et al., 2010).  
One of the biggest criticisms of the CSM is that it does not explicitly account for 
the influence of self-efficacy on health behaviour. There is a great deal of 
evidence that behavioural responses to chronic illness are mediated by self-
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efficacy. Self-efficacy refers to a person’s perceived ability that they will be able 
to succeed in a specific situation or task (Bandura & Adams, 1977). In patients 
with chronic pain, perceived self-efficacy predicted the formation of adaptive 
coping behaviours, and this effect occurred independently of cognitive ideas 
about the consequences of the coping behaviours (Jensen, Turner, & Romano, 
1991). Higher self-reported self-efficacy scores were indicative of increased 
communication with caregivers, more involvement in treatment planning 
(partnership with clinicians), better self-advocacy and increased medication 
adherence in patients with chronic kidney disease (Curtin , et al., 2008). Self-
efficacy has also been linked to increased diet control, exercise and symptom 
monitoring in patients with Type 2 diabetes (Sarkar, Fisher, & Schillinger, 
2006). There is evidence that this relationship is bi-directional, patients who 
engage in self-management interventions also see improvements in self-efficacy 
(Lorig, Sobel, Ritter, Laurent, & Hobbs, 2001). However, more recent studies 
have demonstrated that cognitive representations of illness are strongly related 
to self-efficacy beliefs (Zelber-Sagi, et al., 2017). Being aware of this interaction 
is important, because it implies that enabling the patient to have the tools to 




1.6  Enabling the Patient in Glaucoma 
1.6.1 Self-management 
Self-management programmes based on encouraging appraisal and adaption of 
behaviours have been tested in patients with chronic illness, generally with 
good levels of success. Self-management refers to the process of the patient 
managing their own illness related behaviours (for example, through symptom 
monitoring) in order to maintain day-to-day functional status and lessen the 
impact of disease (Barlow, Wright, Sheasby, Turner, & Hainsworth, 2002).  
Evidence from randomised-control trials of self-management programmes 
suggests that teaching patients appropriate self-management skills leads to 
better outcomes, such as less hospital visits and a reduction in costs for 
healthcare providers (Bodenheimer, Lorig, & Holman, 2002). A study in COAG 
patients found that the development of effective medication self-management 
behaviours led to improvements in vision-related QoL (Wu, Xi, Xia, Lu, & Guo, 
2014). Further evidence from studies in the developing world suggests that 
behaviour change interventions that rely on self-management techniques, 
support patients with cardiovascular disease to engage with their own 
healthcare. Patients are informed of risk factors for disease progression, 
thereby informing their consequence illness beliefs (Piette, et al., 2015).  
However, deciphering the exact components of self-management interventions 
has proven to be tricky.  
A review of 223 studies on self-management interventions found no consistent 
format for interventions (Barlow, Wright, Sheasby, Turner, & Hainsworth, 
2002). Common formats included interventions for drug management 
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(medication adherence), symptom management (including symptom 
monitoring), lifestyle management, and anger, stress and depression 
management. Training interventions included decision making, goal setting, 
managing uncertainty, assertiveness training, communication with doctors, 
clinical decision making, accessing support (asking for help) and educational 
training (Barlow, Wright, Sheasby, Turner, & Hainsworth, 2002). An interesting 
finding from this review was that there was little difference in effectiveness 
between interventions that were led by healthcare professionals and 
interventions that were patient-led (Barlow, Wright, Sheasby, Turner, & 
Hainsworth, 2002). This may mean that a patient-led self-management 
intervention may be a feasible, cost-effective option which could improve 
outcomes, particularly emotional outcomes, in COAG patients. This idea is 
explored as part of a self-monitoring exercise piloted in Chapter Three.  
Another interesting note is that the review did not include any studies on self-
management interventions for people with visual impairment, but this is simply 
because it was published before any real attempt was made to investigate self-
management behaviours in these populations. Since that time, many papers 
have been published which have investigated the use of self-management 
interventions in patients with visual impairment (Newman-Casey, Weizer, 
Heisler, Lee, & Stein, 2013; Brody, et al., 2002). A randomised control trial with 
patients with age-related macular degeneration demonstrated that a self-
management intervention containing cognitive and behavioural components 
led to significant improvements in mood, emotional distress and self-efficacy 
scores over a 6-week period (Brody, et al., 2002). A review of studies of 
educational self-management interventions for improving medication 
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adherence for patients with glaucoma found that the most effective 
interventions combined cognitive training surrounding barriers to adherence 
with educational training on the condition (Newman-Casey, Weizer, Heisler, 
Lee, & Stein, 2013).  
1.6.2 Education 
Education is an important component of self-management interventions in 
glaucoma, but in terms of its ability to enable the patient, it must be discussed in 
its own right. It is widely acknowledged that educational background is one of 
the key demographic factors which determines the cognitive response to illness, 
and subsequent engagement with healthcare services and health behaviours 
(Feinstein, Sabates, Anderson, Sorhaindo, & Hammond, 2006). Condition 
specific education delivered by a healthcare provider can have a positive impact 
on illness representations, particularly in the formation of a concrete illness 
identity and on consequence and control beliefs (Peterson-Sweeney, et al., 
2007). 
However, it has been demonstrated that over half of patients now use the 
internet as an educational tool and this may have important implications 
(Rainie & Fox, 2000).  In COAG specifically, a number of online patient 





Figure 1.11: An image depicting glaucomatous vision loss (Source:  The London 
Eye Hospital: http://www.londoneyehospital.com/conditions/glaucoma/)  
However, research has challenged the traditional perception of glaucomatous 
VF loss as a ‘black tunnel’ and discovered that patients did not see their 
glaucoma as a tunnel effect at all, but rather as missing or blurred patches in 
their vision (Crabb, Smith, Glen, Burton, & Garway-Heath, 2013) (Figure 1.12). 
This misinformation could have huge implications because patients who do not 
associate their own vision with the image of a ‘black tunnel’ may be less likely to 
seek help from eye care professionals and may struggle with forming a concrete 
illness identity. It has been demonstrated in other conditions that patients who 
view their symptoms as ‘atypical’ when compared to societal beliefs about a 
condition presented to healthcare services later in the disease process 




Figure 1.12: Forced choice images used to assess perceived vision in COAG 
(Source: Crabb, Smith, Glen, Burton, & Garway-Heath, 2013).  
This problem is of course speculative, but it highlights the need for consistent 
post-diagnosis education for COAG patients. The study presented in Chapter 
Two therefore closely considers cognitive representations surrounding the 
understanding of COAG in this population.  
1.6.3 Integrated care 
 
Patient education and effective self-management are important tools for 
improving health outcomes, but they do not consider the wider context of the 
illness. Specifically, they may be ineffective tools for patients who are unable to 
monitor or assess their own illness behaviours and knowledge. There are many 
reasons why a patient may not be able to take full responsibility for their illness 
behaviours, but perhaps the most common is because of other health conditions 
becoming a barrier to effective management. Worldwide, around 65% of older 
adults (between the ages of 65 and 84) have more than one chronic illness 
(Banerjee, 2015) and the health consequences of this (termed multimorbidity) 
are not yet properly understood (Vogeli, et al., 2007). We do understand, 
however, that patients with diverse needs value having more input into clinical 
decision making (Mira, et al., 2013). Studies have therefore stressed the 
importance of what is termed integrated care. Integrated care models vary, but 
stakeholders may include the patient, the social support network (consisting 
primarily of informal caregivers (ICGs); friends and family members), 
healthcare providers and policy makers (Borgermans & Devroey, 2017).  
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Social support refers to actual or perceived support that the patient has with 
their condition (Reblin & Uchino, 2008). Social support given to patients to help 
with condition management by family members or friends is termed informal 
caregiving. There is evidence that adequate social support can benefit a patient 
in terms of both condition specific activities (taking medications appropriately) 
and general activities (self-care) (Sayera, Riegel, Pawlowski, Coyne, & Samaha, 
2008). Further evidence shows that patients with latter stage chronic disease 
who have adequate social support are less likely to suffer from psychological 
symptomology (Applebaum, et al., 2014). However, studies in patients with 
heart failure have found that caregivers, like patients, go through a process of 
‘learning to cope’ with the disease that relies on knowledge and the possible 
consequences, which are subject to the same problems as cognitive 
representations in patients (Kennedy, et al., 2017). This presents a problem 
because integrated care models rely on patients and their ICGs mastering a set 
of competencies that include making informed choices about care and 
medications and complying with agreed upon treatments (Borgermans & 
Devroey, 2017). Previous literature has highlighted the importance of ICGs 
providing emotional and informational support in 
patient/companion/physician consultations (triadic consultations). Specifically, 
ICGs may act as a memory aid, emotional support, elaborator, advocate, 
interpreter, company provider, or transcriber and play a key role in clinical 
decision making (Ellingson, 2002).  
Little is known about the role of ICGs in COAG management. Studies have 
demonstrated that family members of COAG patients with multi morbidities act 
as monitors for medication adherence, and seek intervention when medication 
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adherence decreases (Read, et al., 2018). Other research with ICGs for patients 
with COAG has shown ICGs had minimal levels of engagement with the 
condition and expressed concerns about the lack of patient education and the 
development of poor coping mechanisms as a result (Shtein, Newman-Casey, 
Herndon, Coleman, & Lee, 2016; Waisbourd, et al., 2016). This may reflect the 
fact that ICGs who are not given the correct support have been shown to 
experience exhaustion, problems with their own wellbeing and reduced levels 
of self-esteem (Van den Heuvel, de Witte, Schure, Sanderman, & Meyboom-de 
Jong, 2001). Due to their importance to models of integrated care, studying the 
experiences of ICGs for patients with COAG and the possible impact of their role 
is imperative, and this is the main idea of the works presented in Chapter Four 
and Chapter Five. 
1.7  Conclusion 
This review of the literature has demonstrated that the studies on the CSM have 
yielded valid and reliable results. These results provide a fairly comprehensive 
overview of the experience of chronic illness in diseases like Type 2 diabetes 
and cancer. Chronic open-angle glaucoma is a complex disease. Often without 
obvious cause or symptoms, it requires significant lifestyle changes on the part 
of the patient. Whilst some evidence exists on the role of cognition and emotion 
in adaptation to COAG as a chronic illness, most studies in the area focus solely 
on improving medication adherence. Whilst this is an important goal in 
improving lives for COAG patients, there is a distinct lack of research on the 
day-to-day lives on COAG patients and their families.         
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1.8 Rationale and Aims of Thesis 
 
In 2005, the UK Department of Health revealed that it would be shifting the 
focus of the NHS “to move from a service that does things to and for its patients to 
one which is patient-led, where the service works with patients to support them 
with their health needs”. For this to become a reality, patients and their families 
need to be in a position where they are aware of their health needs and able to 
confidently communicate those needs to clinicians/practitioners.  
The work in this thesis aims therefore to investigate the cognitive and 
emotional processes involved in adaptation to COAG as a chronic illness from 
the perspective of both the patient and their informal caregivers. Specifically, 
this thesis is organised as follows: 
• Chapter Two investigates illness representations using a standardised 
instrument (the Brief Illness Perceptions Questionnaire – BIPQ). This 
chapter will describe cognitive representations of illness in two different 
populations (newly diagnosed patients with COAG/OHT and patients 
with a historical diagnosis of COAG/OHT between 2 and 5 years) to 
investigate whether illness representations are different between these 
groups. The primary hypothesis of this study was that COAG patients 
who are newly diagnosed would have more unfavourable (negative) 
illness representations. A secondary aim of this study was to investigate 
differences in illness representations between patients with COAG and 
patients with OHT. 
• Chapter Three investigates the feasibility, in terms of self-advocacy and 
self-monitoring of behaviours, of a self-management intervention for 
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COAG patients. This intervention was delivered in the form of a web-
based diary tool which encompassed both quantitative and qualitative 
data collection. The quantitative data were used to investigate 
improvements in positive health behaviours such as symptom 
monitoring. The qualitative data were used to elucidate information 
regarding the emotional response to the illness. This study specifically 
tested the hypothesis that a group of volunteer patients with an 
established diagnosis (more than 2 years) would be sufficiently 
motivated to regularly self-report on their symptoms.  
• Chapter Four investigates the magnitude of informal caregiving (ICG) in 
COAG using a standardised instrument (Modified Caregiver Strain Index) 
and to place COAG on a spectrum of conditions to understand its impact 
on ICGs in the context of other well-studied disease. This data was 
collected using a postal survey of patients who self-identified an ICG. 
This study tested the hypothesis that measurable levels of caregiver 
strain exist in a sample of ICGs for patients with COAG.   
• Chapter Five uses focus groups to collect qualitative data on 
experiences of ICG in COAG. In the first group, patients and ICGs were 
invited to talk about their experiences of providing and receiving 
informal care. The second group consisted of patients without an ICG, 
who were invited to talk about their attitudes toward informal care and 
experience of COAG. Interpretative phenomenological analysis was used 
to compare experiences of the two groups in order to answer the 
research question; ‘What are the factors that form the experience of 
informal caregiving in COAG?’ 
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• Chapter Six provides a summary of the main findings of the work, 




Chapter Two – Illness Representations in Patients 
Newly Diagnosed with Glaucoma and Ocular 
Hypertension 
Formation and maintenance of cognitive illness representations is important for 
determining long-term outcomes in patients with chronic illnesses. 
Assessments of illness representations and how these relate to health 
behaviours have been investigated before in COAG. It has been demonstrated 
that illness representations, particularly beliefs about the effectiveness of 
treatment, are predictive of actual adherence to glaucoma medications (Rees, 
Leong, Crowston, & Lamoureux, 2010). To the author’s knowledge, there is 
currently no research that has attempted to quantify differences in illness 
representations at multiple time points in the disease process in COAG and how 
these differences may relate to worsening VF. The work presented in this 
chapter aimed to quantify illness perceptions in patients with COAG and OHT at 
diagnosis and at between 2-5 years since diagnosis. A comparison of these 
groups would be used to investigate whether illness representations differ, and 
whether the presence of VF loss is important for formation and maintenance of 
illness representations. It also considers general health and personality as 
factors, which potentially mediate differences in illness representations 
between groups. 
The work presented in this chapter formed a paper published in the British 
Journal of Ophthalmology (McDonald, et al., 2019); see list of supporting 
publications. The co-authors of this work are Trishal Boodhna (TB), Csilla 
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Ajtony (CA), Paula Turnbull (PT), Rupert Bourne (RB) and David Crabb (DC). TB 
gained ethical approval. Help with recruitment came from TB, CA, PT and RB. 
Data were collated and analysed by Leanne McDonald (LM). The paper was 
written by LM, reviewed by DC and approved by all co-authors. The work 
presented in this chapter has also been presented as a poster presentation at 
the Association for Research in Vision and Ophthalmology meeting (Seattle, WA, 
USA, 2016), as a poster presentation at the European Glaucoma Society 
congress (Prague, CZ, 2016), as an oral presentation at the United Kingdom and 
Éire Glaucoma Society Meeting (Cheltenham, UK, 2016) and as an oral 
presentation at the British Congress of Optometry and Vision Science meeting 






Illness representations are feelings or beliefs that influence a person’s 
psychological response to their illness. These representations are, for example, 
associated with clinical outcomes, coping behaviours and adherence to 
treatment (Petrie, Jago, & Devcich, 2007; Chen, Tsai, & Chou, 2011). A 
substantial body of research on illness representations in chronic disease exists 
but studies in people with chronic open-angle glaucoma (COAG) and ocular 
hypertension (OHT) are uncommon (Rees, Leong, Crowston, & Lamoureux, 
2010; Friedman, Hahn, & Gelb, 2008; Saw, Gazzard, & Friedman , 2003; Gray, et 
al., 2012).  
Interesting observations about negative illness representations at the point of 
diagnosis have been revealed in patients with COAG (Hartmann & Rhee, 2006; 
Lacey, Cate, & Broadway, 2009). Some of this negativity is likely attributed to 
the fear of going blind (Jampel, et al., 2007; Janz, et al., 2001). Indeed, it has been 
shown that simply giving a diagnosis of COAG negatively affects measures of 
QoL (Jampel, et al., 2007; Odberg, Jakobsen, Hultgren, & Halseide, 2001). 
Interviews with patients with COAG reveal initial feelings of fear were replaced 
by a more reasoned perspective over time (Glen & Crabb, 2015); this seems 
reasonable given most treated patients will not suffer significant visual 
impairment in their lifetime (Saunders, Russell, & Kirwan, 2014; King, Azuara-
Blanco, & Tuulonen, 2013).  Perhaps a newly diagnosed patient may consider 
their condition will have a significant impact on them only to revise their view 
once they have the condition for a period of time; this has not been assessed in 
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people with COAG/OHT. A better understanding of this idea has clinically 
relevant implications about how ‘diagnosis’ of COAG/OHT should be handled 
and communicated. 
One way to examine illness representations in COAG would be to ask patients 
directly and subject the responses to qualitative analysis (Lacey, Cate, & 
Broadway, 2009; Glen & Crabb, 2015; McDonald, Ferguson, Hagger, Foss, & 
King, 2019). Alternatively, patient reported outcome measures (PROMs) have 
been used to quantify illness representations in chronic conditions (Broadbent, 
Wilkes, & Koschwanez, 2015; Pesut, Bursuc, & Bulajic, 2014).  Results from 
PROMs measuring illness representations have been linked to self-management 
behaviours, including attendence to follow-up appointments (Frostholm, et al., 
2007). They have also shown to be related to a decline in social and physical 
functioning in a variety of conditions (Scharloo, et al., 1998; French, Cooper, & 
Weinman, 2006). A widely used and validated PROM instrument is the Brief 
Illness Perception Questionnaire (BIPQ)) (Broadbent, Petrie, & Main, 2006; 
Broadbent, Wilkes, & Koschwanez, 2015). Therefore, in order to assess a 
patients’ illness representations, this study uses the BIPQ in conjunction with 
other PROMs of QoL and personality, along with a measure of patients’ visual 
function.  
The aim is to quantify illness representations in patients with COAG and OHT. 
The primary hypothesis of the study centres on newly diagnosed COAG and 
OHT patients having worse illness representations when compared to a group 
of patients who have lived with a diagnosis for more than two years. 
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2.2 Materials and Methods 
This was a cross-sectional study involving patients recruited from two clinical 
centres in England (Moorfields Eye Hospital NHS Foundation Trust (Bedford 
Hospital) and North West Anglia NHS Foundation Trust (Hinchingbrooke 
Hospital)). Newly diagnosed patients were introduced to the study at the end of 
the clinic visit where they were first diagnosed. For the purpose of simplicity, in 
the methods and results, these participants are referred to as cases. In addition, 
patients who had held a diagnosis of more than two years (but less than five 
years) were identified from an electronic patient record (EPR; Medisoft, Leeds, 
UK) used at the participating clinics. These participants will be referred to as 
controls.  
The study was approved by the North West - Liverpool East NHS Research and 
Ethics committee and it adhered to the tenets of the Declaration of Helsinki. All 
participants gave their informed written consent prior to taking part. Data were 
anonymised and stored securely. 
Study participants (> 40 years) had a diagnosis of COAG or OHT established by 
standard ophthalmic examination in the participating clinics. Participants were 
only included if they had no other ocular disease (except for previous 
uncomplicated cataract extraction) and a visual acuity of better than 0.3 
logMAR in each eye with astigmatism of less than 2 dioptres. All COAG 
participants had visual field (VF) loss in at least one eye as measured by a 
Humphrey Field Analyser (Carl Zeiss Meditec, Dublin, CA) using the Swedish 
Interactive Threshold Algorithm (Standard 24-2). Goldmann Applanation 
Tonometry was used to measure intraocular pressure.  
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Cases were identified by convenience sampling with an effort to select controls 
by ‘matching’ at a group level to age and VF severity (for COAG) to provide a 
representative cross section of patients. In other words, this allows for an age 
related and disease severity-related analysis. In the COAG groups, mean 
deviation (MD) in the least affected eye (the eye with the better MD) was used 
as a measure for disease severity (Saunders, Russell, & Kirwan, 2014). This was 
taken from the VF recorded in the EPR at the time of diagnosis (cases) or at the 
time closest to the date when a questionnaire pack was returned. Previous 
research suggests that the biggest changes to illness representations happen 
within the first two years of diagnosis, with negative emotional representations 
decreasing and illness coherence (understanding of the condition) increasing 
over that period (Lawson, Bundy, Belcher, & Harvey, 2013)  A 5 year follow up 
period is then used for most longitudinal studies (Bijsterbosch, et al., 2009; de 
Rooij, et al., 2018). This study therefore considered patients between two- and 
five-years post diagnosis as having sufficient diagnosis history. 
A questionnaire pack, including a participant information sheet and consent 
form, was given to participants at the end of their clinic visit and returned by 
post; controls received and returned packs by post. Questionnaire packs 
included three validated instruments designed to measure illness 
representations, general health, and personality type. 
[1] Brief Illness Perception Questionnaire (BIPQ) - The BIPQ has been 
widely used to investigate illness representations in chronic illness (Broadbent, 
Wilkes, & Koschwanez, 2015; Pesut, Bursuc, & Bulajic, 2014; Broadbent, Petrie, 
& Main, 2006). Eight items are scored on a 0-to-10 scale, with 80 representing 
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the most negative illness representations. An open-ended styled ninth item asks 
patients to list the three most important causal factors for their illness. The 
original version of the BIPQ uses the word ‘illness’ but this was replaced by 
‘glaucoma’ or ‘ocular hypertension’ for this study.  
[2] EQ-5D– The EQ-5D-3L (EuroQol, 1990) is a commonly used general health-
related QoL PROM and is approved in the United Kingdom (UK) by NICE as a 
general health measure for health economic analysis. The five items are scored 
accordingly: 1 (no problems), 2 (some problems) or 3 (severe problems) on the 
domains of mobility, self-care, usual activities, pain/discomfort and 
anxiety/depression. Codes were translated into an index score ranging from 1 
(perfect health state) to -0.624 (worst health state) using an existing scoring 
system (Devlin & Brooks, 2017).  
[3] Type D Scale personality questionnaire (DS14) – The DS14 is widely 
used to measure negative affect (e.g. general worry, gloom) and social inhibition 
(e.g. reticence, lack of self-assurance) (Denollet, 2000). This instrument has 
seven items for negative affect and social inhibition, respectively. Each item is 
scored from 0 (least distressed) to 4 (most distressed).  
Data analysis 
The primary hypothesis was that cases would have a worse average BIPQ when 
compared to controls. Sample size calculations (with power and statistical 
significance set at 80 and 5% respectively) were based on detecting a small 5-
point (out of 80) difference in overall mean BIPQ score between cases and 
controls. Using an estimate of standard deviation (SD) of mean scores of 7.5 
points from a previous study (Broadbent, Petrie, & Main, 2006) gave a 
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suggested minimum sample size of 28 participants per group, which was the 
recruitment target.   
Mean BIPQ score, age, best eye MD (BEMD), worse eye MD (WEMD), EQ-5D 
index score and DS14 were compared between cases and controls for the COAG 
and OHT groups. All individual data distributions were checked for normality. 
Univariate association between overall BIPQ against age, DS14 and EQ-5D index 
score was explored to assess covariance in the data. 
An average score from each of the eight separate BIPQ items was also compared 
between cases and controls for the COAG and OHT groups using Multivariate 
Analysis of Covariance (MANCOVA); this corrects for any covariance from age, 
DS14 and EQ-5D and is robust against multiple comparisons. A value of p<0.01 
was considered statistically significant to further reduce the possibility of a 
false positive result. The scores from the separate BIPQ items are not assumed 
to follow a normal distribution. Instead, residuals from the MANCOVA were 
examined for signs of non-normality to make sure the approach was valid. 
Item 9 of the BIPQ asked participants, ‘to list, in rank order, the three most 
important factors that you think caused your glaucoma/ocular hypertension’. 
Two authors (LM and DPC) independently coded the first written response into 
categories following a method described in previous research (Broadbent, 
Petrie, & Main, 2006). Any disagreements were arbitrated with a joint 
consultation by all authors and groupings of coded responses were assessed 
with descriptive statistics.  All statistical analyses were done with SPSS 




The recruitment period for the study ran from January to November 2015. 
Questionnaires were completed by 124 participants, with eight excluded due to 
incomplete consent or unreliable VFs. The final sample of participants (52% 
male) consisted of 58 cases and 58 controls. Participants were nearly all 
Caucasian (98%) with 93% educated to at least a high school level and 32% 
self-reporting degree-level or professional qualification. The majority of 
participants (77%) self-reported that they were married or in a committed 
relationship.  
COAG cases and controls were well related for age, BEMD, WEMD, and DS14 
(Table 2.1).  COAG controls had slightly worse average self-reported general 
health (EQ-5D) when compared to COAG cases (p=0.03). For OHT study groups 
the cases and controls were similar for age, EQ-5D and DS14. 
Table 2.1 – Mean (standard deviation) age, BEMD, WEMD, EQ-5D index and DS14 
for each of the four study groups.  






































  p=0.33 p=0.83 p=0.96 p=0.03 p=0.20  
OHT        
Case 28 63 
(10) 





Control 27 65 
(13) 









The mean (standard deviation; SD) BIPQ score for COAG cases and COAG 
controls was 31 [10] and 34 (13) respectively; these values were not 
significantly different (independent t-test; p=0.30). Similarly, mean (SD) BIPQ 
score for OHT cases (28 [11]) and OHT controls (28 [9]) were not significantly 
different (independent t-test; p=0.90). These results indicate that, on average, 
illness representations are similar in people newly diagnosed compared to 
those that have their diagnosis for at least two years. Moreover, averages for all 
four groups were not different (one–way ANOVA; p=0.46). Therefore, on 
average, overall illness representations in this sample of people with COAG and 
OHT are similar. 
There was no statistically significant association for BIPQ score against age 
(r=0.11; p=0.29). There was a weak but statistically significant univariate 
association for BIPQ against DS14 (r=0.26; p=0.01) and against EQ-5D (r=0.28, 
p=0.04), suggesting illness representations are marginally worsened by a 
distressed personality and worse general health.  
Estimated marginal means with 95% confidence interval (CI) give a sense of the 
distribution of scores for all eight individual BIPQ items (Table 2.2). 
Statistically significant differences between groups on each item are reported 
from a comparison of adjusted means using a MANCOVA adjusted for DS14 and 
EQ-5D scores. In this analysis, statistically significant effects occurred in four 
items in COAG patients. These average effects were all small in magnitude, 
mostly less than an average of 2 points on a 10-point scale.  The largest effect 
was for the item ‘how long do you think your COAG will last?’. In comparison to 
newly diagnosed patients, people with COAG for >2 years better understood 
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their condition would last for a ‘long time’. In comparison to newly diagnosed 
patients, people with COAG for >2 years feel slightly more affected by the 
condition and experienced more symptoms. The latter is interesting given 
disease severity in the two groups was similar on average. Perhaps surprisingly, 
newly diagnosed patients claim to understand their condition slightly better 
than those who have had COAG for >2 years. There were no statistically 
significant differences between cases and controls for people with OHT on any 
of the BIPQ items. 
Some of the average values for items (Table 2.2) are noteworthy. For example, 
most participants understood their COAG/ OHT is going to last forever but a 
number did not. There was also a wide response to the question about control 
over COAG/ OHT, particularly for the OHT patients, revealing that many 
participants felt they did not have good control over their condition.  
Table 2.2 – MANCOVA results for differences between COAG cases and controls, 
and OHT cases and controls for the eight items of the BIPQ. Mean scores (out of 
ten) shown are estimated (marginal) means and 95% confidence interval (CI), 
adjusted for DS14 and EQ-5D index scores. The p values marked with * denote a 
significance level of <0.01 






















































Case 4.5  
(3.1, 5.8) 



























































How well do 



















One hundred and six (91%) participants gave at least one written response to 
the open-ended item asking for the three most important causes (in rank order) 
for COAG/OHT. Where participants (n=46) gave more than one cause only the 
first written response in the list was considered. The summary of the coded 
responses, stratified by cases and controls, are shown in Table 2.3. Most cases 
(60%; 95% CI 45 to 74%) and controls (59%; 95% CI 45 to 72%) who 
completed item 9 correctly identified at least one known major risk factor 
(Coleman & Miglior, 2008). It is noteworthy that 5% (95% CI 1% to 11%) of 
control participants, despite living with their diagnosis >2 years actively wrote, 
“don’t know” when asked for the cause of their condition. The decision to 
analyse only first written response was based on the majority (73%) of second 
and third responses being “incorrect”. The majority of second and third ranked 
causes were related to lifestyle factors (reading and TV, work environment) or 
other ocular or non-ocular disease (thyroid, migraines, diabetes, contact lenses, 














0.05 Case 2.0 
(1.3, 2.7) 
0.39 
Control  3.1 
(2.3, 3.9) 





Table 2.3 – Frequency of first written response by group to Q9 of the BIPQ 
(Broadbent, Petrie, & Main, 2006), ‘Please list, in rank order, the three most 
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This cross-sectional study used an established method of measuring illness 
representations (Broadbent, Petrie, & Main, 2006) to investigate average 
differences between newly diagnosed COAG/OHT patients (cases) and those 
with a diagnosis of more than two years. Results indicate no difference in 
overall illness representations between the cases and those with a diagnosis of 
more than two years. Therefore, perhaps surprisingly, in this group of people, a 
new diagnosis of COAG/OHT does not precipitate a sudden development of 
negative illness representations when compared to other people who have lived 
with the condition for more than two years.  
These findings represent new knowledge about illness representations in 
people with COAG/OHT. For example, results suggest diagnosis may not be as 
distressing as previous studies have indicated (Hartmann & Rhee, 2006; Lacey, 
Cate, & Broadway, 2009; Odberg, Jakobsen, Hultgren, & Halseide, 2001). Overall 
illness representations of participants were, for example, similar to those from 
other studies that have used BIPQ to assess heart palpitations (Broadbent, 
Wilkes, & Koschwanez, 2015) or pre-treatment pulmonary tuberculosis (Pesut, 
Bursuc, & Bulajic, 2014). In contrast, scores were lower on average than those 
found in people with diabetes (Broadbent, Petrie, & Main, 2006). These 
comparisons allow illness representations of COAG/OHT to be placed on a 
spectrum of chronic disease, but it may not be meaningful because of 
differences in the type of study and study populations. For example, the present 
study used an independent groups design with matching, rather than following 
the same patients longitudinally. This presents an issue because the CSM 
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stresses that illness representations are formed on an individual level (Petrie, 
Jago, & Devcich, 2007). Whilst the present study provides good evidence that 
changes may occur, a longitudinal cohort study should be conducted in order to 
fully investigate the dynamic nature of illness representations in COAG.  
Secondary analysis of individual BIPQ items, when corrected for patient’s level 
of distressed personality (measured by DS14) and self-reported QoL (measured 
by EQ-5D) revealed interesting results. Unsurprisingly, newly diagnosed COAG 
patients held less realistic beliefs about their condition compared to people who 
had the diagnosis >2 years. Moreover, newly diagnosed COAG patients reported 
having less severe symptoms compared to those who had the diagnosis >2 
years, despite the two groups having similar average VF loss. In addition, COAG 
patients with a diagnosis for > 2 years had a more realistic perception of how 
long their illness would last compared to those newly diagnosed. Remarkably, 
around one-third of the latter scored less than five on this item, indicating that 
they felt their condition would not last a long time. Other studies, in other 
conditions, suggest patients who do not understand their illness to be long 
term, are more likely to abandon their treatment programmes when compared 
to those who comprehend their illness to be chronic (Petrie & Weinman, 2006; 
Hemphill, Stephens, Rook, Franks, & Salem, 2013). This suggests more should 
be done, at the point of diagnosis, to make sure patients are aware that their 
condition is permanent.   
COAG cases reported they understood their condition better than those with a 
diagnosis of more than two years. This particular result was unexpected. 
Perhaps though, this might be explained by the very recent information 
86 
 
received about COAG during diagnosis. This is contrary to previous findings, 
which demonstrated that understanding of COAG was poor in the majority of 
patients (McDonald, Ferguson, Hagger, Foss, & King, 2019). In addition, 
patients’ causal beliefs were also interesting; the majority of participants could 
identify a “true” risk factor for COAG and OHT (Coleman & Miglior, 2008) but 
many also held untrue causal beliefs. Many patients correctly understood 
COAG/OHT to be largely idiopathic and this warrants further study because 
work in other chronic conditions has shown this perception can influence long-
term outcomes (Delaney, Simpson, & Leroi, 2011).  
Beliefs about control over COAG/OHT varied widely with, for example, many 
patients returning low scores on questions about how much treatment can help. 
This may have arisen because of confusion over illness cures rather than illness 
control. Yet, a negative outlook about treatment potential has been shown to 
impact on wellbeing and adherence to treatment in other chronic disease 
(Heijmans, 1998; Falvo, 2005; Ross, Walker, & MacLoed, 2004). Patients who do 
not think their medication is useful may not take it, especially if they also feel 
that their condition is not long-term (Horne & Weinman, 2002). This finding 
reinforces the importance of communicating the important message about 
necessity of adhering to a life-long treatment to people with COAG/OHT, as it 
has been demonstrated that this can improve medication adherence (Gray, et 
al., 2012). 
A notable finding is the similarity in illness representations between patients 
with ocular hypertension (OHT) and manifest glaucoma (COAG). Long-term 
prognosis for OHT patients is relatively good, with only a small proportion 
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developing COAG (Gordon, Beiser, & Brandt, 2002). These findings indicate OHT 
patients may need different information at diagnosis to help improve 
representations surrounding the consequences of their illness. This will also 
ensure patients understand how their diagnosis is different to a diagnosis of 
manifest glaucoma. 
This study had several strengths. For example, the cases and those with a 
diagnosis of more than two years were stratified and related by age and disease 
severity. Patients with any other significant ocular co-morbidity were excluded 
to help ensure that BIPQ scores were reflective of the patients’ experience of 
their COAG/OHT. Moreover, the analysis took account of self-reported general 
health (EQ-5D) and distressed personality as confounders of response to BIPQ. 
Furthermore, sample sizes were large enough to support a finding of no 
differences in average BIPQ across the groups. Newly diagnosed patients were 
recruited by the same clinician at diagnosis, ensuring continuity of information, 
but this did not allow for testing of variation in response if, for example, 
diagnosis had been given by different doctors.  
There are several limitations to this study. People were only recruited from two 
clinical centres in England, were nearly all Caucasian and a significant 
proportion were well educated, to a graduate or professional level. Previous 
studies have also found racial differences in illness representations (Kim, 
Pavlish, & Evangelista, 2012) but there is evidence that general education level 
may not be associated with illness representations (Hsiao, Chang, & Chen, 
2012). The results of the current study may have been subject to volunteer bias 
too; data was not collected on people who chose not to participate or who did 
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not return questionnaire packs. Moreover, information about patients’ co-
morbidities was not recorded and many elderly people have more than one 
chronic illness (Barnett, et al., 2012). Still this limitation was mediated by using 
a measure of self-reported general health-related QoL (EQ-5D) (Van Nispen, de 
Boer, & Hoeijmakers, 2009) and the analyses were corrected for this. There is a 
small chance that patients in the study had untreated cataract, which may not 
have been noted on the EPR and that this may have acted as a confounding 
variable. Future research could consider using a combination of pattern 
standard deviation and MD as a surrogate for visual function. This study used 
MD alone, as research has demonstrated that MD is most closely allied with real 
world QoL (Alqudah, Mansberger, Gardiner, & Demirel, 2016). Furthermore, 
patients with between a two- and five-year diagnosis history were included as 
controls in this study. Some studies have suggested that the most significant 
changes in illness representations happen in the first two years of diagnosis 
(Lawson, Bundy, Belcher, & Harvey, 2013). However, it is possible that there are 
differences between illness representations in patients with a two-year 
diagnosis history and, for example, patients who were four years post diagnosis, 
which would not be reflected in the analysis. In future research, it may be 
worthwhile to measure time since diagnosis as a linear variable in order to 
investigate changes in COAG illness representations more thoroughly.  
Findings from this study suggest avenues for future research. Investigations 
into treatment beliefs may lead to important information to improve adherence 
rates to medications as suggested by another study in people with glaucoma 
(Schwartz & Quigley, 2008). A study exploring, in more detail, self-reported 
outlook and prognosis for people with OHT and how this ought to differ from 
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patients diagnosed with glaucoma with VF loss would be interesting. A follow-
up study, looking at the impact of more detailed post diagnosis education would 
be worth considering, especially as the BIPQ scores for “how much control do 
you think you have over your OHT/OAG” and “how much do you think your 
treatment can help you OHT/OAG” were disappointingly low.  A study 
examining a wide demographic of patients from different clinical centres would 
be useful. Moreover, a cohort study could follow the same patients to 
investigate changing illness representations in the same individuals over time.  
To conclude, overall illness representations in newly diagnosed patients are 
similar to those with more experience of the condition in glaucoma and ocular 
hypertension. There were some differences on individual domains of the BIPQ, 
notably the experience of symptoms and beliefs about how long the illness 
would last; for example, many newly diagnosed COAG patients do not realise 
their condition permanent. Remarkably, people with a diagnosis of OHT had 
similar negative illness representations as those people with manifest 
glaucoma; this is an important finding given the long-term risk of visual 
impairment associated with glaucoma is different to those with OHT. The 
negative representations held by OHT patients may highlight the need for better 
communication about the nature of their diagnosis and prognosis.  
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Chapter Three – Feasibility Study of a Symptom Self-
Monitoring Intervention for Glaucoma 
Understanding the dynamic nature of illness representations in glaucoma, and 
the factors associated with these informs clinicians about the potential barriers 
and facilitators to a patient’s positive illness behaviours. However, the 
experience of chronic illness extends beyond measurements of illness 
representations.  For example, previous studies on treatment adherence 
interventions in glaucoma have found that factors such as patient enablement 
and knowledge of glaucoma also play a key role in the success of intervention 
programmes (Richardson, et al., 2013; Newman-Casey, et al., 2015). One way to 
better enable patients might be to encourage self-monitoring of illness 
symptoms. Encouraging patients to self-monitor their symptoms may have 
benefits for both emotional and functional outcomes in chronic illness 
(Eastwood, Travis, Morgenstern, & Donaho, 2007; Basch, et al., 2016).  
The work presented in this chapter aimed to explore how people with glaucoma 
might self-monitor visual symptoms and the emotional response to illness, with 
the aim of enabling them to become more engaged in their ‘glaucoma journey’. 
This was investigated through the use of a set of symptom monitoring 
questions, and a diary approach whereby patients could record information 
about their daily experiences with glaucoma. This work also considers 
personality traits as a possible mediator of self-monitoring behaviour. 
The work presented in this chapter formed a paper published in the Journal of 
Ophthalmology (McDonald, Glen, Taylor, & Crabb, 2016); see list of supporting 
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publications. The co-authors of this work are Fiona Glen (FG), Deanna Taylor 
(DT) and David Crabb (DC). Ethical approval was gained by FG. The self-
monitoring diary tool was designed by FG and DC. Recruitment was performed 
by FG and the International Glaucoma Association. Data was collated and 
analysed by Leanne McDonald (LM). The paper was written by LM, reviewed by 
DC and approved by all co-authors. The work presented in this chapter has also 
been presented as a poster presentation at the Association for Research in 
Vision and Ophthalmology meeting (Seattle, WA, USA, 2016) and as an oral 
presentation at the School of Human and Social Sciences Doctoral Research 






Whilst the clinical and biological mechanisms of glaucoma are well explored, 
the impact of glaucoma on an individual’s wellbeing has been relatively 
understudied (Glen & Crabb, 2015; Glen, Crabb, & Garway-Heath, 2011). Patient 
reported outcome measures (PROMs) estimate perceived health status, 
functional status or health-related QoL. PROMs, often administered as 
questionnaires, have been used to assess the effect of glaucoma on QoL in 
research studies for some time (Parrish, et al., 1997; Nelson, Aspinall, 
Papasouliotis, Worton, & O'Brien, 2003) PROMs are starting to be used as end-
points in clinical trials of treatments for glaucoma (Vickerstaff, Ambler, Bunce, 
Xing, & Gazzard, 2015). Such use of PROMs is a positive step because they 
directly assess impact of symptoms of disease on a patient, certainly as they 
perceive it themselves. To date PROMS are not used in regular clinical 
management of patients with glaucoma. Yet the benefits for this idea have been 
speculated upon and PROMS are being increasingly used in the clinical 
management of other conditions (Devlin & Appleby, 2010; Timmins, 2008).   
In the United Kingdom (UK) there are more than one million hospital visits a 
year for glaucoma (Wright & Diamond, 2014); clinicians likely have inadequate 
time and resources to cope with these visits. Moreover, opportunities for 
patients to discuss their psychological wellbeing or the functional impact of 
their glaucoma at these visits, are uncommon. This is a pity because better 
information between clinic visits and time for patient/clinician interaction may 
lead to better glaucoma management (Mirzaei, et al., 2013). At the same time, 
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patients spend only a few hours a year in the eye clinic having their glaucoma 
monitored, but they spend more than 5000 waking hours each year engaged in 
everything else (Asch, Muller, & Volpp, 2012). This statistic suggests that there 
should be time for patients to potentially self-monitor their symptoms in 
between clinic visits. Self-monitoring approaches have proved effective in other 
chronic conditions such as type 2 diabetes (Farmer, Gibson, Tarassenko, & Neil, 
2005); these methods might be useful for people with glaucoma and this is the 
main idea explored in this study. 
Self-monitoring, in this case, is defined as a method where individuals keep a 
record of their behaviour (e.g. feelings during event), in connection with efforts 
to change/control behaviours (American Psychological Association, 2020). In 
previous literature, self-monitoring of chronic illness in cardiac and cancer 
patients, (both physical symptoms and emotional impact) has shown 
improvements in self-reported functional status and slower declines in QoL 
(Basch, et al., 2016; Eastwood, Travis, Morgenstern, & Donaho, 2007). Self-
monitoring of illness has also been explored in AMD patients through the use of 
diaries, and the findings indicate that these methods may provide a useful way 
of capturing the emotional response to illness (Stanford, Waterman, Russell, & 
Harper, 2009). In the long term, the opportunity to reflect on their emotional 
representations may benefit patients in terms of QoL, leading to the 
development of more adaptive coping mechanisms. It is thought that 
acknowledgement of negative emotions contributes to habituation, whereby 
through writing, thinking or talking about the emotions, these emotions become 
a less intense and invasive experience (de Ridder, Geenen, Kuijer, & van 
Middendorp, 2008). This is likely because bringing emotional representations 
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to the forefront, leads to appraisal of coping strategies (Moss-Morris, et al., 
2002). Therefore, increased engagement with the condition may lead to better 
overall wellbeing.  
Personality may be linked to a patient’s engagement with their condition, and 
their ability to monitor their own emotional representations. For example, 
higher trait levels of extraversion have been linked to an increased uptake of 
intervention and self-management programmes (Furnham, 1989). Other 
investigations of the so-called “big five” personality traits (Openness to 
experience, Conscientiousness, Extraversion, Agreeableness, Neuroticism) 
revealed that higher levels of extraversion and emotional stability are 
significantly related to uptake of self-monitoring (Barrick, Parks, & Mount, 
2005; Kring, Smith, & Neale, 1994). 
This work explores how people with glaucoma might self-monitor visual 
symptoms and emotional responses with the aim of enabling them to become 
more engaged in their ‘glaucoma journey’. It also examines how self-monitoring 
may be influenced by personality traits. This study specifically tests the 
hypothesis that a group of volunteer patients will be sufficiently motivated to 
regularly self-report on their physical symptoms and emotional state; 
examining the feasibility of this using a web-based diary tool. 
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3.2 Materials and Methods 
 
Participants responded to an invitation to take part in the study from a patient 
based charitable organisation (IGA - http://www.glaucoma-association.com). 
The study was a prospective mixed methods feasibility study, which took place 
over eight weeks in 2015. 
Ten participants were recruited from different glaucoma clinics across England; 
all had a clinical diagnosis of chronic open-angle glaucoma (COAG) and the 
mean (SD) time since diagnosis for the participants was 18 (9) years. A 
minimum sample size of ten participants has been suggested for any thematic 
analysis study to produce sufficiently trustworthy results (Sim, Saunders, 
Waterfield, & Kingstone, 2018). Due to the pilot nature of the study, a sample of 
10 participants was deemed sufficient to investigate the feasibility of the web-
based tool. Participants were asked to respond if they had glaucoma alone and 
no other ocular disease other than prior uncomplicated cataract surgery.  
The study was approved by a Research and Ethics Committee (City, University 
of London, School of Health Sciences) and adhered to the tenets of the 
Declaration of Helsinki. Data was anonymised and stored in a secure location. 
All participants gave their informed written consent prior to taking part. 
Pre-testing 
Participants were asked to attend a face-to-face baseline visit at the university 
to complete a series of pre-test measures to confirm their eligibility for the 
study, before being introduced to the web-based diary tool. Visits lasted 
approximately 2 hours and participants were provided with refreshments. A 
Mini Mental State Examination (MMSE) was used to exclude people with any 
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measureable cognitive impairment. Studies suggest that a cut-off score of 27 
(26 or below) out of 30 detects cognitive impairment in 90% of cases (O'Bryant, 
et al., 2008). None of the study participants scored below this cut-off. 
Participants then underwent an examination of their vision by a qualified 
optometrist (DJT). This examination included refraction, measurement of 
contrast sensitivity (CS), visual acuity (VA) and a slit lamp examination on both 
eyes. An examination of the visual field (VF) confirmed that all participants had 
measureable VF loss in at least one eye. VFs were measured (Swedish 
Interactive Threshold Algorithm Standard 24-2) using a Humphrey Field 
Analyser (HFA) [Carl Zeiss Meditec, Dublin, CA]. The best sensitivity values at 
each location of the monocular VF’s were merged to construct an integrated 
visual field (IVF) (Asaoka, et al., 2011). This technique is useful because it 
provides a simple visual representation of a patient’s binocular vision.   
Participants completed the EuroQol 5-Dimensions (EQ-5D) questionnaire and 
the Ten Item Personality Inventory (TIPI) at the start of the study in a face-to-
face interview.  
[1] EQ-5D - EQ-5D (EuroQol, 1990) is a five-item measure, designed to measure 
general health. The items are scored either 1 (no problems), 2 (some problems) 
or 3 (severe problems) on the domains of mobility, self-care, usual activities, 
pain/discomfort and anxiety/depression. The individual 1-digit item scores are 
combined into a 5-digit number, which describes health state. For example, a 
score of 12112 indicates a participant has some problems with self-care and 
anxiety but no other perceived problems.  
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[2] Ten-Item Personality Inventory - TIPI (Gosling, Rentfrow, & Swann, 2003) 
estimates levels of extraversion, agreeableness, conscientiousness, emotional 
stability and openness to experience. The scale consists of 10 items, each scored 
on a 7-point Likert scale from 1 (disagree strongly) to 7 (agree strongly). Two 
items exist for each of the five traits, and scores for each trait are a mean of the 
two items (1-7). 
Web-based monitoring and diary tool 
Participants were introduced to the web platform at their face-to-face baseline 
visit and provided with a unique login. The web platform was designed to be 
user friendly and easy to navigate (Figure 3.1). Participants were provided 
with a guidebook, which gave web tool instructions. 
Participants were asked to complete a set of bespoke ‘symptom monitoring’ 
questions every three days. Participants were asked how much driving, walking, 
searching for objects, using a computer, watching television and eating and 
drinking were affected by glaucoma. These questions were scored on a 5-point 
Likert scale from ‘not at all’ to ‘very much’. A summary measure at each time 
point was generated (5 (no symptoms) and 45 (maximum symptoms)).  
 Participants were sent automatic email prompts every three days as a 
reminder to complete the questions. Participants were also invited to complete 
a written diary, documenting any aspect of their glaucoma that they felt would 
be helpful to record. They could do this by typing directly into the web-based 
tool as frequently as they wanted to and could even upload photographs. This 
would be recorded by time and date. Again, they were prompted by an 




Figure 3.1 - A screenshot of the web-based diary tool used by the participants. 
The page is split into “to be completed” and “completed” tasks. 
Study Evaluation 
 Participants were asked to complete a series of questions about the usefulness 
of the exercise at the end of the eight-week study period; 
1) How valuable did you find keeping a diary about your vision and 
experiences? 1 “not valuable” – 5 “very valuable” 
2) To what extent has your view of your glaucoma and/or vision changed 
since the beginning of the study? “I am more aware of my vision loss 
since beginning the study”, “Since beginning the study, I notice the 
effects of my vision loss more during my everyday activities”, “I have 
found new ways of dealing with my glaucoma since the beginning of the 
study”, “I have been better at remembering to take my drops since 
beginning the study”. 
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3) Did you ever keep a journal or write down information about your vision 
and glaucoma care before the study? Yes/no 
4) Will you ever keep a journal or write down information about your 
vision and glaucoma care after the study? Yes/no 
5) What methods would you consider using to help keep a diary or log of 
your vision and glaucoma care? Website, computer documents, paper 
journal, smartphone app, other, none. 
Analysis 
 The composite symptom scores for each time point were used to plot change in 
symptom awareness over the course of the study. Individual personality traits 
for each participant were compared to mean scores on the TIPI in a cross-
sectional sample of the UK population (Holmes, 2010). Frequency of words 
written was used as a proxy for level of diary usage. Univariate association 
between diary use and scores on personality traits were explored using 
Spearman’s rho. The results from the evaluation questionnaire were assessed 
with simple summary statistics. 
The information from the online diary tool was analysed using thematic 
analysis (Braun & Clarke, 2006).  The lead researcher (LM) collated raw diary 
responses from each participant and read through the responses several times 
for familiarity. The next step involved coding any units (sentence, paragraph) 
that related to the patient’s emotional response to their illness. Each diary was 
coded separately, and then related sections of text were grouped into themes. 
Themes were only generated where at least two participants talked about a 
subject in their diaries; data from single participants was excluded from the 
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analysis. The analysis was then shared with DC to ensure that there were no 
major errors in judgement. Data analysis stopped when no further information 




3.3 Results and Findings 
 
Participants (50% male) had a median age of 70 (interquartile range [IQR] 66 to 
76) years. Participants were from different regions of the UK and were educated 
to a minimum of high school level. All participants were married or living with a 
long-term partner.  
A summary of patient’s vision and baseline data is given in Table 3.1. HFA 
mean deviation (MD) in the better eye (BEMD) was used as a proxy measure for 
glaucoma disease severity. BEMD ranged from early to advanced, with median 
(IQR) BEMD -9.1 (-6.1, -13.4) dB. Four participants had BEMD worse than -
12dB, and this level is sometimes described as advanced VF loss (Saunders, 
Russell, & Crabb, 2012).  
Table 3.1 - A summary of patient’s vision and baseline data. 
















M1 21 -0.2 1.95 -13.7 11111 
M2 5 0 1.5 -7.9 11111 
M3 26 -0.02 1.65 -5.5 11211 
M4 23 -0.1 0.9 -17.4 21111 
M6 25 0 1.95 -11.4 11111 
F1 29 -0.1 1.2 -9.2 11111 
F2 11 -0.1 1.35 -19.4 11211 
F3 6 0 1.95 -2.2 11121 
F4 15 0.1 1.35 -13.6 21211 
F5 15 0 1.35 -9.0 11221 
 
Symptom monitoring 
The completion rate of the symptom monitoring questions (96% over the eight-
week period) was remarkably good.  Composite symptom scores (from 5-45) 
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for each time point were used to plot individual change in symptom awareness 
over the study period. Loess curves were fitted to the data points in order to 
illustrate any ‘trend’ in symptom awareness during the study period (Jacoby, 
2000). These trends are purely illustrative given the short follow-up period. 
Participants were remarkably engaged with the diary entry tool. The median 
(IQR) number of diary words recorded per patient was 1858 (703, 4094) over 
the 8-week period.  
Six participants reported higher levels of extraversion and/or openness to 
experience than the UK sample. Emotional stability was weakly correlated 
(rho=0.39; p=0.05) with the uptake of the diary exercise (number of words 
written in the diary exercise).  There were no other statistically significant 
associations, but the sample size was very small.  
Thematic analysis 
Four main themes emerged from the thematic analysis at a semantic (explicit) 
level.  
Frustration 
Participants often reported a feeling of frustration regarding their impaired 
ability to complete tasks because of their vision: 
‘It is very difficult to describe what it's like except that I know that my vision is not 
the same as it was a few years ago, it's not good and it's not right’ (F2). 
Some participants felt frustration at themselves, describing that they should be 
able to complete certain tasks such as reading: 
‘As reading has become less pleasant, the piles of items waiting to be read tend to 
build up. Must try harder!’ (F3). 
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‘Not driving - wouldn't feel safe. Extremely difficult to read & shop. Getting very 
bad tempered & frustrated after almost 2 weeks of this.’ (F5). 
 
Anxiety and cessation of activities 
Some participants reported that they had stopped performing certain activities 
due to fears associated with their vision loss. Some of the instances of avoidance 
behaviour were pre-planned: 
‘I find it difficult to see in the dark these days as I struggle where there is very little 
contrast. I have stopped driving at night but live in an urban area that is 
reasonably well served by public transport.’ (F2). 
There were also instances that appeared to be triggered by situational anxiety:  
 ‘During the night I started worrying about coping with trains and planes on my 
own and where I’d be able to find somewhere to rest up during Monday, as the 
only flight was very early. I felt so awful by Sunday morning that I decided I’d have 
to stay at home. So much for thinking I am back to normal…’ (F3). 
Social support 
Participants in this sample discussed social support networks mostly in a 
positive light but sometimes reported feeling guilty at having to rely on a 
partner for social support and feared becoming a burden: 
‘[Name omitted] drove me there but didn’t come on the walk herself – I always feel 
a bit guilty about this...’ (M6). 
‘I don't like to rely on my partner for lifts, but he often obliges. I will go out on foot 
with my trusty torch where necessary’ (F2). 
Participants reported strong social support networks, including partners, 
friends and emphasised the importance of professional support groups: 
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 ‘IGA AGM was very much worthwhile attending. Loop system was working well so 
I could hear clearly. Particularly interested in all the research going on, DVLA 
[Driver and Vehicle Licensing Agency] aspect most relevant’ (F4). 
Social support networks seemed to consist of different people for different 
participants; one reported a lot of activity involving friends, but some only 
talked about partners. Regardless of whom the network consisted of, 
participants spoke about the importance of their social support network 
understanding their glaucoma related issues: 
‘I wouldn’t have recognized him if he hadn’t spoken – that sort of non-
acknowledgement can probably seem rude to anyone who doesn’t know about 
your glaucoma (I did apologize to him using the glaucoma excuse).’ (M2). 
Some also identified social activities as an important ‘distraction’ factor: 
‘I'm not one for staying in bed but would prefer to keep active. Not up to my usual 
standard but still enjoyed the session.  Didn't have time to ponder on how I felt 





Participants described different aspects of their glaucoma care in their diary 
entries. Most participants indicated that they had high levels of trust and a 
helpful dialogue with at least some of their care team: 
‘Just glad my glaucoma was picked up when it was. If this is the sight I have 'for 
ever' whatever that means for me - then I am very grateful to have been looked 
after in the way I have been. ’ (F1). 
There were very few participants who reported negative aspects of care, 
although some participants reported concern regarding interactions with 
professionals during their glaucoma care, which led to mistrust: 
‘Opticians, new varifocals on order, titanium, bit pricey @ 640. But prefer to stick 
with local independent opticians. As one of larger chains, in my view, ""missed"" 
evidence of Glaucoma in its early stages when I complained that right eye vision 
through their new specs/lens provide was slightly inferior to left. This goes back 
some 8 years.’ (M2). 
Overall, the participants in this study reported having very positive 
relationships with their clinicians.  
Evaluation of study 
Overall, participants reported that they found the diary exercise valuable, with 
eight out of ten participants rating the exercise ‘valuable’ or ‘very valuable’. One 
participant did not engage with the diary exercise and rated it not valuable at 
all. One participant rated the exercise neutral. 
Interestingly, eight participants said they felt more aware of their vision loss 
and its effects since the beginning of the study. Only two of the ten participants 
106 
 
felt that the intervention improved their medication adherence. Three 
participants felt that they had developed new ways of dealing with their vision 
loss. 
Four participants said that they were more likely to keep an independent diary 
about their vision after completing the eight-week diary exercise. From the 
options given in the evaluation questions (Figure 3.2), five participants said 
they were most likely to use a web based or computer-based diary tool.  
Participants’ experiences of the diary exercise were mostly positive. 
Participants generally felt that they received benefit from the diary exercise and 
that they would continue to benefit from using the process in the future: 
‘Thank you for asking me to take part in this research. No-one else knows the 
hassles I have mentioned, many others have bigger daily problems to cope with, so 
mine are trivial in comparison’ (F4). 
Although the majority of comments were positive, one participant reported 
negative feelings: 
‘I don't think my sight is any worse than it was a few weeks ago, only that I am 
more focused on it. I am not sure that this is a good thing because it makes me 






Figure 3.2 - Shows results from 10 participants ordered according to the severity 
of binocular visual field loss. From left to right: face indicates self-response to 
review question about the value of the self-monitoring exercise; time series plot 
shows a composite visual symptom score recorded over a study period of 8 weeks. 
Binocular visual field is shown as grey scale of integrated visual field. Individual 
bar chart indicates response to Ten Item Personality Inventory (TIPI) 
questionnaire (E: extraversion, A: agreeableness, C: conscientiousness, ES: 
emotional stability, and O: openness). Red bars indicate that trait is significantly 
higher than a reference population. For example, volunteer M6 had four 





A group of self-selected volunteer patients, with a range of disease severity and 
personality types, adhered well to using a web-based diary tool to monitor their 
glaucoma symptoms. Participants were able to report their own symptoms with 
remarkable regularity yielding plots of how their symptoms were potentially 
changing over time. Most participants felt more aware of their vision loss after being 
in the exercise. Themes emerging from the qualitative synthesis of the diary entries 
were related to behavioural aspects that might be overlooked in typical patient-
clinician consultations. This study speculates that aspects of a patient’s emotional 
response to glaucoma (frustration/anxiety) could be flagged by an on-line 
monitoring tool and then assessed in clinical consultations.   
An investigation of the feasibility of self-monitoring symptoms of COAG has not been 
done before. This study therefore represents new knowledge, as it has at least 
demonstrated how this might be feasible in groups of volunteer patients. Research 
into surveillance of glaucoma away from the clinic has, for example, focused on 
monitoring intraocular pressure and aids for improving adherence to treatment 
(Araci, Su, Quake, & Mandel, 2014; Mudie, et al., 2016; Boland, et al., 2014). Here it 
has been demonstrated that this approach might also be useful in recording 
information about wellbeing between clinic visits. Self-monitoring techniques have 
been shown to play a useful role in patient care in other chronic conditions (Farmer, 
Gibson, Tarassenko, & Neil, 2005; Eastwood, Travis, Morgenstern, & Donaho, 2007). 
The volunteers in this study were remarkably positive about the idea of self-
monitoring. This may be related to the volunteer’s personalities. For example, six 
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participants reported higher levels of extraversion and openness to experience, than 
a reference standard. Extraversion in particular has been linked to better uptake of 
self-monitoring interventions in the past (Furnham, 1989).  
Several patients in the study reported feeling anxious about their glaucoma. This is 
interesting because a higher prevalence of anxiety disorders has been demonstrated 
in other chronic illness (Brenes, 2003). Research has suggested that age and vision 
in the better eye are significant predictors for anxiety in glaucoma patients 
(Mabuchi, et al., 2012). Patients also reported frustration at losing their everyday 
abilities. Evidence from other eye diseases has found links between loss of 
functional abilities and frustration (Lamoureux, Hassell, & Keefe, 2004).  Negative 
feelings likely have an impact on patient’s self-efficacy and, if they are not identified 
and addressed, patients may be more likely to develop depression (Horowitz, 
Reinhardt, & Kennedy, 2005).  An online monitoring tool may allow some patients to 
articulate these anxieties and this could be clinically useful in the management of 
glaucoma. 
The results from this study hint at important clinical applications and these can be 
speculated on briefly now. Evidence suggests that PROM’s such as the ones used in 
this study, as well as self-monitoring exercises, provide important clinical 
information about patients and act as part of a collaborative management plan in 
chronic illness (von Korff, Gruman, Schaefer, Curry, & Wagner, 1997). Many patients 
may not get an opportunity to discuss their condition during clinic appointments 
(Friedman, Hahn, & Gelb, 2008; Friedman, et al., 2009). A diary tool may allow 
patients to use reflective thinking in order to pinpoint difficulties with their 
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condition. For example, one participant in the study reported that she felt her 
problems were ‘trivial’ compared to others and chose not to share them. Plotting 
self-reported symptoms, using an appropriate tool, could have the same 
motivational behavioural effect as measuring daily steps as a measure of exercise 
(Middelweerd, Mollee, van der Wal, Brug, & te Velde, 2014). This might be useful in 
terms of engagement and adherence with treatment. Patients in this study also 
discussed the importance of their social support network as a protective factor for 
their wellbeing. Previous research has demonstrated that adequate social support 
can benefit a patient in terms of both condition specific activities (taking 
medications appropriately) and general activities (self-care) (Sayera, Riegel, 
Pawlowski, Coyne, & Samaha, 2008). There is further evidence that patients with 
latter stage chronic disease who have adequate social support are less likely to 
suffer from psychological symptomology (Applebaum, et al., 2014). The impact of 
glaucoma on social support networks may therefore provide an interesting avenue 
for future research. 
Participants in this study provided a substantial amount of written information 
about their psychological wellbeing, which may not previously have been shared 
with clinicians. Patients may be less likely to disclose psychological distress with 
clinicians due to fear of stigmatisation or involvement of mental health services 
(Stablein, Hall, Pervis, & Anthony, 2015; Dew, Morgan, Dowell, Bushnell, & Collings, 
2007). Interestingly some evidence suggest patients are more likely to disclose 
information of a sensitive nature if they are able to do so using technologically 
advanced methods, such as through a web-based tool (Kobak, 2001; Lucas, Gratch, 
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King, & Morency, 2014). An online tool may therefore yield more information about 
a patient’s psychological wellbeing when compared to a hospital consultation and 
this should be investigated further.  
One patient concluded that a constant focus on monitoring symptoms led to 
negative feelings and experiences. This is very noteworthy. Previous research has 
suggested that private self-focus and rumination is associated with depression and 
generalised anxiety in some people (Mor & Winquist, 2002). However, other studies 
have suggested that expression of negative emotions can contribute to habituation 
(de Ridder, Geenen, Kuijer, & van Middendorp, 2008). This observation would be 
important to consider in the development of the idea of self-monitoring symptoms 
in COAG. Moreover, the diary tool was making patients more aware of problems 
with their vision and this has significant implications that need to be considered in a 
future study. It would be interesting to integrate a positive psychology exercise (for 
example, an exercise where participants are asked to record positive aspects of their 
day, such as the ‘three good things’ technique) into future iterations of any self-
monitoring exercise (Action for Happiness, 2016). Research has demonstrated that 
positive psychology exercises enhance patient engagement with their condition and 
have been shown to improve life satisfaction (Wood, Froh, & Geraghty, 2010). It may 
be interesting to consider a traditional diary vs. a positive psychology tool alongside 
measures of adherence to treatment and QoL measures to investigate whether 
different types of emotional disclosure lead to different outcomes. Interestingly only 




The experimental design of this study had several strengths. The web pages were 
well designed, and all data was safely and securely captured. The combined use of 
qualitative diary and symptom monitoring questions may also be a strength of the 
study. Of the ten participants, only one chose not to use the qualitative diary tool 
throughout the course of the study – however, this participant did complete the 
symptom monitoring questions. The current study used a multifaceted approach, 
which allowed participants to engage only with the parts of the exercise that they 
were comfortable with. This is in contrast to previous investigations of self-
monitoring behaviour in COAG, where methods have solely focused on measuring 
medication adherence (Richardson, et al., 2013; Newman-Casey, Weizer, Heisler, 
Lee, & Stein, 2013). The benefits of the diary element of the exercise may be linked 
to the expression of emotional representations of illness, with literature suggesting 
that inhibition of emotions results in delays to health seeking behaviour (Wiebe & 
Korbel, 2003). However, there may be issues with using a diary tool in a busy clinic 
environment. It is unlikely that clinicians would have enough time to read through 
diary entries. Previous self-monitoring studies have investigated emotional 
wellbeing through the use of PROMs, where significant changes in scores are 
automatically communicated (via email) with nursing teams (Basch, et al., 2016). In 
this study, nurses frequently initiated clinical action in response to the email alerts. 
Future research should consider using PROMs, rather than written diaries, in order 
to measure emotional representations of illness. Changes in PROM scores could be 
communicated to specialist glaucoma nursing teams or ECLOs, who may have more 
time to respond to changes in wellbeing. This would allow for emotional 
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representations of illness to be measured using traditional psychometrics whilst not 
overwhelming stretched clinical services.  
There are also several limitations to our study. The study sample was small, and the 
glaucoma profile of the patients was very varied; this prevents us from drawing real 
conclusion other than proving the practical feasibility of the approach. Volunteers 
were self-selected and motivated. Volunteers had good levels of education and were 
sufficiently engaged with their glaucoma because, for example, they belong to a 
patient organisation. It is hard to predict if adherence to the exercise would be so 
good in another population. There is also a lack of available research on the 
optimum frequency of self-monitoring. A systematic review of studies suggests that 
participants are generally satisfied with monitoring once a week, but that some felt 
that this was insufficient. Participants were generally not happy to monitor 
themselves daily either (Walsh, Golden, & Priebe, 2016). The current study asked 
participants to self-monitor their behaviour every three days, and this seemed to be 
an acceptable frequency. However, future research could investigate the frequency 
of symptom monitoring and its impact on engagement. Furthermore, due to the 
small sample size and feasibility approach of the study, it is difficult to form any 
conclusions about the validity or reliability of the web-based tool.  One factor that 
improves the reliability of the results is the use of low-inference descriptors in the 
thematic analysis. Quoting participants verbatim increases the likelihood that the 
accounts presented are as representative as possible of the real-life experience. It is 
common practice in thematic analysis research to also attempt to capture latent 
themes (underlying ideas, patterns or assumptions) (Braun & Clarke, 2006). The 
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analysis for this study only considered semantic (explicitly stated) themes to 
improve the reliability of the information on emotional representations of 
participants.   
In conclusion, volunteer patients, with a range of disease severity and personality 
types, adhered remarkably well to using a web-based diary tool to monitor their 
self-reported glaucoma symptoms. A web-based diary intervention for the self-
monitoring of glaucoma may therefore be practical. Future work should examine the 
feasibility of this approach in larger groups of patients with broader methods of 
recruitment and examine if it can change behaviour or be clinically useful. The 
monitoring tool must be carefully designed in order to ensure participants are 
benefitting, and it is not increasing anxiety. 
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Chapter Four – Assessment of Informal Caregiver Burden 
in Glaucoma 
 
As disability in glaucoma increases, so may the importance of the social support 
network in maintaining patient wellbeing. However, the experience of being what is 
deemed an informal caregiver can be a complex issue incorporating physical, 
psychological, financial and emotional changes (Burleson Sullivan & Miller, 2015). 
When these experiences are negative, it is termed caregiver strain (Peters, 
Jenkinson, Doll, Playford, & Fitzpatrick, 2013). Assessments of caregiver strain are 
important because informal caregivers have been shown to experience exhaustion, 
problems with wellbeing and reduced levels of self-esteem (Van den Heuvel, de 
Witte, Schure, Sanderman, & Meyboom-de Jong, 2001). There is also evidence that 
negative connotations with the role of an informal caregiver can impact long-term 
patient-caregiver relationships (Fingerman, Pitzer, Lefkowitz, Birditt, & Mroczek, 
2008; Connidis & McMullin, 2002). Previous research involving interviews with 
informal caregivers providing care to patients with COAG has revealed that there 
are strains associated with this role (Shtein, Newman-Casey, Herndon, Coleman, & 
Lee, 2016). To the author’s knowledge, no studies have aimed to quantify the levels 
of caregiver strain in those providing care to patients with COAG. 
The work in this chapter therefore aimed to estimate caregiver strain in people 
attending a glaucoma clinic, using a widely used and well validated standardised 
instrument. The primary aim of this work was to compare values from this index to 
values from other chronic conditions where ICG strain has been investigated using 
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the same measure, specifically Parkinson’s Disease, Motor Neuron Disease and 
Multiple Sclerosis. This study also tested a secondary hypothesis that measures of 
worsening VF in COAG would be associated with worsening caregiver strain.   
The work presented in this chapter formed a paper published in Eye (Lond.) 
(McDonald, Turnbull, Chang & Crabb, 2020); see list of supporting publications. The 
co-authors of this work are Paula Turnbull (PT), Lydia Chang (LC) and David Crabb 
(DC). Ethical approval was gained by Leanne McDonald (LM) (Appendix 1). Help 
with recruitment came from PT and LC. Data was collated and analysed by LM. The 
paper was written by LM, reviewed by DC and approved by all co-authors. The work 
presented in this chapter has also been presented as a poster presentation at the 
Association for Research in Vision and Ophthalmology meeting (Honolulu, HA, USA, 
2018) and at the United Kingdom and Éire Glaucoma Society Meeting (London, UK, 
2018). Additionally, this work has been presented as an oral presentation given at 
the School of Human and Social Sciences Doctoral Research conference (London, UK, 
2018) and the British Congress of Optometry and Vision Science meeting 












Chronic Open Angle Glaucoma (COAG), like many other chronic conditions affecting 
older adults, does not limit lifespan but can make life more challenging. For 
example, patients can report significant problems with activities of daily living, such 
as driving, reading and mobility as their VF worsens (Crabb, 2016; Glen & Crabb, 
2015). Such difficulties may lead to a reliance on a spouse, partner, close friend or 
family member for support (Shtein, Newman-Casey, Herndon, Coleman, & Lee, 
2016; Keeffe, Chou, & Lamoureux, 2009). A person caring for someone with a 
chronic or disabling condition, but not in a formal capacity, can be termed an 
informal caregiver.  
Informal caregiving (ICG), much like the condition that the patient is experiencing, 
can be a complex issue incorporating physical, psychological, financial and 
emotional changes (Burleson Sullivan & Miller, 2015). When these experiences are 
negative, it is termed caregiver strain (Peters, Jenkinson, Doll, Playford, & 
Fitzpatrick, 2013). For example, informal caregivers have been shown to experience 
exhaustion, problems with wellbeing and reduced levels of self-esteem (Van den 
Heuvel, de Witte, Schure, Sanderman, & Meyboom-de Jong, 2001). Informal 
caregiver (ICG) strain is most likely to affect women and those who do not have 
adequate social support themselves (Yee & Schulz, 2000; McCullagh, Brigstocke, 
Donaldson, & Kalra, 2005). Conversely, ICGs who are psychologically well adjusted, 
have good social support and implement adaptive coping strategies have a 
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decreased probability of experiencing caregiver strain. ICGs often do not report 
their caregiver status to healthcare professionals and as such may not receive 
appropriate support (Royal College of General Practitioners, 2012).   
ICG strain is well studied in conditions like cancer (Northouse, Katapodi, 
Schafenecker, & Weiss, 2012) and mental illness (Chang, et al., 2016) where burden 
of care is often significant. More recently, ICG strain in long-term conditions has 
received attention. For example, ICG strain in Parkinson’s disease (PD) and Multiple 
Sclerosis (MS), was found to be significant when measured quantitatively using a 
modified version of the Caregiver Strain Index (MCSI) (Peters, Jenkinson, Doll, 
Playford, & Fitzpatrick, 2013). The same may be true for long-term chronic eye 
conditions. For example, ICG strain has recently been described in people with age-
related macular degeneration (AMD) especially as the condition leads to visual 
impairment (Schmier, Halpern, Covert, Delgado, & Sharma, 2006; Gohil, et al., 2015; 
Vukicevic, Heraghty, Cummins, Gopinath, & Mitchell, 2016; Hanemoto, Hikichi, 
Kikuci, & Kozawa, 2017; Gopinath, et al., 2017). Moreover, specific aspects of ICG 
strain for AMD like that associated with frequent treatment visits to clinic have been 
flagged (Gohil, et al., 2015; Hanemoto, Hikichi, Kikuci, & Kozawa, 2017). The impact 
of providing informal care in glaucoma has been investigated previously in 
interviews with ICGs, but these studies generally focus on ICGs for patients with 
very poor vision (Shtein, Newman-Casey, Herndon, Coleman, & Lee, 2016) or on ICG 
strain in paediatric glaucoma patients (Gothwal, Bharani, & Mandal, 2015; 
Kantipuly, et al., 2019).  It would therefore be interesting to investigate whether the 
issues flagged by Shtein et al. (2016) also occur in ICGs with less severe VF loss. To 
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the author’s knowledge, there has been no attempt to quantify ICG strain in adult 
COAG and this is the main idea presented in this paper. 
This study aims to estimate ICG strain in people in a glaucoma clinic in England with 
a cross-sectional study using a widely used and well validated standardised 
instrument (MCSI) (Thornton & Travis, 2003). The primary aim is to compare 
values from this index to values from other chronic conditions where ICG strain has 
been investigated using the same measure, specifically those described in Peters et 
al. (2013) (Peters, Jenkinson, Doll, Playford, & Fitzpatrick, 2013). This study also 
tests a secondary hypothesis that measures of worsening VF in COAG are associated 




4.2 Materials and Methods 
 
A cross-sectional study involving patients recruited from the glaucoma clinic of 
Hinchingbrooke Hospital (part of North West Anglia NHS Foundation Trust) was 
conducted. The study was approved by the NHS Research and Ethics committee of 
the East of Scotland (17/ES/0044 ref number: 216487) and adhered to the tenets of 
the Declaration of Helsinki. Patient participants were selected consecutively from an 
Electronic Patient Record (EPR) (Medisoft, Leeds, UK) by the study coordinator (PT) 
and the clinic’s main glaucoma consultant (LC). To be eligible, patients (>40 years) 
had to be currently treated for a diagnosis of COAG with VF loss in at least one eye. 
COAG suspects and patients with OHT were excluded. Participants were only 
included if they had no other ocular disease (except for uncomplicated cataract 
extraction) and a corrected binocular VA of better than LogMAR 0.3 at their last 
clinic visit. Patients were selected consecutively from the date they last attended the 
clinic, and this had to be within 6 months of the data extraction. Names and 
addresses were recorded along with age (in years) and a measure of VF loss in both 
eyes (mean deviation; MD) from their last clinic visit as acquired using a Humphrey 
Field Analyser (Carl Zeiss Meditec, Dublin, CA). The EPR also has a field for the 
number of significant non-ocular co-morbidities and this number was recorded too.  
The aim was to select a total of 250 patients representing a population of people 
with COAG being treated in a clinic in England (see analysis; sample size).  This 
study deliberately aimed to include 50 patients (some selected non-consecutively) 
designated as having advanced COAG, defined as MD worse than -12 dB in both eyes. 
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This measure for advanced VF loss has been widely used before in, for example, 
health economic evaluations of COAG and coincides with a high likelihood that the 
patient does not satisfy the VF component for legal fitness to drive (Boodhna & 
Crabb, 2016; Saunders, Russell, & Crabb, 2012). 
A questionnaire pack, including a participant information document, was posted to 
the address of selected participants. Due to the postal nature of the survey, 
participants were asked to complete a statement of implied consent (Appendix 2). 
The patient information document asked participants to identify an informal 
caregiver (if applicable) with the following question: ‘Can you identify someone who 
is an informal caregiver for your glaucoma? This might be a spouse, a partner, a 
relative or friend who helps you with any aspect related to your glaucoma.’ 
The questionnaire pack included two sections printed on different coloured paper, 
one for the patient participant and one for their potential informal caregiver (ICG) 
(Appendix 3).  The patient participant section had demographic questions and a 
validated instrument (EQ-5D) to measure self-reported general health. EQ-5D is 
commonly used by NICE for health economic evaluations during clinical 
interventions. The EQ-5D-5L was used, in which items are scored from 1 (no 
problems) to 5 (severe problems) on the five domains of mobility, self-care, usual 
activities, pain/discomfort and anxiety/depression.  An EQ-5D index score was 
generated in a standard way with 1 representing full health (a score of 1 on all f 
items), and, on the basis of a so-called UK tariff (applicable to our participants), a 
worst health state of -0.594 (van Hout & Janssen, 2012).  
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If an ICG was identified by the patient, then they completed a separate section of the 
questionnaire with its own consent statement; this included demographic questions, 
the EQ-5D and Modified Caregiver Strain Index (MCSI) questionnaires (Thornton & 
Travis, 2003). MCSI has been widely used with more than 200 citations in the 
literature. MCSI estimates levels of ICG strain in terms of financial, physical, 
psychological, social, and personal strain using 13 items, each of which is scored 
‘yes, regularly’, ‘yes, sometimes’ or ‘no’. Scores range from 0 (‘no’ on all items) to 26 
(‘yes, regularly’ on all items). 
The questionnaire pack was sent with two stamped-addressed envelopes to ensure 
that responses could be returned privately. A ‘thank you’ note/reminder was sent 
two weeks later to encourage responses. Data from the questionnaires was double 
entered. Median imputation was used for any missing values. Data was anonymised 
and stored in a secure location.  
Data analysis  
The primary outcome was mean MCSI in the ICGs of the participating patients and a 
comparison with values reported from a study for ICGs for people with MS and PD 
(Peters, Jenkinson, Doll, Playford, & Fitzpatrick, 2013); these values were 11 and 12 
respectively. From that study the between person standard deviation (SD) for MCSI 
was 6 units. Therefore, a sample-size calculation for a one-sample t-test aiming to 
demonstrate a difference of at least 2 units between mean MCSI in our data, as 
compared to ones described in Peters et al. (power and alpha set at 0.80 and 0.05 
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respectively) required at least 75 ICG responses. Assuming a response rate of 30% 
(Peters et al had 37%) meant we aimed to post 250 questionnaire packs. 
The secondary aims were to compare MCSI between ICGs of patients with and 
without advanced VF loss, and then to explore the association between MCSI and 
worsening COAG as measured by VF loss corrected for other measures, such as sex, 
age and self-reported general health (EQ-5D). Two-sample t-tests (assumed unequal 
variances) were used to compare means and Chi-square tests were used for 
categorical values. Associations were explored with Pearson correlation coefficients 
and a generalised linear model to correct for covariance. A value of 0.05 was used 
for statistical significance. Analysis was done in SPSS Statistics 24 (IBM Corp., 






Invitations were sent to 243 patients falling short of enriching the sample with the 
target of inviting 50 patients with advanced COAG (n=39). Finding eligible patients 
fulfilling the advanced VF criteria with preserved VA or not having other ocular 
pathology was problematic. One-hundred and 16(48%) patients responded. Median 
(interquartile range [IQR]) time period between a questionnaire pack being posted 
and returned was 14 (7, 25) days. Mean (SD) age of the patients who responded 
(n=116) to the postal survey was 73 (10). Mean (SD) best eye MD (BEMD) of the 
patients who responded was -3.7 (6.4)dB. 
Nine patients returned questionnaires declining to take part. Two other patients 
were not analysed: on checking data entry of the clinical record one was found not 
to satisfy the inclusion criteria for VA and the other had too many missing items to 
be analysed meaningfully. This left 105 patients for data analysis.  
Only 38 (36%) of the 105 patients analysed had an informal caregiver (ICG). These 
patients represent just 16% of the total of n=243 contacted, a value lower than 
anticipated in the sample size calculations (30%) perhaps reflecting that most 
people in glaucoma clinics do not consider their condition warrants an ICG. This in 
itself is an important finding in relation to the conditions investigated by Peters et 




A participant stating that they had an ICG might be related to their marital status. 
For example, in the patients with an ICG, 87% (33/38) self-reported they were 
married or in a committed relationship as opposed to being single, divorced, 
widowed or separated; in contrast this proportion was 60% (40/67) in the patients 
who did not have an ICG and the difference was statistically significant (p=0.004). 
Percentage of male participants with and without an ICG was 47% (18/38) and 55% 
(37/67) respectively; these values were not significantly different (p=0.439)  
The primary outcome for the study was Mean (SD) MCSI; this was 2.4 (3.4) in the 38 
ICGs who completed the questionnaire (95% CI: 1.3, 3.6). This value was 
overwhelmingly statistically different (p<0.001, one-sample t-test) from the mean 
value of ~11 reported in ICGs for people with MS and PD in Peters et al.  Moreover, 
nearly half (n=18; 47%) of this sample of ICG respondents returned a MCSI of zero 
(indicating no ICG strain, responding negatively to all 13 items). Furthermore, only 
three ICGs recorded a MCSI >7, a value that some studies have described as 
meaningful caregiver strain. Taken together these results suggest ICG strain in 
COAG, as measured by MCSI, is negligible for most of the ICGs of glaucoma patients. 
Mean (SD) best eye MD in patients with (n=38) and without (n=67) an ICG was -6.9 
(9.1) dB and -2.1 (4.0) dB respectively; these values are statistically different 
(p=0.004) hinting ICG strain increases with worsening VF loss. Moreover, 
percentage of patients with an ICG was much higher in patients with advanced VF 
loss (82%; 9/11) when compared to those with non-advanced VF loss (31%; 29/94) 




To further highlight this effect of ICG strain being inflated in advanced COAG, Table 
4.1 gives the patient participant and ICG response stratified by our measure of 
COAG severity. For example, ICG mean (SD) MCSI was much worse when the patient 
had advanced VF loss (5.6 [4.9]). The three ICGs with MCSI > 7 were for patients 
advanced VF loss too; this is noteworthy. There was no real evidence to suggest that 
the sex and age profile, or number of co-morbidities, of the two groups of patients, 
were different. Yet patients with advanced VF loss, and their ICGs, had worse self-
reported general health (EQ-5D) compared to the others in the clinic and their 
respective ICGs.  
Table 4.1 - Comparison between patients with and without advanced VF loss and their 
respective ICG responses. Means with standard deviations (p-value for two-sample test 
[unequal variances]) and numbers with percentages (p value for Chi-square test) are 
given for the measurements and categorical values respectively.  (An asterisk denotes 
statistical significance at p<0.05.)   
 




Patients (n=29) with 
non-advanced  loss 
p-value 
 
Patient age (years) 78 (9) 72 (7) 0.077 
Patient:  female 5 (56%) 15 (52%) 0.841 
Better eye mean deviation 
dB 
-21.5 (6.1) -2.4 (3.2) <0.001* 
Worse eye mean deviation 
dB 
-26.5 (4.9) -6.8 (5.3) <0.001* 
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Patient:  EQ-5D score  0.66 (0.21) 0.87(0.15) 0.018* 
Patient: Number of co-
morbidities 
1.9 (2.8) 1.5 (1.4) 0.690 
Modified Care Strain 
Index (MCSI)  
5.6 (4.9) 1.5 (2.2) 0.040* 
Informal caregiver (ICG):  
number of females 
5 (56%) 13 (45%) 0.573 
Informal caregiver (ICG) : 
EQ-5D score 
0.77 (0.07) 0.91 (0.12) <0.001* 
 
Associations of measured variables with worsening MCSI in the 38 patients with 
ICGs are shown in Table 4.2. Worsening VF and poorer self-reported general health 
(EQ-5D) of the patient were moderately associated with worsening ICG MCSI. This 
analysis was exploratory because the study was not powered for this. Still, no other 
variables had a statistically significant association with MCSI.  Given the influence of 
patient EQ-5D the data analysis returned to the comparison of mean ICG MCSI 
between the patients with advanced (n=9) and non-advanced VF loss (n=29) using a 
general linear model (sometimes referred to as ANCOVA). After controlling for EQ-
5D as a covariate the difference in MCSI between the two groups still remained 
statistically significant (p=0.035 vs p=0.001 [unadjusted with equal variances 
assumed]) but the effect diminished with a mean (95% CI) difference in MCSI of 2.7 
(0.2, 5.2) reduced from 4.1 (1.8, 6.4) (unadjusted). This analysis still suggests having 
advanced VF loss inflates ICG strain but in this data this is partly explained by the 
same patients having a co-varying worse self-reported general health. Of course, 
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worse general health may or may not be related to having advanced VF loss, but this 
cannot be untangled with the current data. 
Table 4.2 - Pearson correlation coefficients for different measured variables against 






Patient age (years) + 0.11 0.499 
Better eye mean deviation dB - 0.46 0.003* 
Worse eye mean deviation dB - 0.62 <0.001* 
Patient:  EQ-5D score  - 0.53 0.001* 
Patient: Number of co-morbidities + 0.31 0.063 
Informal caregiver (ICG) : EQ-5D score - 0.26 0.113 
 
MCSI items (questions) with the 38 ICG’s responses are given in Table 4.3. One 
third of ICGs have at least sometimes made changes in personal plans because of 
their role. Other relatively more common strains surrounded work adjustments and 
less time for other family members. MCSI items referring to disturbed sleep, 
physical strain and a feeling of being ‘overwhelmed’ were completely rejected by all 
but a few ICGs. 
Some other results from this sample of participants are worth noting. Nearly all 
patients (98%; 103/105) were Caucasian and 38% (40/105) self-reported being 
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educated to degree level or higher. In this sample of 38 ICGs there were roughly 
equal numbers of men (n=18) and women (n=20). Mean (SD) MCSI was similar 
(p=0.606) for men (2.1[3.6]) and women (2.7 [3.4]) too.  
Table 4.3 - The 13 items from the Modified Care Strain index questionnaire ranked by 
the frequency of responses by the informal caregivers (ICGs). The top and bottom item 
in the table represent the item cited as the most common and least common strain 























There have been changes in personal plans because of my 
caregiving 
66 31 3 
There have been work adjustments because of my caregiving 76 16 8 
Caregiving is confining/restricting 74 26 0 
There have been other demands on my time (e.g. other family 
members need me) which I have been unable to deal with 
76 24 0 
It is upsetting to find the person I care for has changed so much 
from his/her former self 
79 18 3 
There have been family adjustments because of my caregiving 82 18 0 
Caregiving is inconvenient 84 16 0 
There have been emotional adjustments because of my 
caregiving 
87 10 3 
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My caregiving is a financial strain 87 13 0 
Some behaviour is upsetting (the person I care for has upsetting 
behaviours) 
89 8 3 
My sleep is disturbed by my caregiving 89 11 0 
Caregiving is a physical strain 92 8 0 








A cross-sectional postal survey was used to elicit a measure of informal caregiver 
(ICG) strain for glaucoma patients in a single clinic in England. Patients were 
selected consecutively but the sample was enriched with a number of patients with 
advanced VF loss. Only 36% of patients who responded felt they had an ICG and in 
these, caregiver strain as measured by a standardised instrument (modified 
caregiver strain index; MCSI) was negligible. Although, in a subset of patients with 
advanced VF loss in both eyes, but preserved VA and no other ocular comorbidity, 
the ICGs response on MCSI was considerably inflated.  
Results from this study represent new knowledge about ICG strain in glaucoma 
patients. This data might be useful for clinicians and practitioners who may not have 
considered ICG in COAG before. A raised awareness is useful because there is 
evidence that ICGs who are given adequate support do not experience as much 
strain (Royal College of General Practitioners, 2012). Moreover, this data might be 
useful for targeting patients who need extra support in addition to health economic 
models for glaucoma care (Van den Burg, Al, Van Exel, Koopmanschap, & Brouwer, 
2008) 
Comparing MCSI values between different conditions seems attractive but is fraught 
with issues because of the different sampling and methodology used in different 
studies. For example, CSI (not the modified version) >7 has been reported in 36% of 
ICGs of people recovering from hip fracture surgery (Ariza-Vega, Ortiz-Pina, 
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Kristensen, Castellote-Caballero, & Jimenez-Moleon, 2019), 15% of ICGs of people 
with adult cancer (Hsu, et al., 2017) and 24% of ICGs of people with mild relapsing-
remitting MS (van der Hiele, et al., 2019). In contrast this study only had three ICGs 
with MCSI >7; this could be reported as 3/105 (3%) of people who were 
contacted/replied, or 3/38 (8%) of ICGs analysed or 3/9 (33%) of the people with 
advanced COAG; these different figures illustrate how sampling can affect results. 
The results of this study were aligned to Peters et al (Peters, Jenkinson, Doll, 
Playford, & Fitzpatrick, 2013) but even their study had different methodology to the 
current study. Still, for the primary outcome, mean MCSI for ICGs of patients in 
glaucoma clinics was considerably lower than values estimated by Peters et al. for 
MS and PD. 
Greater ICG strain being related to worse VFs is another novel finding of this study; 
the association was true in the least and most affected eye. Mean MCSI was three 
times larger in this sample of patients with advanced VF loss compared to other 
patients in the clinic; this co-varied by the patients self-reported general health-
related QoL (EQ-5D) but the effect remained after EQ5D score was statistically 
corrected for in the MANCOVA. This result is unsurprising because studies have 
indicated a rapid decline in vision related QoL in COAG as both eyes progress to end 
stage VF loss (Peters , Heijl, Brenner, & Bengtsson, 2015; Jones, Bryan, & Crabb, 
2017) and this likely reflects the greater help these people need.  Of course, the 
findings of this study add to the evidence that halting VF progression is a clinical 
imperative, not just for the patient but also for the wellbeing of the ICG of a patient. 
A longitudinal study would be needed to explore how ICG increases as COAG 
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progresses in an individual and this could untangle the effect from declines in 
general health.  
ICG strain in another age-related eye condition, AMD, has been explored but making 
comparison with these studies is also tricky. For example, a study specifically 
assessed people on ranibizumab (injection) therapy for neovascular AMD and found 
it was associated with significant ICG strain (Gohil, et al., 2015). Other studies have 
highlighted ICG strain in AMD but none sampled consecutively from people in clinics 
nor used MCSI, so it is difficult to make comparisons (Schmier, Halpern, Covert, 
Delgado, & Sharma, 2006; Vukicevic, Heraghty, Cummins, Gopinath, & Mitchell, 
2016). A large multicentre cross-sectional study conducted in Portugal 
demonstrated visual impairment, defined as worse than 0.30 logMAR (Snellen 6/12) 
in the better seeing eye, incurs ICG strain (Marques, et al., 2018). This research, 
however, measured ICG strain in terms of the self-reported number of hours of 
informal care provided per year (reported by the patient). This may present a 
problem because other studies have demonstrated that patients’ and caregivers’ 
experiences of informal care are often different. Patients may therefore underreport 
the amount of care provided (Doekhie, Strating, Buljac-Samardzic, van de 
Bovenkamp, & Paauwe, 2018). The results in this study from patients with advanced 
VF loss add to this knowledge because ICG strain was measured by ICG self-report 
and using a validated measure (MCSI). This study also adds new knowledge because 
the results showed inflated ICG strain but, because of the study design, the VA of 
participants was better than 6/12. This means we can be more confident that the 
relationship found in this study between MD and ICG strain is valid.  
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There are good explanations for why ICG strain was insignificant in the majority of 
this sample of patients. Many of these patients are receiving treatment for a 
condition that is almost always asymptomatic until advanced in nature. In addition, 
patients had relatively preserved VA and no other ocular morbidity.  In addition, 
although MCSI is widely used, it is unlikely to capture specific ICG strain for people 
with COAG. For example, it was obvious that some MCSI items (Table 4.3), like care 
being physically draining, were rejected.  Analogous to this issue is the debate about 
items within patient reported outcome measures (PROMs) that are not glaucoma 
specific and how they might, for example, be insensitive to glaucoma progression 
(Skalicky, Lamoureux, Crabb, & Ramulu, 2019; Jones, Garway-Heath, Azuara-Blanco, 
Crabb, & UKGTS Investigators, 2019).  
It is reasonable to speculate there may be ICG strain in COAG around the different 
treatments (drops/surgery) and this could be the subject of future work. Other 
idiosyncratic ICG strains for COAG might include the psychological burden of having 
a potentially blinding condition or loss of visual function that might restrict mobility 
or remove a driving licence. We know patients are very concerned about the latter 
(Bhargava, Bhan-Bhargava, Foss, & King, 2008) and this would likely impact on their 
ICG too. Qualitative analysis of interviews with patients and their ICGs could 
pinpoint these strains; this is the subject of further work presented in Chapter Five 
of this thesis. In turn, this research could lead to development of a simple COAG 
specific instrument that could be administered in a clinic to detect if there was a 
‘silent’ developing ICG strain. Others have discussed the importance of identifying a 
precipice when patients lose self-medicating capability, and this might be 
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identifiable with an appropriate instrument for the ICG (Read, et al., 2018). 
Furthermore, there was a lack of patients in the EPR who satisfied the criteria for 
advanced VF loss. Participants with advanced VF loss in this study had a mean (SD) 
MD of -21.5 (6.1) dB in their better eye, whilst the criteria for advanced VF loss was 
an MD of worse than -12dB in both eyes. This distinctly high level of VF loss may be 
responsible for the differences found between the groups. As both better and worse 
eye MD were found to significantly predict ICG strain in this study, future research 
should consider using a binocular measurement of VF loss as a surrogate for visual 
function rather than implementing monocular criteria (Asaoka, et al., 2011).  
Other results from this study are worth discussing. The high number of patients who 
declared not to have an ICG is interesting too. This might suggest that patients do 
not consider their COAG warrants an ICG. Yet there was a strong link between 
having an ICG and being married or having a partner. In turn this highlights the 
importance of identifying patients who may be socially isolated or living on their 
own. Moreover, in this data, there were no differences in the sex profile of the ICGs 
with men and women reporting the same level of ICG strain. This contradicts studies 
where ICG strain has been thought to be something that affects women more than 
men (Yee & Schulz, 2000; McCullagh, Brigstocke, Donaldson, & Kalra, 2005). 
This study had several strengths. A widely used, standardised instrument was 
employed; the sampling was conducted carefully; and the study considered other 
variables allowing for an analysis that corrected for covariates. At the same time this 
study has several limitations. The sample came from one centre; the patients were 
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nearly all Caucasian and education levels were relatively high. Some studies have 
indicated that there may be cultural and ethnic differences in the experience of ICG 
strain (Haley, Roth, Howard, & Safford, 2010). VF records were extracted from an 
EPR and may have changed in the maximum six-month period before a participant 
responded, although this is unlikely. Moreover, this study was only cross-sectional, 
relied on self-report and could only examine associations. 
In conclusion, this study is novel in assessing ICG strain in patients from a glaucoma 
clinic. The data demonstrates that ICG strain in the great majority of these patients 
is largely negligible but, importantly, it worsens as disease severity worsen. Patients 
with advanced VF loss in both eyes have considerably inflated ICG strain although 
some of this might be explained by worsening general health in these people too. 
Further work should be done to improve our understanding of the specific nuances 
of ICG in relation to COAG. 
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Chapter Five – Why Do Carers Care? Experiences of 
Informal Caregiving in Glaucoma. 
 
Patient reported outcome measures (PROMs) provide us with some information 
about the experience of providing care for patients with chronic illness. However, 
they are limited as they do not provide information on the specific nuances of the 
condition. In COAG, it has been demonstrated that caregivers’ express concerns 
about the lack of patient education and patient’s reliance on caregivers. Caregivers 
express further concerns about the development of maladaptive coping mechanisms 
(Shtein, Newman-Casey, Herndon, Coleman, & Lee, 2016; Waisbourd, et al., 2016). 
Studies have suggested that caregivers, much like patients, go through a process of 
adjustment to the disease that relies on knowledge and the possible consequences 
of the illness (Kennedy, et al., 2017). However, our knowledge of the experience of 
this process in COAG is limited.  
We do not know, for example, the role that caregivers play in COAG management, 
the experience of giving/receiving care and the reasons why COAG patients may (or 
may not) need an ICG. This study aimed to investigate these questions using focus 
groups analysed by interpretative phenomenological analysis (IPA) in order to 
better understand patient and ICG experiences of caregiving in COAG. Specifically, 
this work aimed to answer the question; ‘What are the factors that form the 
experience of informal caregiving in COAG?’ 
The co-authors of this work are Paula Turnbull (PT), Lydia Chang (LC) and David 
Crabb (DC). Ethical approval was gained by Leanne McDonald (LM). Participants 
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were recruited from Hinchingbrooke hospital by PT and LC. The focus groups 
discussed in this chapter were conducted by LM with PT acting as an observer. Data 







COAG is associated with a variety of self-reported problems in activities of daily 
living, such as driving, reading and mobility, particularly when it is in the advanced 
stages (Crabb, 2016). However, patients with more moderate VF loss also report 
complex functional issues (Ramulu, et al., 2014) and may avoid certain activities as a 
result (Glen & Crabb, 2015). This in turn may lead to an increased reliance on family 
members or friends for support with activities, which is termed informal caregiving 
(Shtein, Newman-Casey, Herndon, Coleman, & Lee, 2016; Keeffe, Chou, & 
Lamoureux, 2009; Schmier, Halpern, Covert, Delgado, & Sharma, 2006). The 
experience of being an ICG, which incorporates physical, psychological, financial and 
emotional changes is likely far more complex than the scope of the current tools 
designed to measure it.  In clinical consultations alone, the ICGs may take on roles 
such as memory aid, emotional support, clinical decision maker, elaborator, 
advocate, interpreter, company provider, or transcriber (Ellingson, 2002). 
Successful ICGs can benefit a patient in terms of condition specific activities (taking 
medications appropriately) and general activities (self-care), as well as minimising 
the risk of maladaptive emotional responses such as depression (Sayera, Riegel, 
Pawlowski, Coyne, & Samaha, 2008; Applebaum, et al., 2014). However, this relies 
on the ICG having the expertise and knowledge to help with management of the 
condition (Borgermans & Devroey, 2017). 
Previous research with ICGs for patients with COAG has shown ICGs had minimal 
levels of engagement with the condition and expressed concerns about the lack of 
140 
 
patient education, patients reliance on ICG support and the development of 
maladaptive coping mechanisms (Shtein, Newman-Casey, Herndon, Coleman, & Lee, 
2016; Waisbourd, et al., 2016). Negative feelings toward the ICG role have been 
shown to affect the wellbeing of both patient and ICG (Fingerman, Pitzer, Lefkowitz, 
Birditt, & Mroczek, 2008). Where ICGs feel obligated to help the patient with their 
condition, there is a risk that they may develop psychological ambivalence 
(contradictory feelings about the patient) (Connidis & McMullin, 2002), which may 
impact long-term relationships.   
There is also evidence that patients with COAG fear becoming burdensome on their 
friends and family and that this can lead to self-imposed restrictions in activities 
(Glen & Crabb, 2015). These restrictions could lead to the patient experiencing 
isolation and social disconnectedness. In patients with osteoporosis, maintaining 
physical activities was important for maintaining long-term psychological and 
physical health (Kerr, et al., 2017). Moreover, it has been demonstrated that 
perceived isolation is an important indicator of poor mental health (York Cornwell 
& Waite, 2009).  
There is limited knowledge about experiences of ICG in patients with COAG, but 
current literature does suggest that there may be specific concerns that need to be 
addressed. These include questions surrounding the role of the ICG, the experience 
of giving/receiving care and the reasons why patients may need an ICG. This study 
therefore aims to investigate these broad questions using focus groups analysed by 
interpretative phenomenological analysis (IPA) to investigate patient and ICG 
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experiences of caregiving in COAG. Specifically, this work aims to answer the 




5.2 Materials and Methods 
 
Design 
This study uses focus groups analysed by interpretative phenomenological analysis 
(IPA) to investigate patient and caregiver experiences of caregiving in COAG. IPA is 
an idiographic qualitative analysis approach concerned with understanding the 
lived experience of an individual and the meaning placed on these experiences 
(Smith & Osborn, 2012). IPA methodology has been widely used in the health 
professions in order to understand healthcare and illness from the patient 
perspective (Biggerstaff & Thompson, 2005).  
Focus groups took place at one clinical centre in England (North West Anglia NHS 
Foundation Trust; Hinchingbrooke Hospital) across two days in July 2018. A 
purposive sample was initially recruited from a list of participants who had 
previously participated in the study presented in Chapter Four. Thirty-three 
participants with a range of disease severities were invited by telephone to take 
part in two focus groups. To be eligible for the study, patients had to be > 18 years 
and have a clinical diagnosis of COAG. Participants were only included if they had no 
other ocular disease (except for uncomplicated cataract extraction) and a visual 
acuity of better than 6/12 in at least one eye. All participants had measurable visual 
field (VF) loss in at least one eye. VFs were measured in clinic using a Humphrey 
Field Analyser (HFA; Carl Zeiss Meditec, Dublin, CA) using the Swedish Interactive 
Threshold Algorithm (SITA Standard 24-2).  
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Previous research has indicated that the optimum number of participants for a focus 
group is 6-8 (Bowling & Ebrahim, 2005). We therefore aimed to recruit 6-8 
individual participants for a ‘no caregiver’ focus group (Group A), which acted as a 
comparison group during the analysis and 3-4 pairs of participants for the 
‘caregiver’ focus group (Group B). Seven individuals agreed to take part in Group A, 
however three participants opted out of the study on the day due to sickness. Group 
B consisted of four pairs of participants (8 participants in total). The final sample 
consisted of 12 participants, 8 of which were patients and 4 of whom were 
caregivers.   
Procedure 
To prepare for the focus groups, LM and PT reviewed the semi structured interview 
schedule for familiarity (Appendix 4) and the audio recording equipment was 
tested. The focus groups took place in a meeting room at Hinchingbrooke hospital 
and signposting was provided from the hospital entrance. It was anticipated that the 
focus groups would last 90 minutes (including the consent procedure), and the 
room was booked for 180 minutes to ensure that participants would have enough 
time to discuss their experiences. A copy of the participant information sheet, 
consent form and debrief sheet were printed out for each participant and LM and PT 
greeted participants as they arrived. Participants were also provided with 
refreshments. All participants were asked to read a participant information sheet 
upon arrival at the hospital. They were then asked to provide written consent to 
take part in the study, with the exception of one participant in Group B (B1) who, 
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due to their advanced VF loss, asked the researcher to read the participant 
information sheet and provided verbal consent. The focus groups were led by the 
primary researcher (an experienced qualitative researcher) using a semi-structured 
interview schedule (Appendix 4). The focus groups lasted 47 minutes and 63 
minutes for groups A and B respectively. Both focus groups were audio recorded 
and transcribed verbatim.  
The five step IPA process involved initially reading each transcript several times for 
meaning and making initial notes to ensure that the primary researcher had a good 
sense of the data. Secondly, initial themes were developed from the codes; similar 
themes were clustered together in order to create superordinate themes. Each of 
the superordinate themes existed across both transcripts. The final step was to 
create a master table of themes. The themes were reviewed by the co-authors.  
The study was approved by the NHS Research and Ethics committee of the East of 
Scotland (17/ES/0044 ref number: 216487) and it adhered to the tenets of the 
Declaration of Helsinki. All participants gave their informed consent prior to taking 
part. Data from the focus groups was transcribed verbatim, anonymised and stored 






Patient participants in Group A and Group B had a median (IQR) age of 71 (62 to 81) 
and 77 (67, 87) respectively (Table 5.1). Participants were all educated to a high 
school level and were all Caucasian. Six of the eight participants (75%) were 
married, one participant was single, and one participant was widowed. In Group A, 
mean (SD) HFA mean deviation was -2.33 (-3.46) dB and -7.93 (-3.51) dB in the 
better and worse seeing eye respectively. In Group B, mean (SD) HFA mean 
deviation was -8.21 (-4.71) dB in the better eye and -14.96 (-2.91) dB in the worse 
eye. 
Table 5.1: A summary of patient’s vision and demographic information 
 Patient 
sex 
CG sex Marital 
status 










Group A       
A1 F - Married 62 -11.31 -0.60 
A2 M - Married 82 -10.61 -7.51 
A3 M - Married 78 -0.80 -4.79 
A4 M - Single 64 -5.00 -0.39 
Group B         
B1 F F (B5) Widowed 90 -16.91 -13.94 
B2 F M (B6) Married 75 -10.97 -10.00 
B3 M F (B7) Married 65 -17.33 -3.40 
B4 F M(B8) Married 80 -14.62 -5.5 
 
Interpretative phenomenological analysis revealed three superordinate themes in 
relation to the experience of informal caregiving in COAG. Broadly, the caregiver 
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experience consisted of an obligation toward the patient, mediated in Group B by 
positive outcomes and feelings of empathy for the patient's circumstances. 
Caregivers and patients also stressed the importance of the caregiver in effective 
communication with care teams. Loss of independence appeared to be the defining 
feature in increasing care needs, with participants in Group A expressing more 
individualistic beliefs and participants in Group B stressing the importance of 
collaborative care. 
Communication with care teams 
Better communication with physicians/care teams was identified as an important 
factor for patients with a caregiver. Patients in Group B stated the importance of 
having a caregiver present during hospital appointments. The role of the caregiver 
in the context of appointments varied amongst participants, but primarily, the 
caregiver’s role comprised of taking notes and assisting the patient with 
synthesising and understanding the information that was being communicated by 
care teams. 
‘I think it’s always been a good thing to have [name omitted] in the consulting with us 
when you’re having the eyes tested and when you’re being looked at because they’re 
asking you various questions and you’re going through it. There's [sic] drops in your 
eyes and the eyes are stinging and everything else, and yes, you are asking questions 
but at the same time, I don’t think you’re taking it all in, where [name omitted] is. 
[Name omitted] is taking it all in. I'm coming out and saying ‘well, he’s said this’ and 
she’s saying ‘no, I don’t think he did, he said this and he meant that’ so you’ve always 
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got another idea of what’s going on there and what’s happening.’ B3, M, moderate 
VF loss.    
Caregivers in Group B expressed the importance of being present for investigations 
in order to relay information or ask questions. They expressed sympathy for 
patients who were not accompanied to their appointments. 
‘So I, I think that’s very important actually, that somebody has got the support – if I’m 
able to give it to [name omitted] or you’re able to give. I think that should be 
encouraged. When I sit in the clinic waiting, we all sit in the clinic waiting the hours, 
but you see the odd person go through on their own and I actually feel for that person. 
They call a name and the person gets up and goes.’  B6, M, wife moderate VF loss.  
Participants within Group A also unexpectedly identified that they found it useful to 
have a caregiver present when attending hospital appointments. These participants 
seemed not to view attending appointments as part of a caregiver role, but rather 
’help’. 
‘In fact, whenever I go, if my wife can come with me – and very often she needs to if I 
am having drops, of course, for driving – then she will take notes. I don’t - I just need to 
concentrate on what’s going on. It's a great help, yeah. Because I think otherwise it is – 
somebody's – if somebody’s doing a field of vision test and saying something, you can’t 
sit there and write things down that you want to remember.’ A2, M, moderate VF 
loss. 
Caregivers in Group B also stressed the importance of being given sufficient 
information regarding patient outcomes so that they had an understanding of what 
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the patient was likely to experience. The discourse around outcomes in Group B 
primarily addressed surgical outcomes. Caregivers expressed frustration at not 
being aware of the potential outcomes of surgery. 
‘From my perspective, and probably [name omitted] as well, had we have known – and 
maybe that information isn’t out there. Maybe there isn’t the information out there to 
know that if you’re in that small percentage of where the trabeculectomy fails, what 
then are the long term effects, the amount of drops you will need to use, the possible 
discomfort, the change all the time in your prescription for vision? Because I think 
that’s worn you down.’ B7, F, husband moderate VF loss.  
Not receiving adequate information regarding appointments was also identified as a 
major frustration by caregivers in Group B. Caregivers discussed an important 
element of their role consisting of communicating with the hospital to ensure that 
regular monitoring appointments were provided. The frustration expressed, 
suggested caregivers felt their loved one would be overlooked if it weren’t for their 
pro-active role in relaying information about appointments.  
‘Also, I think the other frustration is that you go to the glaucoma clinic and they say, 
‘yes we’ll see you in three months’. Three months comes and goes, and you don’t hear 
anything. Then it goes four months, five months and you still don’t hear anything. So 
you end up having to phone them and say ‘when are we going to come?’. ‘Oh, oh, oh, oh 
yeah. Oh yeah we’ll get you in, we’ll do you in another two months’. They end up – what 
should have been a three month follow up we do six months or longer. It would have 
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gone even longer if you hadn’t chased it. There can be significant changes, as we all 
know, in that time period.’ B5, F, mother severe VF loss. 
Overall, communication with physicians and care teams seemed to be a core 
element of the caregiver role in COAG. Participants in Group A also expressed this, 
despite not identifying a caregiver as part of the study. This suggests that family and 
friends may play an important role in the understanding and management of COAG, 
regardless of the label assigned.   
Obligation toward patient 
Caregivers in Group B used language, which suggested that they felt a certain 
amount of obligation toward the day-to-day management of COAG. This sense of 
obligation was often expressed in the context of administering medication. 
‘It’s very difficult if one is going out. You think ‘oh no, I'm not going to be back in time 
for the eye drops’ and this sort of thing. You’re not just thinking of yourself. You’re 
having to think of...[pause] well, you need to be there to get the drops in.’ B5, F, 
mother severe VF loss. 
In previous literature, caregivers for patients with visual impairments have 
expressed guilt and this may impact the relationship between patient and caregiver 
in the long term (Vukicevic, Heraghty, Cummins, Gopinath, & Mitchell, 2016). In this 
study, however, the sense of obligation seemed to be mediated by positive outcomes 
for the patient and most caregivers who expressed these feelings did not describe a 
sense of guilt. 
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‘I accept that we do drops at night or whatever, but honestly, personally it’s made no 
difference to me at all. But the other gratifying side is an improvement in the eyes. 
We've had a trabeculectomy in one eye and a stent in the other eye. We go back next 
week, or in 10 days to get that final result, if the pressures have dropped everyone’s all 
quite happy. You know what I mean? That in itself has been worth me doing a few 
drops at night.’ B8, M, wife moderate VF loss. 
Some patients in Group B, however, expressed a degree of guilt and self-blame that 
their caregivers felt the obligation to administer medication. 
‘...but when I have the operation and there’s a lot of bottles and I cannot press them. 
So, if I'm out somewhere, somebody else has to do them. But other than that [name 
omitted] has to do them. That's the only bug bear, and that’s my fault, not his.’ B2, F, 
moderate VF loss. 
Caregivers in Group B discussed their obligation toward helping the patient 
maintain their independence, particularly post-surgery, in hopes of improving the 
patient's QoL and speeding up recovery. These feelings seemed to arise due to 
empathy with the patient’s circumstances. 
‘Well yeah, because you do constantly think when someone is recovering from 
something, that part of the rehabilitation is to get them out and about because we all 
know that if you’re unwell – because after surgery you are. Even if you know there’s 
going to be recovery because most of these things are flexible in the long term. Part of 
that is getting well. You would be thinking – each day I would programme in – more so 
than we would ordinarily have lived our lives, take him to the garden centre, take him 
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to this, do that, because you’re constantly aware that might improve recovery.’ B7, F, 
husband moderate VF loss. 
Participants in Group A expressed the importance of the support of their loved one’s 
post-surgery, but in contrast to Group B also stressed the need for any interventions 
to also fit around their own personal plans. 
‘I was mostly self-sufficient. I remember feeling really fortunate that the date of the 
operation came through and it was – because I work school hours, it was lumped on to 
the February half term and I remember thinking ‘oh great, I’ve only got to take one 
week off school instead of two’. It’s funny, the things that go through your head at this 
time. But yes, afterwards, my husband was very closely involved in administering all 
the drugs because, as you know, some have to be every hour all day. Every waking 
hour. So, there’s quite a lot to remember. He was quite instrumental in making sure I 
did that properly. But everything else was fine.’ A1, F, moderate VF loss 
It’s unclear from the accounts in Group A, whether this sense of obligation toward 
the patient was present, but the patient’s description of their partner being ‘quite 
instrumental in making sure I did that properly’ suggests a degree of responsibility.  
Losing independence 
A theme that was commonly expressed by participants in Group A was the 
importance of maintaining their independence, whilst the participants in Group B 
stressed a more collaborative approach to their health, which involved their 
caregiver at all stages. Participants in Group A anticipated that worsening disease 
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and subsequent loss of independence may lead to increased care needs, and that 
this was likely to impact on their emotional functioning. 
‘As the disease progresses and has a physical impact where maybe – I hope in the 
distant future – I might need some form of physical support to get around. Obviously, I 
won’t be able to drive and all these things that I anticipate might happen. I suppose it 
might have a psychological impact, whereas my life hasn’t changed very much, apart 
from having operations and attending appointments and putting in drops daily. All 
that is very important of course, you never forget it. It’s always in the back of your 
mind. But I think once it starts to impact your life, and maybe losing independence in 
the future, I think then it might have a psychological impact.’ A1, F, moderate VF 
loss. 
Driving was the primary factor discussed by participants in Group A. All participants 
in Group A expressed concern about the impact that losing their driving license 
would have on their wellbeing. 
‘I think, for me, I share the view that I’m okay, if you like. I haven’t had a situation 
where I’ve had to – where I’ve failed my eye test for driving, which would have a major 
impact on my life, I would think, if that happened. But I feel fairly secure in that I have 
issues with one of my eyes but the other one I’ve got extremely good vision on. So, I 
don’t think I’ve going to have to face that challenge. Certainly not on the next review.’ 
A3, M, early VF loss. 
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Other participants who identified concerns expressed that these challenges were 
not an immediate concern, rather something that could be faced at a later date, and 
stressed the importance of support services being in place at this stage. 
‘I can imagine that having some sort of access to – almost like the Samaritans for 
people who are suicidal, for somebody to ring up and say ‘this is what I’m afraid of, 
what should I do?’, who can perhaps point me in the right direction. I can see that sort 
of service being very valuable. It doesn’t sound like we [the group] would need to ring 
it, but I can imagine quite a lot of situations where people might. People who have 
perhaps got sight deterioration in excess of ours.’ A4, M, early VF loss 
Fear of going blind was expressed by reflecting on the experiences of others rather 
than the patient’s own experience. Framing fears in this way may be an attempt to 
dissociate from the negative group identity of ‘glaucoma patient’, which may act as a 
protective factor for psychological wellbeing (Weiss & Lang, 2012). 
‘You watch these things about people who have had massive degeneration and things 
like that and they do become very lonely and very introspective and very depressed 
because the loss of any sense, but your sight in particular, does affect your whole life. 
There’s so many things you can’t do, you can’t enjoy. You can’t read, you can’t watch 
television, you can’t drive, you can’t see the countryside. There’s so much you’re 
missing out on losing your sight. If you go deaf, okay, you can’t hear, but you get 
subtitles, it’s not the end of the world. Going blind must be absolutely terrible and 
knowing that you’re going blind must be even worse.’ A2, M, moderate VF loss. 
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Participants in Group B had less fears surrounding loss of independence and 
appeared to have a more collaborative attitude to their COAG management, which 
involved the caregiver having a high level of knowledge about the condition. This 
high level of disease knowledge may give caregivers increased confidence in 
carrying out their caregiving tasks (Mok, Chan, Chan, & Yeung, 2013). 
‘I think, from a carer’s point of view, there’s been lots of information – and in fairness - 
I've probably read a lot more of it than [name omitted] has. There is the information. 
We didn’t feel at any point that we couldn't have rung and had the support. We had a 
specialist eye nurse than we could have rung pretty much 24/7.’ B7, F, husband 






In this study, a focus groups design was used to investigate experiences of 
caregiving in glaucoma in a single clinic in England. Participants were selected 
purposively based on self-identified caregiver status. This was to ensure that 
comparisons between experiences in different patient groups were possible using 
interpretative phenomenological analysis (IPA). This research aimed to answer the 
question; ‘What are the factors that form the experience of informal caregiving in 
COAG?’ From the qualitative synthesis, it emerged that participants with an ICG 
stressed the importance of their ICG being involved in communicating with care 
teams and administering medications. ICGs felt a sense of obligation toward the 
patient, but this was not generally associated with negative emotions. Those without 
an ICG feared a loss of independence more than those with an ICG. This study 
speculates that aspects of COAG management, which are generally considered to 
primarily involve the patient, (e.g. hospital visits, taking medications) may need to 
include an ICG in order to inform successful health behaviours for some patients.   
Results from this study represent new knowledge about the experience of being an 
ICG for a glaucoma patient, and the experience of having an ICG from the patient 
perspective. This data might be useful for clinicians and practitioners who may not 
have considered ICG in COAG before. Particularly in a clinical setting, where it has 
been demonstrated that having an ICG present during consultations can help 
improve communication. Additionally, an ICG may be useful for when the clinician is 
attempting to gather information on medical history and monitor symptoms 
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(Laidsaar-Powell, et al., 2013). Moreover, this data might be useful for targeting 
advanced glaucoma patients without an ICG to prevent isolation and poor 
medication adherence in this population.  
The sense of obligation reported by ICGs in this study is another novel finding. This 
may be particularly important, because previous research has demonstrated that 
family ICGs who feel a sense of obligation to provide care and are unable to exercise 
their own agency, are more likely to experience psychological ambivalence 
(contradictory feelings or emotions about their family member) (Connidis & 
McMullin, 2002). One of the participants in Group B, the daughter of the patient, 
highlighted that they felt a sense of obligation to administer eye drops and that they 
felt guilt when they were unable to do this because of personal plans. This may be 
an interesting avenue for future research, as it has been demonstrated that 
ambivalent adult parent- child relationships may affect the long-term psychological 
wellbeing of both parties (Fingerman, Pitzer, Lefkowitz, Birditt, & Mroczek, 2008). 
However, other participants in this study reported that their caregiving role was 
rewarding. Research in ICGs demonstrates that many who provide informal care for 
family members with a serious illness reported that their role was rewarding, 
allowing for stronger personal relationships (Anderson & White, 2018). It may be 
important then for clinicians or support groups to recognise the diversity of 




Results of this study also support the findings of previous research that indicate 
there may be a precipice of care in COAG when patients lose the ability to self-
administer medication (Read, et al., 2018). Several participants in Group B 
highlighted problems with administering their own drops, and for some ICGs, 
administering drops and attending hospital appointments were their only care 
responsibilities. On the other hand, none of the participants in Group A reported 
problems with administering their drops. One participant did describe the 
involvement of her husband in drop administration post-operatively, as she was 
unable to administer her own medication. This supports the idea that care needs in 
COAG may be determined by the ability to administer medications. It may also be 
argued that the precipice of care in COAG could extend beyond medication 
administration. Many of the participants in Group A reported fears of losing their 
independence in other domains, particularly losing their driving license. This 
finding is very similar to findings found in qualitative investigations of experiences 
in patients with early dementia, where loss of self and protrusive knowledge of the 
condition becoming worse were mapped on to the CSM domains of identity and 
understanding (Harman & Clare, 2006). Previous research has demonstrated that 
losing the ability to drive is a key concern for COAG patients (Bhargava, Bhan-
Bhargava, Foss, & King, 2008). This fear of losing independence may be partly 
mediated by patients’ fear of becoming a burden on family and friends (Glen & 
Crabb, 2015). Therefore, in future research, the idea of the existence of a precipice 
of care should also be investigated in relation to losing the ability to drive.  
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This study had several strengths. To the author’s knowledge, this is the first study to 
use interpretative phenomenological analysis to investigate experiences of COAG. 
Because it is a purely idiographic approach and each case is considered individually 
before themes are generated, IPA allows for a detailed examination of lived 
experience, free from the confines of pre-existing theoretical conceptions (Smith & 
Osborn, 2015). The use of focus groups with open ended questions allowed for 
richer data collection, as the lead researcher designed the questions to reflect a 
broad range of topic areas (caregiving role, experience of caregiving, support for 
caregivers/patients) rather than focusing on specific issues (e.g. the role of the 
caregiver in administering medication). This allowed the participants to create and 
steer their own dialogue with minimal intervention from the researcher (Smith & 
Osborn, 2012). Focus groups may provide a richer dialogue when compared to 
traditional semi-structured interviews, due to the diversity of the participants. On 
the other hand, the use of focus groups, rather than one-to-one semi-structured 
interviews, led to some participants being more dominant in the dialogue (for 
example, B3 and B7 (husband and wife) in Group B). This presents a problem 
because it is likely to have affected the quality of the dialogue from the other 
participants. However, focus groups and IPA, when used together, did produce 
detailed information about the experience of having an ICG in COAG and allowed for 
direct comparison of experiences with patients who did not have a caregiver. 
Moreover, VF records were extracted from an EPR on the day of the focus groups, so 
they provided an up to date estimate of the participant’s vision at the time of the 
study. Using two different populations and comparing their experiences allowed us 
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to investigate the idea that a precipice of care may exist in COAG management and 
add ideas to literature already published on this topic.  
There were also several limitations to the study. For example, the optimum number 
of participants for a focus group is 6-8 (Bowling & Ebrahim, 2005). The current 
study was only able to recruit enough participants to Group B (n=8), with only four 
participants (out of seven who had agreed) attending in Group A. This may affect the 
transferability of the results to a wider population of COAG patients and caregivers, 
due to the limited number of opinions that were analysed.  In addition, the number 
of focus groups may also have been problematic. A large thematic analysis of 40 
focus groups suggested that around 80% of themes were discoverable with two to 
three focus groups, but that the optimum number of focus groups is between three 
and six (Guest, Namey, & McKenna, 2017).  However, due to the more idiographic 
nature of IPA compared to thematic analysis, a sample size of between four and ten 
participants is generally considered optimal (Hefferon & Gil-Rodriguez, 2011). 
There is a risk, however, that data saturation was not reached in this study and this 
is an important limitation to consider when assessing the dependability of the 
results. Many of the participants in both Group A and Group B reported other health 
conditions during the focus groups, but this information was not formally recorded. 
This may be important because around 65% of older adults between 64 and 85 
years old have more than one co-morbid chronic condition (Banerjee, 2015). Due to 
the study design, this study may have captured the experiences of co-morbid 
conditions in an informal capacity. Future research should aim to include this more 
explicitly in any conversation about ICG in COAG. This study also did not consider 
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personality as a factor, which may be important because we know that patient 
personality can affect the response to chronic illness (Furnham, 1989; Williams, 
O'Connor, Grubb, & O'Carroll, 2011). Further evidence shows the personality of the 
ICG can be influential on the patients’ physical and mental health, and that this is 
mediated by the ICGs perceived ability to successfully manage the condition 
(Lockenhoff, Duberstein, Friedman, & Costa Jr, 2011).  
 In conclusion, this study is novel in investigating the experience of having an ICG in 
COAG. The data demonstrates that having an ICG may be most likely when loss of 
independence occurs, and that this is something that patients without an ICG fear. 
ICGs in this study played a key role in communication with care teams, which may 
have benefits for both patients and clinicians. Further research should be 
undertaken to investigate the influence of self-efficacy and personality on CG 
experiences and to identify whether certain groups, such as divorced or widowed 
COAG patients with advanced VF loss, are at risk of poor management due to the 




Chapter Six – Summary of Main Findings and Future Work  
 
6.1 Summary of Main Findings 
 
The aim of this work was to explore the experience of living with Chronic Open-
angle Glaucoma (COAG). Specifically, to investigate the cognitive and emotional 
processes that may be involved in illness management from the perspective of both 
the patient and their immediate social support network (informal family 
caregivers). This work supports existing literature on the patient experience of 
COAG as a chronic illness and suggests the consideration of some external factors in 
order to fully capture this experience. Both quantitative and qualitative 
methodologies were employed to investigate the aims and research question of this 
thesis appropriately. This thesis identified and addressed prominent gaps in the 
literature surrounding the lived experience of COAG and these are summarised here. 
The study reported in Chapter Two was the first to measure illness representations 
in newly diagnosed patients with COAG/OHT. A comparison of illness 
representations of patients with a diagnosis of between 2 and 5 years can then be 
formed, allowing us to investigate the nature of illness representations over the 
course of the disease process. This study provided evidence that when personality 
type and general health are considered, newly diagnosed patients with COAG have 
marginally more positive perceptions of life in general, experience of symptoms and 
“understanding” of their condition (all p<0.01). In contrast, COAG patients with a 
diagnosis >2 years understood better their condition was long-term (p<0.01). These 
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results suggest that COAG diagnosis may not be as distressing as previous studies 
have indicated (Hartmann & Rhee, 2006; Lacey, Cate, & Broadway, 2009; Odberg, 
Jakobsen, Hultgren, & Halseide, 2001). Interestingly, no differences in illness 
representations were found between patients with OHT and patients with COAG and 
there were no differences in the OHT group who were newly diagnosed, compared 
to those who had an established diagnosis. One possible explanation for this novel 
finding is that OHT patients may be employing the ‘no symptoms, no asthma’ belief 
when it comes to their condition (Halm, Mora, & Leventhal, 2006).  This is a 
maladaptive coping mechanism where the diagnosis is essentially ignored until it 
starts to present symptoms. It is thought that this thinking could shield patients 
from negative emotional responses to illness, such as anxiety and depression 
(Scharloo, et al., 1998; Llewellyn, McGurk, & Weinman, 2007). Patients with OHT do 
not experience symptoms from their condition, and this may explain their 
remarkably positive illness representations and the finding that there were no 
differences between cases and controls. The similarity of illness representations 
between the OHT and COAG patients also indicated the need for better 
communication of the diagnosis of OHT and appropriate advice on the actual long-
term risk of VF loss in this population. Participants with an established diagnosis did 
not feel as positive about life in general and did not feel that they understood their 
condition well, despite this group not having worse VF loss than the group of newly 
diagnosed participants. This may be reflective of the largely idiopathic nature of 
COAG.  Patients with a strong illness identity demonstrate more positive illness 
representations overall (Hale, Treharne, & Kitas, 2007) and are more likely to 
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engage with recommended treatment programmes (Hemphill, Stephens, Rook, 
Franks, & Salem, 2013). Results of this study indicated that COAG patients had poor 
understanding of their condition and indicated that they had little confidence in 
their treatment. This supports previous qualitative studies on illness 
representations in COAG, which demonstrated that those with a fragmented illness 
identity were less likely to adhere to treatment (McDonald, Ferguson, Hagger, Foss, 
& King, 2019). Although this study presents a novel and interesting view of the 
possible changes to cognitive representations of illness over the course of the 
disease, it is important that these results are interpreted with caution, as illness 
representations form along on individual level and are influenced by factors such as 
life experience and personality (Petrie, Jago, & Devcich, 2007). This means that 
group comparisons may be limited in their usefulness.   
The study reported in Chapter Three tested the feasibility of a multi-faceted online 
self-monitoring tool designed to enable the patient to become more involved in their 
COAG journey through self-monitoring visual symptoms and keeping a diary of their 
experiences. This study provided insight into the emotional representations 
involved in living with COAG. Previous studies investigating the emotional response 
to COAG have been conducted but mostly with newly diagnosed patients (Hartmann 
& Rhee, 2006; Lacey, Cate, & Broadway, 2009; Odberg, Jakobsen, Hultgren, & 
Halseide, 2001). Results showed good uptake of the self-monitoring exercise, with 
96% of symptom monitoring questions completed and participants recording a 
median (interquartile range) of 1858 (703, 4094) words in their monitoring diary 
over the eight-week study period. Patients reported a variety of important life 
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changes due to their COAG, such as increased frustration and cessation of activities 
as well as stressing the importance of social support and clinician trust as protective 
factors for their wellbeing.  These findings are interesting because they provide 
some evidence that anxiety (particularly around activities) and depression still 
affect patients who are in the latter stages of their disease process. Most patients 
found the monitoring exercise to be useful and felt that they would benefit from 
continuing to use self-monitoring diaries in the future. The content of the self-
monitoring activity presented in this chapter incorporated elements of other 
interventions in eye disease literature, such as diaries to monitor emotional 
representations (Stanford, Waterman, Russell, & Harper, 2009) and monitoring of 
medication adherence (Newman-Casey, Weizer, Heisler, Lee, & Stein, 2013). This 
study also incorporated a measure of personality (Gosling, Rentfrow, & Swann, 
2003) and found that patients’ emotional stability was weakly correlated with 
uptake of the self-monitoring exercise (rho=0.36, p<0.05), which may have 
important implications. Particularly as one of the participants in the study identified 
that a constant focus on symptoms, lead to negative emotions over the study period. 
This could be an important finding to consider when designing self-monitoring 
exercises for patients in the future, as private self-focus and rumination is 
associated with depression and generalised anxiety in some people (Mor & 
Winquist, 2002). However, expression of negative emotions has been shown to lead 
to long-term habituation in others (de Ridder, Geenen, Kuijer, & van Middendorp, 
2008). It is possible that this relationship may be mediated by personality factors, 
such as the ones measured in this study, but the small sample size and lack of 
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information on the validity of the self-monitoring exercise means that this idea 
needs to be investigated further.  
Participants in Chapter Three identified social support as a key factor when 
contributing to their adjustment to illness and in forming successful illness 
behaviours. Therefore, the impact of supporting a patient with COAG on informal 
caregivers was investigated in Chapter Four. This was achieved through estimating 
ICG strain in COAG using a standardised instrument and comparing against 
estimates in other neurological illnesses. This study provided evidence that ICG 
strain in COAG really only becomes apparent when the patient is in the more 
advanced stages of the disease, and that it is much lower than ICG strain reported in 
other conditions such as Parkinson’s Disease and Multiple Sclerosis (Peters, 
Jenkinson, Doll, Playford, & Fitzpatrick, 2013). Mean (standard deviation) caregiver 
strain was considerably inflated in the advanced patients (5.6 [4.9] vs 1.5 [2.2] for 
non-advanced; p=0.040). In the patients with an ICG, 87% (33/38) self-reported 
they were married or in a committed relationship as opposed to being single, 
divorced, widowed or separated; in contrast this proportion was 60% (40/67) in 
the patients who did not have an ICG and the difference was statistically significant 
(p=0.004). This indicates that the presence of an ICG is likely to be related to 
whether a patient is married or in a committed relationship.  Participants in this 
study specifically identified ICG strain in the areas of work and emotional 
adjustments, changes to personal plans and changes in their personal relationship 
with the patient. These findings add to previous work which has suggested that ICGs 
for patients with COAG expressed concerns about the lack of patient education and 
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the development of poor coping mechanisms as a result (Shtein, Newman-Casey, 
Herndon, Coleman, & Lee, 2016; Waisbourd, et al., 2016). The study presented in 
Chapter Four provides evidence that ICG strain in COAG is related to worsening 
vision and QoL, but it does not take into consideration potential co-morbid 
conditions. This is important because previous studies have identified co-morbid 
conditions as potentially important indicators for the presence of an ICG in COAG 
(Read, et al., 2018). Interestingly, no differences were found in the levels of ICG 
strain experienced by men and women, which is in contrast to previous literature 
suggested that women were the most affected by this role (Yee & Schulz, 2000; 
McCullagh, Brigstocke, Donaldson, & Kalra, 2005). However, it was noted that the 
measure used to investigate ICG strain in this study (MCSI; Thornton & Travis, 
2003) may not have been sensitive enough to capture condition specific strains.  
Based on the findings of the study in Chapter Four, it was hypothesised that there 
may be COAG specific strains that formed part of the ICG experience in COAG. 
Chapter Five therefore aimed to investigate this idea further. Focus groups were 
conducted with two different groups and interpretative phenomenological analysis 
(IPA) was used to present an account of the participants’ experiences of ICG in 
COAG. Participants without an ICG feared a loss of independence, whereas those 
with an ICG and their ICGs stressed collaboration where loss of independence 
became a problem. ICGs and the patients discussed the importance of the ICG being 
involved in communicating with care teams and administering medications, factors 
also identified as being protective to the patients’ wellbeing the diary exercise 
presented in Chapter Three. In a clinical setting, it has been demonstrated that 
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having an ICG present can help improve doctor-patient communication, particularly 
during history taking, as the ICG is often able to provide more information than the 
patient (Laidsaar-Powell, et al., 2013) and the findings from this research indicate 
that this may be the case in COAG too. ICGs in the study felt a sense of obligation 
toward the patient, but this was not generally associated with negative emotions, 
except in one participant. The majority of ICGs reported changes to personal plans, 
for example to attend hospital appointments, and emotional adjustments during the 
focus group, but these were not generally negative. The findings of this study 
indicate that the estimate of ICG strain in Chapter Four may be capturing the 
experience of being an ICG, rather than ICG strain. This study speculates that a more 
integrated approach should be taken to COAG management in order to inform 
successful health behaviours for some patients.  However, it is important to consider 
that this study may have been underpowered compared to the optimum number of 
participants for a focus groups study (Bowling & Ebrahim, 2005). It is likely that 
other factors may also influence the experience of being an ICG in COAG, such as 
personality and the ICGs perceived ability to successfully manage the condition 




6.2 Future Work 
 
The studies reported in this thesis provide some understanding of the cognitive and 
emotional processes involved in adjustment to and management of COAG. Yet, 
because they represent novel areas of study in COAG, they also raise a number of 
interesting questions, which should form the basis for future research in this area. 
Specific areas for future research are discussed in this section: 
Chapter Two demonstrated that illness representations may be dynamic in COAG, 
but this study was performed as a case-control cross-sectional study, which only 
included participants at two clinical centres with a fairly homogenous patient group. 
This makes it hard to determine the effect of demographic characteristics on illness 
representations in the COAG population, and this should be taken into consideration 
in future research. A longitudinal cohort study examining a wider demographic of 
patients from different clinical centres would be useful for exploring these ideas. It 
may be particularly interesting to also include the idea of the instrumental social 
support network in COAG that was presented in Chapters Three, Four and Five in 
any cohort study. Previous research has demonstrated discordance between illness 
representations of caregivers and patients, with caregivers having notably more 
negative representations (Richardson, Morton, & Broadbent, 2015). The interaction 
between patient and caregiver illness representations was also found to have an 
effect on patient QoL and implications for care, so this is an important area for 
further investigation. A notable finding from the study in Chapter Two was the 
similarity between illness representations in patients with COAG and patients with 
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OHT. A study exploring, in more detail, self-reported outlook and prognosis 
(consequence beliefs) for people with OHT and how this differs from patients 
diagnosed with COAG with VF loss would be interesting. This could form part of a 
follow-up study to look at the impact of more detailed post diagnosis education in 
both COAG and OHT. Patients could be placed in different educational intervention 
groups to investigate how post diagnosis education impacts the formation and 
maintenance of illness representations. Previous research has identified nine key 
health education needs for COAG/OHT patients (Waterman, et al., 2013) and a study 
incorporating these may be useful as a basis for change surrounding the information 
delivered to patients with OHT at the point of diagnosis. 
The work in Chapter Three posits the idea that self-monitoring visual and 
psychological status outside of clinic may be a useful tool for patients. Further work 
should investigate the usefulness and feasibility of a carefully designed self-
monitoring intervention in a larger group of patients. This will also allow for better 
concsions to be formed around the impact of patient personality on engagement 
with self-monitoring interventions. The findings suggested that an online diary may 
yield more information about a patient’s psychological wellbeing when compared to 
a hospital consultation and this should be investigated further by determining what, 
if any, insight patients provide clinicians with during consultations. A notable 
finding of the work in Chapter Three was that one of the ten participants felt that a 
constant focus on symptoms was damaging to their psychological wellbeing. This 
suggests that any further research into the idea of self-monitoring visual symptoms 
in COAG may benefit from the inclusion of aspects of positive psychology. Positive 
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psychology interventions have been shown to improve happiness, satisfaction and 
enhance patient motivation (Wood, Froh, & Geraghty, 2010). It may therefore be 
worthwhile to trial an intervention, which includes one or more aspects of the 
Action for Happiness ‘Happiness Action Pack’ (Action for Happiness, 2016). This 
work should also put a specific focus on targeting patients who may need extra 
psychological support because of a lack of perceived or actual social support.  
The work in Chapter Four raised important questions about the nature of informal 
caregiving (ICG) in COAG. Caregivers identified work and emotional adjustments, 
changes to personal plans and changes in their relationship with the patient as key 
areas for concern. This was supported by the findings in Chapter Five where ICGs 
reported a sense of obligation toward the patient; particularly post operatively and 
with their daily medications. Although the ICGs in this study did not have 
particularly negative connotations with their caregiving role, it is important to raise 
awareness, as we know from previous research, that feelings toward the ICG role 
can affect the patient-ICG relationship in the long term (Vukicevic, Heraghty, 
Cummins, Gopinath, & Mitchell, 2016; Fingerman, Pitzer, Lefkowitz, Birditt, & 
Mroczek, 2008; Anderson & White, 2018).  A raised awareness is also useful because 
there is evidence that ICGs who are given adequate support do not experience as 
much strain (Royal College of General Practitioners, 2012). The establishment of 
caregiver support groups in COAG would form an interesting topic for future 
research. There is evidence that caregiver support groups give ICGs the opportunity 
to seek guidance, information and encouragement (White & Dorman, 2000). These 
support groups need not be large face to face meetings, but could take the form of 
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telephone or internet groups, as there is evidence that these provide equally 
effective improvements in mood states and self-reported caregiver burden (Brown, 
et al., 1999). There is evidence that online caregiver support groups may be less 
egalitarian and less concerned with social status than face-to-face support groups, 
which could benefit those from disadvantaged backgrounds (White & Dorman, 
2001).  
Identifying and supporting ICGs in COAG is imperative, but more research should 
also be conducted on the role that ICGs may play, particularly in terms of 
contributions to hospital consultations and clinical decision making. The 
participants in Chapter Five reported that they found it extremely useful to have 
their ICG present during hospital consultations, and some participants who did not 
identify an ICG also reported that they found having a companion present during 
consultations was useful or would be useful. It may be important then to speak to 
clinicians about their experiences of what is deemed triadic consultations. Research 
evidence on this topic has diverse conclusions. A review of 52 studies on triadic 
consultations found that whilst some clinicians view ICGs as a useful tool for 
symptom monitoring and history taking, some view ICGs as problematic in hospital 
consultations (Laidsaar-Powell, et al., 2013). There may also be scope to conduct 
future research with clinicians using the TRIO guidelines to improve clinical 
communication if challenges arise with the presence of family ICGs (Laidsaar-
Powell, Butow, Boyle, & Juraskova, 2018).   
172 
 
In Chapter Five there were differences between those who identified an ICG and 
those who did not and these may form an interesting basis for future work. 
Participants in the group that did not identify an ICG (Group A) still reported that 
they received help with instilling eye drops, particularly post-operatively and some 
reported that their partner attended their hospital appointments. This may be 
because the word ‘caregiver’ lacks consistent conceptualisation (Hermanns & 
Mastel-Smith, 2012). This again highlights the need for raised awareness around the 
ICG role in COAG. The largest difference between those with an ICG and those 
without was their emotional response to loss of independence. Participants in 
Group A repeatedly talked about the need to maintain independence, whereas this 
was not mentioned in Group B, where a more collaborative approach was taken. 
This highlights idiosyncratic strains for COAG patients that might include the 
psychological burden of having a potentially blinding condition or loss of visual 
function that might restrict mobility or remove a driving licence. It is notable that 
participants in Chapter Five framed their fears of going blind by reflecting on the 
experiences of others, which other studies have suggested may be a maladaptive 
coping mechanism employed to enhance short-term wellbeing (Weiss & Lang, 
2012).  However, in this population, eventual loss of sight may present larger 
psychological challenges. There is evidence that a strong illness identity, which may 
be absent in patients who do not identify with a COAG diagnosis, leads to acceptance 
of the diagnosis and better functional and psychological outcomes (Hale, Treharne, 
& Kitas, 2007; Kirby, Broom, Sibbritt, Refshauge, & Adams, 2015). This may in turn 
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affect the identity of their ICG, should they need one in the future (Eifert, Adams, 
Dudley, & Perko, 2015).  
Others have discussed the importance of identifying a precipice when patients lose 
self-medicating capability, and this might be identifiable with an appropriate 
instrument for the ICG (Read, et al., 2018).  Therefore, in future research the idea of 
the existence of a precipice of care should also be investigated in relation to other 





6.3 Autobiographical Reflection 
 
The importance of honest reflexivity when using qualitative methodology in social 
scientific research is widely acknowledged. This is the process of becoming self-
aware and making an effort to consider your own thoughts and actions as a 
researcher, and how these may impact data collection or data analysis (Mills, 
Durepos, & Wiebe, 2010). As the author of this thesis, it is important for me to 
acknowledge my own position and the reflexive process that I employed when 
conducting the studies. At the beginning of my PhD, I was relatively new to 
qualitative data analysis, and found little guidance within the ophthalmology 
research community on methodological best practice. I believe that this may have 
influenced me to take a cautious approach to data analysis, particularly in Chapter 
Three, where I identified and presented only semantic (explicit) themes within the 
data. A trend within thematic analysis is to also present latent themes, which are 
based on underlying ideas or assumptions and go beyond the actual content of the 
data set (Braun & Clarke, 2006). Due to the lack of research on the topic of the 
patient experience in COAG, there were few existing assumptions to rely on and 
therefore only semantic themes were identified in the data.  A more experienced 
qualitative researcher may have used theoretical assumptions from other chronic 
illnesses to make use of the latent aspects of the data. During the final year of my 
PhD, I was employed as a lecturer in health psychology, and became part of an 
academic community, which I felt placed a higher value on the findings of qualitative 
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research. This position also gave me access to experienced qualitative researchers 
and enabled me to build my skills in this area. For the research presented in 
Chapter Five, I employed a reflexive journal in order to assess the impact of my 
own questions and experiences regarding caregiving in COAG. A certain degree of 
expectation existed when I initially began reading the data set, which was due to the 
findings of the work presented in Chapter Four. The use of interpretative 
phenomenological analysis (IPA) in this study was key to minimising the impact of 
these assumptions on the data analysis. IPA is challenging, as the researcher must 
interpret the experiences of another individual in real terms. Smith and Osborn 
(2012) describe the process as, ‘the researcher trying to make sense of the 
participants trying to make sense of their world’. In this way, IPA is more of a 
descriptive tool rather than an analytical one. The use of the reflexive journal 
minimised the possibility that I was not going beyond what existed within the data 
set or making assumptions about participant experiences. These reflections are 
important when making conclusions based on the qualitative analyses conducted 
within this thesis.   
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6.4 Final word 
 
The material presented within this thesis provides an overview of the complex 
emotional and cognitive processes involved in adaptation to COAG as a chronic 
illness. The work demonstrates that living with COAG is a dynamic process, 
involving both the patient and their informal caregivers. This thesis highlights the 
need for more work investigating the cognitive and emotional processes of patients 
with COAG. There is also a need to investigate the role of the clinical team in 
adapting to COAG, with the view to providing a more integrated, multifaceted 
approach to clinical care in COAG. 
177 
 
List of Supporting Publications  
 
Peer reviewed manuscripts 
 
McDonald, L., Glen, F. C., Taylor, D. J. & Crabb, D., P. (2017) Self-Monitoring 
Symptoms in Glaucoma: A Feasibility Study of a Web-Based Diary Tool. Journal of 
Ophthalmology. Article ID: 8452840. 8 pages. https://doi.org/10.1155/2017/8452840 
McDonald, L., Boodhna, T., Ajtony, C., Turnbull, P., Bourne, R. R. A. & Crabb, D. P. 
(2019) Illness Perceptions in People Newly Diagnosed with Glaucoma and Ocular 
Hypertension. British Journal of Ophthalmology. 
http://dx.doi.org/10.1136/bjophthalmol-2018-313781 
McDonald, L., Chang, L., Turnbull, P. & Crabb D.P. (2020) Taking the strain? The 







United Kingdom and Éire Glaucoma Society (UKÉGS) – City, University of 
London 2018 – London, England – Poster Presentation 
Taking the strain? The impact of glaucoma on patient’s informal caregivers. 
Leanne McDonald, Lydia Chang, Paula Turnbull, David P. Crabb 
 
British Congress of Optometry and Vision Science (BCOVS) – Anglia Ruskin 
University 2018 – Cambridge, England – Oral Presentation 
Taking the strain? The impact of glaucoma on patient’s informal caregivers. 
Leanne McDonald, Lydia Chang, Paula Turnbull, David P. Crabb 
 
The Association of Research in Vision and Ophthalmology (ARVO) 2018 – 
Honolulu, Hawaii, USA – Poster Presentation 
Taking the strain? The impact of glaucoma on patient’s informal caregivers. 
Leanne McDonald, Lydia Chang, Paula Turnbull, David P. Crabb 
 
The School of Health Sciences Doctoral Research Conference – City, University 
of London 2018 – London, England – Oral Presentation 
Taking the strain? The impact of glaucoma on patient’s informal caregivers. 
Leanne McDonald, Lydia Chang, Paula Turnbull, David P. Crabb 
 
British Congress of Optometry and Vision Science (BCOVS) – University of 
Plymouth 2017 – Plymouth, England – Oral Presentation 
Illness Perceptions in People Newly Diagnosed with Glaucoma and Ocular 
Hypertension. 




United Kingdom and Éire Glaucoma Society (UKÉGS) 2016 – Cheltenham, 
England – Oral Presentation 
179 
 
Illness Perceptions in People Newly Diagnosed with Glaucoma and Ocular 
Hypertension. 
Leanne McDonald, Trishal Boodhna, Csilla Ajtony, Rupert R. A. Bourne, David P. 
Crabb 
The Association of Research in Vision and Ophthalmology (ARVO) 2016 – 
Seattle, Washington, USA – Poster Presentation 
Self-Monitoring Symptoms in Glaucoma: A Feasibility Study of a Web-Based Diary 
Tool 
Leanne McDonald, Fiona C. Glen, Deanna J. Taylor, David P. Crabb 
The Association of Research in Vision and Ophthalmology (ARVO) 2016 – 
Seattle, Washington, USA – Poster Presentation 
Illness Perceptions in People Newly Diagnosed with Glaucoma and Ocular 
Hypertension. 
Csilla Ajtony, Leanne McDonald, Trishal Boodhna, Rupert R. A. Bourne, David P. Crabb 
 
The School of Health Sciences Doctoral Research Conference – City, University 
of London 2016 – London, England – Oral Presentation 
Illness Perceptions in People Newly Diagnosed with Glaucoma and Ocular 
Hypertension. 
Leanne McDonald, Trishal Boodhna, Csilla Ajtony, Rupert R. A. Bourne, David P. 
Crabb 
 
European Glaucoma Society Congress (EGS) 2016 – Prague, Czech Republic – 
Poster Presentation 
Illness Perceptions in People Newly Diagnosed with Glaucoma and Ocular 
Hypertension. 







Aaronson, N. K. (1988). Quantitative issues in health-related quality of life assessment. 
Health Policy, 10(3), 217-230. 
Action for Happiness. (2016). Action For Happiness: Happiness Action Pack. Retrieved from 
Action For Happiness: 
https://www.actionforhappiness.org/media/80216/happiness_action_pack.pdf 
Alqudah, A., Mansberger, S. L., Gardiner, S. K., & Demirel, S. (2016). Vision-related quality of 
life in glaucoma suspect or early glaucoma patients. Journal of Glaucoma, 629-633. 
Altangerel, U., Spaeth, G. L., & Steinmann, W. C. (2006). Assessment of function related to 
vision (AFREV). Ophthalmic Epidemiology, 67-80. 
Anderson, E. Q., & White, K. M. (2018). “It Has Changed My Life”: An Exploration of 
Caregiver Experiences in Serious Illness. The American Journal of Hospice and 
Palliative Care, 35(2), 266-274. 
Applebaum, A. J., Stein, E. M., Lord-Bessen, J., Pessin, H., Rosenfeld, B., & Breitbart, W. 
(2014). Optimism, Social Support, and Mental Health Outcomes in Patients with 
Advanced Cancer. Psychooncology, 299-306. 
Araci, I. E., Su, B., Quake, S. R., & Mandel, Y. (2014). An implantable microfluidic device for 
self-monitoring of intraocular pressure. Nature Medicine, 20(9), 1074-1078. 
Ariza-Vega, P., Ortiz-Pina, M., Kristensen, M. T., Castellote-Caballero, Y., & Jimenez-Moleon, J. 
J. (2019). High perceived caregiver burden for relatives of patients following hip 
fracture surgery. Disability and Rehabilitation, 41(3), 311-318. 
Asaoka, R., Crabb, D. P., Yamashita, T., Russell, R. A., Wang, Y. X., & Garway-Heath, D. F. 
(2011). Patients Have Two Eyes!: Binocular versus Better Eye Visual Field Indices. 
Investigative Ophthalmology and Visual Science, 52(9), 7007-7011. 
Asch, D., Muller, R., & Volpp, K. (2012). Automated hovering in healthcare – watching over 
the 5000 hours,. The New England Journal of Medicine, 367(1), 1-3. 
Asoaka, R. (2013). The relationship between visual acuity and central visual field sensitivity 
in advanced glaucoma. British Journal of Ophthalmology, 1355-1356. 
Austenfeld, J. L., & Stanton, A. L. (2004). Coping through emotional approach: a new look at 
emotion, coping, and health-related outcomes. Journal of Personality, 72(6), 1335-
1363. 
Baker, C., & Stern, P. N. (1993). Finding meaning in chronic illness is key to self-care. The 
Canadian Journal of Nursing Research, 23-36. 
Bandura, A., & Adams, N. E. (1977). Analysis of self-efficacy theory of behavioral change. 
Cognitive Therapy and Research, 287-310. 
181 
 
Banerjee, S. (2015). Multimorbidity—older adults need health care that can count past one. 
The Lancet, 385(9968), 587-589. 
Barlow, J., Wright, C., Sheasby, J., Turner, A., & Hainsworth, J. (2002). Self-management 
approaches for people with chronic conditions: a review. Patient Education and 
Counselling, 177-187. 
Barnett, K., Mercer, S. W., Norbury, M., Watt, G., Wyke, S., & Guthrie, B. (2012). Epidemiology 
of multimorbidity and implications for health care, research, and medical education: 
a cross sectional study. The Lancet, 380, 37-43. 
Basch, E., Deal, A. M., Kris, M. G., Scher, H. I., Hudis, C. A., Sabbatini, P., . . . Schrag, D. (2016). 
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer 
Treatment: A Randomized Controlled Trial. Journal of Clinial Oncology, 34(6), 557-
565. 
Batcheller, L., & Baker, D. (2019). Cost of disease modifying therapies for multiple sclerosis: 
Is front-loading the answer? Journal of the Neurological Sciences, 404(15), 19-28. 
Bell, R. W., & O'Brien, C. (1997). Accuracy of referral to a glaucoma clinic. Opthalmic and 
Physiological Optics, 17(1), 7-11. 
Bernell, S., & Howard, S. W. (2016). Use Your Words Carefully: What Is a Chronic Disease? 
Frontiers in Public Health, 4, 159. 
Bhargava, J. S., Bhan-Bhargava, A., Foss, A. J., & King, A. J. (2008). Views of glaucoma patients 
on provision of follow-up care; an assessment of patient preferences by conjoint 
analysis. British Journal of Ophthalmology, 92(12), 1601-1605. 
Biggerstaff, D., & Thompson, A. R. (2005). Interpretive phenomenological analysis (IPA): a 
qualitative methodology of choice in health care research. Qualitative Research in 
Psychology, 5, 214-224. doi:http://dx.doi.org/10.1080/14780880802314304 
Bodenheimer, T., Lorig, K., & Holman, H. (2002). Patient self-management of chronic disease 
in primary care. Journal of the American Medical Association, 2469-2475. 
Boland, M. V., Chang, D. S., Frazier, T., Plyer, R., Jefferys, J. L., & Friedman, D. S. (2014). 
Automated telecommunication-based reminders and adherence with once-daily 
glaucoma medication dosing: the automated dosing reminder study. JAMA 
Ophthalmology, 132(7), 845-850. 
Boodhna, T., & Crabb, D. P. (2016). More frequent, more costly? Health economic modelling 
aspects of monitoring glaucoma patients in England. BMC Health Services Research, 
16(1), 611. 
Borgermans, L., & Devroey, D. (2017). A Policy Guide on Integrated Care (PGIC): Lessons 
Learned from EU Project INTEGRATE and Beyond. International Journal of 
Integrated Care, 17(4), 8. doi:http://doi.org/10.5334/ijic.3295 
Bourne, R. R., Jonas, J. B., Bron, A. M., Cicinelli, M. V., Das, A., Flaxman, S. R., . . . Resnikoff, S. 
(2018). Prevalence and causes of vision loss in high-income countries and in Eastern 
182 
 
and Central Europe in 2015: magnitude, temporal trends and projections. British 
Journal of Ophthalmology, 102(5), 575-585. 
Bowling, A., & Ebrahim, S. (2005). Handbook of health research methods. Investigation, 
measurement and analysis. Maidenhead. UK.: Open University Press. 
Boyd, K. (2019, March 27). What is Gonioscopy? Retrieved from American Academy of 
Ophthalmology: https://www.aao.org/eye-health/treatments/what-is-gonioscopy 
Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in 
Psychology, 3(2), 77-101. 
Brenes, G. A. (2003). Anxiety and chronic obstructive pulmonary disease: prevalence, 
impact and treatment,. Psychosomatic Disorders, 65(6), 963-970. 
Brisenden, S. (1986). Independent Living and the Medical Model of Disability. Disability, 
Handicap & Society, 1(2), 173-178. 
doi:https://doi.org/10.1080/02674648666780171 
Broadbent, E., Petrie, K. J., & Main, J. (2006). The Brief Illness Perception Questionnaire. 
Journal of Psychosomatic Research, 60, 631-637. 
Broadbent, E., Wilkes, C., & Koschwanez, H. (2015). A systematic review and meta-analysis 
of the Brief Illness Perception Questionnaire. Psychology and Health, 30, 1361-1385. 
Brody, B. L., Roch-Levecq, A., Gamst, A. C., Maclean, K., Kaplan, R. M., & Brown, S. I. (2002). 
Self-management of Age-Related Macular Degeneration and Quality of Life: A 
Randomized Controlled Trial. Archives of Ophthalmology, 120(11), 1477-1483. 
doi:doi:10.1001/archopht.120.11.1477 
Brown, G. C., Brown, M. M., & Sharma, S. (2000). Difference between ophthalmologists' and 
patients' perceptions of quality of life associated with age-related macular 
degeneration. Canadian Journal of Ophthalmology, 35(3), 127-133. 
Brown, R., Pain, K., Berwald, C., Hirschi, P., Delehanty, R., & Miller, H. (1999). Distance 
Education and Caregiver Support Groups: Comparison of Traditional and Telephone 
Groups. Head Trauma Rehabilition, 14(3), 257-268. 
Burleson Sullivan, A., & Miller, D. (2015). Who is taking care of the caregiver? Journal of 
Patient Experience, 2(1), 7-12. 
Burmedi, D., Becker, S., Heyl, V., Wahl, H.-W., & Himmselsbach, I. (2009). Emotional and 
social consequences of age-related low vision. Visual Impairment Research, 47-71. 
doi:https://doi.org/10.1076/vimr.4.1.47.15634 
Caplan, S., & Whittemore, R. (2013). Barriers to Treatment Engagement for Depression 
among Latinas. Issues in Mental Health Nursing, 34, 412-424. 
Carnethon, M. R. (2009). Physical activity and cardiovascular disease: how much is enough? 
American Journal of Lifestyle Medicine, 44-49. 
Carr, A. J., Gibson, B., & Robinson, P. G. (2001). Is quality of life determined by expectations 
or experience? British Medical Journal, 322(7296), 1240-1243. 
183 
 
Casson, R. J., Chidlow, G., Wood, J. P., Crowston, J. G., & Goldberg, I. (2012). Definition of 
glaucoma: clinical and experimental concepts. Clinical and Experimental 
Ophthalmology, 40(4), 341-349. 
Chan, E. W., Chiang, P. P., Liao, J., Rees, G., Wong, T. Y., Lam, J. S., . . . Lamoureux, E. (2015). 
Glaucoma and associated visual acuity and field loss significantly affect glaucoma-
specific psychosocial functioning. Ophthalmology, 494-501. 
Chan, M. P., Broadway, D. C., Khawaja, A. P., Yip, J. L., Garway-Heath, D. F., Burr, J. M., . . . 
Foster, P. J. (2017). Glaucoma and intraocular pressure in EPIC-Norfolk Eye Study: 
cross sectional study. British Medical Journal, 358. 
Chang, S., Zhang, Y., Jeyagurunathan, A., Lau, Y. W., Sagayadevan, V., Chong, S. A., & 
Subramaniam, M. (2016). Providing care to relatives with mental illness: reactions 
and distress among primary informal caregivers. BMC Psychiatry, 16, 80. 
Chen, S. L., Tsai, J. C., & Chou, K. R. (2011). Illness perceptions and adherence to therapeutic 
regimens among patients with hypertension: a structural modelling approach. 
International Journal of Nursing Studies, 48, 235-245. 
Clare, L., Quinn, C., Jones, I. R., & Woods, R. T. (2016). “I Don’t Think Of It As An Illness”: 
Illness Representations in Mild to Moderate Dementia. Journal of Alzheimer's 
Disease, 51(1), 139-150. 
Coleman, A. L., & Miglior, S. (2008). Risk factors for glaucoma onset and progression. Survey 
of Opthalmology, 53(1), S3-10. 
Connidis, I. A., & McMullin, J. A. (2002). Sociological Ambivalence and Family Ties: A Critical 
Perspective. Journal of Marriage and Family, 64(3), 558-567. 
Crabb, D. P. (2016). A view on glaucoma - are we seeing it clearly? Eye (Lond), 30(2), 304-
313. 
Crabb, D. P., Fitzke, F. W., & Hitchings, R. A. (2004). A practical approach to measuring the 
visual field component of fitness to drive. British Journal of Ophthalmology, 88, 1191-
1196. 
Crabb, D. P., Saunders, L. J., & Edwards, L. A. (2017). Cases of advanced visual field loss at 
referral to glaucoma clinics – more men than women? Ophthalmic and Physiological 
Optics, 37(1), 82-87. 
Crabb, D. P., Smith, N. D., Glen, F. C., Burton, R., & Garway-Heath, D. F. (2013). How does 
glaucoma look? Ophthalmology, 1120-1126. 
Curtin , R. B., Walters, B. A., Schatell, D., Pennell, P., Wise, M., & Klicko, K. (2008). Self-efficacy 
and self-management behaviors in patients with chronic kidney disease. Advances in 
Chronic Kidney Disease, 191-205. 
Damji, K. F., Bovell, A. M., Hodge, W. G., Buhrmann, Y., Shah, K., Buhrmann, R., & Pan, Y. I. 
(2006). Selective laser trabeculoplasty versus argon laser trabeculoplasty: results 




Damman, W., Liu, R., Kaptein, A. A., Evers, A. W., van Middendorp, H., Rosendaal, F. R., & 
Kloppenburg, M. (2018). Illness perceptions and their association with 2 year 
functional status and change in patients with hand osteoarthritis. Rheumatology, 
57(2), 2190-2199. 
de Ridder, D., Geenen, R., Kuijer, R., & van Middendorp, H. (2008). Psychological adjustment 
to chronic disease. The Lancet, 372(9634), 19-25. 
Delaney, M., Simpson, J., & Leroi, I. (2011). Perceptions of causeand control of impulse 
control behaviours in people with Parkinson's disease. British Journal of Health 
Psychology, 522-535. 
Denollet, J. (2000). Type D Personality: A potential risk factor refined. Journal of 
Psychosomatic Research, 49, 255-266. 
Devlin, N. J., & Appleby, J. (2010). Getting the most out of PROMs: Putting health outcomes at 
the heart of NHS decision making. London: King's Fund. 
Devlin, N., & Brooks, R. (2017). EQ-5D and the EuroQol Group: Past, Present and Future. 
Applied Health Economics and Health Policy, 15, 127-137. 
Dew, K., Morgan, S., Dowell, A., Bushnell, J., & Collings, S. (2007). ‘It puts things out of your 
control’: fear of consequences as a barrier to patient disclosure of mental health 
issues to general practitioners. Sociology of Health and Illness, 29(7), 1059-1074. 
Division of Mental Health and Prevention of Substance Abuse. (1997). WHOQOL Measuring 
Quality of Life. Geneva: World Health Organization. 
Eastwood, C. A., Travis, L., Morgenstern, T. T., & Donaho, E. K. (2007). Weight and Symptom 
Diary for Self-monitoring in Heart Failure Clinic Patients. The Journal of 
Cardiovascular Nursing, 22(5), 382-389. 
Eifert, E. K., Adams, R., Dudley, W., & Perko, M. (2015). Family Caregiver Identity: A 
Literature Review. American Journal of Health Education, 46(6), 357-367. 
Ellingson, L. L. (2002). The roles of companions in geriatric patient-interdisciplinary 
oncology team interactions. Journal of Aging Studies, 16, 361-382. 
EuroQol. (1990). EuroQol - a new facility for the measurement of health-related quality of 
life. Health Policy, 16, 199-208. 
Falvo, D. (2005). Psychosocial and Functional Aspects of Chronic Illness and Disability. In D. 
Falvo, Medical and Psychosocial Aspects of Chronic Illness and Disability (p. 1). 
London, UK: Jones and Bartlett Publishers International. 
Farmer, A., Gibson, O. J., Tarassenko, L., & Neil, A. (2005). A systematic review of 
telemedicine interventions to support blood glucose self-monitoring in diabetes. 
Diabetic Medicine, 22(10), 1372-1378. 
Feinstein, L., Sabates, R., Anderson, T. M., Sorhaindo, A., & Hammond, C. (2006). What are 
the effects of education on health? London: OECD. 
185 
 
Fenwick, E. K., Ong, P. G., Eyn Kidd Man, R., Cheng, C. Y., Sabanayagam, C., Wong, T. Y., & 
Lamoureux, E. L. (2016). Association of Vision Impairment and Major Eye Diseases. 
JAMA Ophthalmology, 134(10), 1087-1093. 
Ferris, F. L., Kassoff, A., Bresnick, G. H., Bailey, I. (1982) New visual acuity charts for clinical  
research. American Journal of Ophthalmology, 94(1), 91-96. 
Fingerman, K. L., Pitzer, L., Lefkowitz, E. S., Birditt, K. S., & Mroczek, D. (2008). Ambivalent 
Relationship Qualities Between Adults and Their Parents: Implications for the 
Wellbeing of Both Parties. The Journals of Gerontology: Series B, 63(6), 362-371. 
French, D., Cooper, A., & Weinman, J. (2006). Illness perceptions predict attendance at 
cardiac rehabilitation following acute myocardial infarction: A systematic review 
with meta-analysis. Journal of Psychosomatic Research, 61(6), 757-767. 
Friedman, D. S., Hahn, S. R., & Gelb, L. (2008). Doctor-patient communication, health-related 
beliefs, and adherence in glaucoma: results from the glaucoma adherence and 
persistency study. Ophthalmology, 115, 1320-1327. 
Friedman, D. S., Hahn, S. R., Quigley, H. A., Kotak, S., Kim, E., Onofrey, M., . . . Mardekian, J. 
(2009). Doctor–Patient Communication in Glaucoma Care: Analysis of Videotaped 
Encounters in Community-Based Office Practice. Ophthalmology, 116(12), 2277-
2285. 
Frostholm, L., Oernboel, E., Christensen, K. S., Toft, T., Olesen, F., Weinman, J., & Fink, P. 
(2007). Do illness perceptions predict health outcomes in primary care patients? A 
2-year follow-up study. Journal of Psychosomatic Research, 62(2), 129-138. 
Furnham, A. (1989). Personality correlates of self-monitoring: The relationship between 
extraversion, neuroticism, type a behaviour and Snyder's self-monitoring construct. 
Personality and Individual Differences, 10(1), 35-42. 
Gaasterland, D. E., Blackwell, B., Dally, L. G., Caprioli, J., Katz, L. J., Ederer, F., & Investigators, 
A. G. (2001). The Advanced Glaucoma Intervention Study (AGIS): 10. Variability 
among academic glaucoma subspecialists in assessing optic disc notching. 
Transactions of the American Ophthalamological Society, 99, 177-184. 
Gazzard, G., Konstantakopoulou, E., Garway-Heath, D., Garg, A., Vickerstaff, V., Hunter, R., . . . 
LiGHT Trial Study Group. (2019). Selective laser trabeculoplasty versus eye drops 
for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre 
randomised controlled trial. The Lancet, 393, 1505-1516. 
Geruschat, D. R., & Turano, K. A. (2007). Estimating the Amount of Mental Effort Required 
for Independent Mobility: Persons with Glaucoma. Investigative Ophthalmology and 
Visual Science, 3988-3994. 
Gillespie-Gallery, H., Subramanian, A., & Conway, M. L. (2013). Micro-costing the provision 
of emotional support and information in UK eye clinics. BMC Health Services 
Research, 13, 482. 




Glen, F. C., & Crabb, D. P. (2015). Living with glaucoma: a qualitative study of functional 
implications and patients' coping behaviours. BMC Ophthalmology, 15, 128. 
Glen, F. C., Crabb, D. P., & Garway-Heath, D. F. (2011). The direction of research into visual 
disability and quality of life in glaucoma. BMC Ophthalmology, 11-19. 
Glen, F. C., Crabb, D. P., Smith, N. D., Burton, R., & Garway-Heath, D. F. (2012). Do patients 
with glaucoma have difficulty recognizing faces? Investigative Ophthalmology and 
Visual Science, 3629-3637. 
Glen, F. C., Smith, N. D., & Crabb, D. P. (2013). Saccadic eye movements and face recognition 
performance in patients with central glaucomatous visual field defects. Vision 
Research, 42-51. 
Gohil, R., Crosby-Nwaobi, R., Forbes, A., Burton, B., Hykin, P., & Sivaprasad, S. (2015). 
Caregiver burden in patients recieving Ranibizumab therapy for neovascular 
macular degeneration. PLOS One, 10(6), e0129361. 
Goldberg, I., Clement, C. I., Chiang, T. H., Walt, J. G., Lee, L. J., Graham, S., & Healey, P. (2009). 
Assessing Quality of Life in Patients With Glaucoma Using the Glaucoma Quality of 
Life-15 (GQL-15) Questionnaire. Journal of Glaucoma, 6-12. 
Gopinath, B., Craig , A., Kifley, A., Liew, G., Bloffwitch, J., Van Vu, K., . . . Mitchell, P. (2017). 
Implementing a multi-modal support service model for the family caregivers of 
persons with age-related macular degeneration: a study protocol for a randomised 
controlled trial . BMJ Open, 7(8), e018204. 
Gordon, M. O., Beiser, J. A., & Brandt, J. D. (2002). The ocular hypertension treatment study: 
baseline factors that predict the onset of primary open-angle glaucoma. Archives of 
Ophthalmology, 120, 714-720. 
Gosling, S. D., Rentfrow, P. J., & Swann, W. B. (2003). A very brief measure of the big five 
personality domains. Journal of Research in Personality, 37(6), 504-528. 
Gothwal, K., Bharani, S., & Mandal, A. K. (2015). Glaucoma Quality of Life of Caregivers of 
Children With Congenital Glaucoma : Development and Validation of a Novel 
Questionnaire ( CarCGQoL ) Vijaya. Investigative Ophthalmology and Visual Science, 
56(1), 770-777. 
Gray, T. A., Fenerty, C., Harper, R., Spencer, A. F., Campbell, M., Henson, D. B., & Waterman, H. 
(2012). Individualised patient care as an adjunct to standard care for promoting 
adherence to ocular hypotensive therapy: an exploratory randomised controlled 
trial. Eye (Lond), 26(3), 407-417. 
Guo, L., Moss, S. E., Alexander, R. A., Ali, R. R., Fitzke, F. W., & Cordeiro, M. F. (2008). Retinal 
Ganglion Cell Apoptosis in Glaucoma Is Related to Intraocular Pressure and IOP-
Induced Effects on Extracellular Matrix. Investigative Opthalmology and Visual 
Science, 46(1), 175-182. 
Hagger, M. S., & Orbell, S. (2003). A meta-analytic review of the common-sense model of 
illness representations. Psychology and Health, 18(2), 141-184. 
187 
 
Hale, E. D., Treharne, G. J., & Kitas, G. D. (2007). The common-sense model of self-regulation 
of health and illness: how can we use it to understand and respond to our patients' 
needs? Rheumatology, 904-906. 
Haley, W. E., Roth, D. L., Howard, G., & Safford, M. M. (2010). Caregiving Strain and 
Estimated Risk for Stroke and Coronary Heart Disease Among Spouse Caregivers. 
Differential Effects by Race and Sex. Stroke, 41(1), 331-336. 
Halm, E. A., Mora, P., & Leventhal, H. (2006). No symptoms, no asthma: the acute episodic 
disease belief is associated with poor self-management among inner-city adults with 
persistent asthma. Chest, 129(3), 573-580. 
Hanemoto, T., Hikichi, Y., Kikuci, N., & Kozawa, T. (2017). The impact of different anti-
vascular endothelial growth factor treatment regimens on reducing burden for 
caregivers and patients with wet age-related macular degeneration in a single-
center real-world Japanese setting. PLoS ONE, 12(12), e0189035 . 
Hartman, S. J., Marinac, C. R., Belletierre, J., Godbole, S., Natarajan, L., Patterson, R. E., & Kerr, 
J. (2017). Objectively measured sedentary behavior and quality of life among 
survivors of early stage breast cancer. Supportive Cancer Care, 2495-2503. 
Hartmann, C. W., & Rhee, D. J. (2006). The patients’ journey: glaucoma. British Medical 
Journal, 333, 738-739. 
Hassell, J. B., Lamoureux, E. L., & Keeffe, J. E. (2006). Impact of age related macular 
degeneration on quality of life. British Journal of Ophthalmology, 593-596. 
Heffernan, E., Coulson, N. S., Henshaw, H., & Barry, J. G. (2016). Understanding the 
psychosocial experiences of adults with mild-moderate hearing loss: An application 
of Leventhal’s self-regulatory model. International Journal of Audiology, 55(3), 1-10. 
doi:https://www.researchgate.net/deref/http%3A%2F%2Fwww.tandfonline.com
%2Faction%2FshowCitFormats%3Fdoi%3D10.3109%2F14992027.2015.1117663 
Heijl, A., Bengtsson, B., & Oskarsdottir, S. E. (2013). Prevalence and severity of undetected 
manifest glaucoma. Results from the Early Manifest Glaucoma Trial screening. 
Opthalmology, 120(8). 
Heijmans, M. J. (1998). Coping and adaptive outcome in chronic fatigue syndrome: 
Importance of illness cognitions. Journal of Psychosomatic Research, 39-51. 
Hemphill, R. C., Stephens, M. A., Rook, K. S., Franks, M. M., & Salem, J. K. (2013). Older adults’ 
beliefs about the timeline of type 2 diabetes and adherence to dietary regimens. 
Psychol Health, 139-153. 
Henson, D, B., Chaudry, S., Artes, P. H., Faragher, E. B., & Ansons, A. (2000).  
Response Variability in the Visual Field: Comparison of Optic Neuritis, Glaucoma, 
Ocular Hypertension and Normal Eyes. Investigative Ophthalmology and Visual 
Science, 41, 417-421.  
 
Hermanns, M. L., & Mastel-Smith, B. A. (2012). Caregiving: A Qualitative Concept Analysis. 
188 
 
Holmes, M. (2010). A study to investigate the reliability and validity of the Ten-Item 
Personality Inventory, when compared with two robust inventories, within a British 
sample,. Manchester Metropolitan University Psychology Journal, 6, http://e-
space.mmu.ac.uk/576699/. 
Horne, R., & Weinman, J. (2002). Self-regulation and self-management in asthma: exploring 
the role of illness perceptions and treatment beliefs in explaining non-adherence to 
preventer medication. Psychology and Health, 1, 17-32. 
Horowitz, A., Reinhardt, J., & Kennedy, G. (2005). Major and subthreshold depression among 
older adults seeking vision rehabilitation services. American Journal of Geriatric 
Psychiatry, 13(3), 180-187. 
Hsiao, C. Y., Chang, C., & Chen, C. D. (2012). An investigation on illness perception and 
adherence among hypertensive patients. The Kaohsiung Journal of Medical Sciences, 
28(8), 442-447. 
Hsu, T., Loscalzo, M., Ramani, R., Forman, S., Popplewell, L., Clark, K., . . . Hurria, A. (2017). 
Are Disagreements in Caregiver and Patient Assessment of Patient Health 
Associated with Increased Caregiver Burden in Caregivers of Older Adults with 
Cancer? Oncologist, 22(11), 1383-1391. 
Hu, F. B. (2003). Sedentary lifestyle and risk of obesity and type 2 diabetes. Lipids, 103-108. 
Jacoby, W. G. (2000). Loess: a non-parametric graphical tool for depicting relationships 
between variables. Electoral Studies, 19(4), 577-613. 
Jampel, H. D., Frick, K. D., Janz, N. K., Wren, P. A., Musch, D. C., Rimal, R., . . . Group, C. S. 
(2007). Depression and mood indicators in newly diagnosed glaucoma patients. 
American Journal of Ophthalmology, 144(2), 238-244. 
Janz, N. K., Wren, P. A., Guire, K. E., Musch, D. C., Gillespie, B. W., Lichter, P. R., & Collaborative 
Initial Glaucoma Treatment Study. (2007). Fear of blindness in the Collaborative 
Initial Glaucoma Treatment Study: patterns and correlates over time. 
Ophthalmology, 2213-2220. 
Janz, N. K., Wren, P. A., Lichter, P. R., Musch, D. C., Gillespie, B. W., & Guire, K. E. (2001). 
Quality of life in newly diagnosed glaucoma patients: The Collaborative Initial 
Glaucoma Treatment Study. Ophthalmology, 108(5), 887-897. 
Jensen, M. P., Turner, J. A., & Romano, J. M. (1991). Self-efficacy and outcome expectancies: 
relationship to chronic pain coping strategies and adjustment. Pain, 44(3), 263-269. 
Jones, L., Bryan, S. R., & Crabb, D. P. (2017). Gradually Then Suddenly? Decline in Vision-
Related Quality of Life as Glaucoma Worsens. Journal of Opthalmology, 2017, 7 
Pages. 
Jones, L., Garway-Heath, D. F., Azuara-Blanco, A., Crabb, D. P., & Investigators, U. K. (2019). 
Are Patient Self-Reported Outcome Measures Sensitive Enough to Be Used as End 
Points in Clinical Trials?: Evidence from the United Kingdom Glaucoma Treatment 
Study. Ophthalmology, 126(5), 682-689. 
189 
 
Kantipuly, A., Pillai, M. R., Shroff, S., Khatiwala, R., Raman, G. V., Krishnadas, S. R., . . . Ehrlich, 
J. R. (2019). Caregiver Burden in Primary Congenital Glaucoma. American Journal of 
Ophthalmology. 
Keeffe, J. E., Chou, S. L., & Lamoureux, E. L. (2009). The Cost of Care for People With 
Impaired Vision in Australia. Archives of Ophthalmology, 127(10), 1377-1381. 
Kennedy, B. M., Jaligam, V., Conish, B. K., Johnson, W. D., Melancon, B., & Katzmarzyk, P. T. 
(2017). Exploring Patient, Caregiver, and Healthcare Provider Perceptions of Caring 
for Patients With Heart Failure: What Are the Implications? The Ochsner Journal , 93-
102. 
Kerr, C., Bottomley, C., Shingler, S., Giangregorio, L., de Freitas, H. M., Patel, C., . . . Gold, D. T. 
(2017). The importance of physical function to people with osteoporosis. 
Osteoporosis International, 28(5), 1597-1607. 
Kerr, N. M., Wang, J., & Barton, K. (2017). Minimally invasive glaucoma surgery as primary 
stand‐alone surgery for glaucoma. Clinical and Experimental Ophthalmology, 45(4), 
393-400. 
Khaw, P. T., Sherwood, M. B., Doyle, W., Smith, F., Grierson, I., McGorray, S., & Schultz, G. S. 
(1992). Intraoperative and post operative treatment with 5-Fluorouracil and 
mitomycin-c: long term effects in vivo on subconjunctival and scleral fibroblasts. 
International Ophthalmology, 16(4-5), 381-385. 
Kim, Y., Pavlish, C., & Evangelista, L. S. (2012). Racial/ethnic differences in illness 
perceptions in minority patients undergoing maintenance haemodialysis. 
Nephrology Nursing Journal, 39, 39-49. 
King, A., Azuara-Blanco, A., & Tuulonen, A. (2013). Glaucoma. British Medical Journal, 346. 
Kirby, E., Broom, A., Sibbritt, D., Refshauge, K., & Adams, J. (2015). Suffering, recognition and 
reframing: Healthcare choices and plural care pathways for women with chronic 
back pain. Current Sociology, 1-17. 
Kobak, K. (2001). Patient Reactions to Computer Interviews. Retrieved from Healthcare 
Technology Systems: http://www.healthtechsys.com/pdf/hts-209-
patient_reactions_white_paper.pdf. 
Kotowski, J., Wollstein, G., Ishikawa, H., & Schuman, J. S. (2014). Imaging of the Optic Nerve 
and Retinal Nerve Fiber Layer: an Essential Part of Glaucoma Diagnosis and 
Monitoring. Survey of Ophthalmology, 59(4), 458-467. 
Lacey, J., Cate, H., & Broadway, D. C. (2009). Barriers to adherence with glaucoma 
medications: a qualitative research study. Eye, 23, 924-932. 
Laidsaar-Powell, R. C., Butow, P. N., Bu, S., Charles, C., Gafni, A., Lam, W. W., . . . Juraskova, I. 
(2013). Physician–patient–companion communication and decision-making: A 




Laidsaar-Powell, R., Butow, P., Boyle, F., & Juraskova, I. (2018). Managing challenging 
interactions with family caregivers in the cancer setting: Guidelines for clinicians 
(TRIO Guidelines-2). Patient Education and Counseling, 101(6), 983-994. 
Lamoureux, E., Hassell, J., & Keefe, J. (2004). The impact of diabetic retinopathy on 
participation in daily living. Archives of Ophthalmology, 122(1), 84-88. 
Lawrenson, J. (2013). Glaucoma: the challenge of early case detection. Ophthalmic and 
Physiological Optics, 33(1), 3-6. 
Lee, D. A., & Higginbotham, E. (2005). Glaucoma and its treatment: a review. American 
Journal of Health-System Pharmacy, 62(7), 691-699. 
Lee, Y. H., Kim, C. S., & Hong, S. P. (2004). Rate of visual field progression in primary open-
angle glaucoma and primary angle-closure glaucoma. Korean Journal of 
Ophthalmology, 106-115. 
Leventhal, H., Brissette, I., Leventhal, E. A., Cameron, L. D., & Leventhal, H. (2003). The Self-
Regulation of Health and Illness. London: Routledge. 
Leventhal, H., Meyer, D., Nerenz, D. R., & Rachman, S. (1980). The common sense 
representation of illness danger. New York: Pergamon Press. 
Li, N., Chen, X. M., Zhou, Y., Wei, M. L., & Yao, X. (2006). Travoprost compared with other 
prostaglandin analogues or timolol in patients with open-angle glaucoma or ocular 
hypertension: meta-analysis of randomized controlled trials. Clinical and 
Experimental Ophthalmology, 34(8), 755-764. 
Llewellyn, C. D., McGurk, M., & Weinman, J. (2007). Illness and treatment beliefs in head and 
neck cancer: Is Leventhal's common sense model a useful framework for 
determining changes in outcomes over time? Journal of Psychosomatic Research, 17-
26. 
Lockenhoff, C. E., Duberstein, P. R., Friedman, B., & Costa Jr, P. T. (2011). Five-factor 
personality traits and subjective health among caregivers: the role of caregiver 
strain and self-efficacy. Psychology and Aging, 26(3), 592-604. 
Longworth, L., Yang, Y., Young, T., Mulhern, B., Hernandez-Alava, M., Mukuria, C., . . . Brazier, 
J. (2014). Use of generic and condition-specific measures of health-related quality of 
life in NICE decision-making: a systematic review, statistical modelling and survey. 
Health Technology Assessment, 18(9), 1-224. 
Lorig, K. R., Sobel, D. S., Ritter, P. L., Laurent, D., & Hobbs, M. (2001). Effect of a self-
management program on patients with chronic disease. Effective Clinical Practice, 
256-262. 
Lorig, K., & Holman, H. (2003). Self-Management Education: History, Definition, Outcomes, 
and Mechanisms. Annals of Behavioral Medicine, 26, 1-7. 
Lucas, G., Gratch, J., King, A., & Morency, L. P. (2014). It’s only a computer: virtual humans 
increase willingness to disclose. Computers in Human Behaviour, 37(1), 94-100. 
191 
 
Lutgendorf, S. K., & Ullrich, P. (2002). ognitive processing, disclosure, and health: 
Psychological and physiological mechanisms. In S. J. Lepore, & J. M. Smyth, The 
writing cure: How expressive writing promotes health and emotional wellbeing (pp. 
177-196). Washington, DC, USA: American Psychological Association. 
Mabuchi, F., Yoshimura, K., Kashiwagi, K., Yamagata, Z., Kanba, S., Iijima, H., & Tsukaha, S. 
(2012). Risk factors for anxiety and depression in patients with glaucoma. 
Ophthalmology, 96, 821-825. 
Mabuchi, F., Yoshimura, K., Kashiwagik, Shioe, K., Yamagata, Z., Kanba, S., . . . Tsukahara, S. 
(2008). High Prevalence of Anxiety and Depression in Patients With Primary Open-
angle Glaucoma. Journal of Glaucoma, 552-557. 
Macloed, U., Mitchell, E. D., Burgess, C., Macdonald, S., & Ramirez, A. J. (2009). Risk factors 
for delayed presentation and referral of symptomatic cancer: evidence for common 
cancers. British Journal of Cancer, 92-101. 
Mann, D. M., Ponieman, D., Leventhal, H., & Halm, E. A. (2009). Predictors of adherence to 
diabetes medications: the role of disease and medication beliefs. Journal of 
Behavioural Medicine, 32(3), 278-284. 
Mann, S., Ostroff, J., Winkel, G., Goldstein, L., Fox, K., & Grana, G. (2004). Posttraumatic 
growth after breast cancer: patient, partner, and couple perspectives. Psychosomatic 
Medicine, 66(3), 442-454. 
Marques, A. P., Macedo, A. F., Hernandez-Moreno, L., Ramos, P. L., Butt, T., Rubin, G., . . . 
Portugese visual impairment study group , (.-g. (2018). The use of informal care by 
people with vision impairment. PLoS One, 13(6), e0198631. 
Martin, C. M. (2007). Chronic disease and illness care: Adding principles of family medicine 
to address ongoing health system redesign. Canadian Family Physician, 53(12), 
2086–2091. 
Masland, R. H. (2012). The Neuronal Organization of the Retina. Neuron, 76(2), 266-280. 
McCullagh, E., Brigstocke, G., Donaldson, N., & Kalra, L. (2005). Determinants of caregiving 
burden and quality of life in caregivers of stroke patients. Stroke, 36, 2181-2186. 
McDonald, L., Turnbull, P., Chang, L., & Crabb, D. P. (2020). Taking the Strain? Impact of 
glaucoma on patients’ informal caregivers. Eye (Lond.), 34, 197-204. 
McDonald, L., Boodhna, T., Ajtony, C., Turnbull , P., Bourne, R. A., & Crabb, D. P. (2019). 
Illness perceptions in people newly diagnosed with glaucoma and ocular 
hypertension. British Journal of Ophthalmology. 
McDonald, L., Glen, F. C., Taylor, D. J., & Crabb, D. P. (2016). Self-Monitoring Symptoms in 
Glaucoma: A Feasibility Study of a Web-Based Diary Tool. Journal of Ophthalmology, 
8. 
McDonald, S., Ferguson, E., Hagger, M. S., Foss, A. J., & King, A. J. (2019). A theory-driven 
qualitative study exploring issues relating to adherence to topical glaucoma 
medications. Patient Preference and Adherence, 13, 819-828. 
192 
 
Medeiros, F. A., & Weinreb, R. N. (2012). Is Corneal Thickness an Independent Risk Factor 
for Glaucoma? Ophthalmology, 119(3). 
Medeiros, F. A., Gracitelli, C. P., Boer, E. R., Weinreb, R. N., Zangwill, L. M., & Rosen, P. N. 
(2015). Longitudinal Changes in Quality of Life and Rates of Progressive Visual Field 
Loss in Glaucoma Patients. Ophthalmology, 293-301. 
Medeiros, F., Zangwill, L. M., Bowd, C., Mansouri, K., & Weinreb, R. N. (2012). The Structure 
and Function Relationship in Glaucoma: Implications for Detection of Progression 
and Measurement of Rates of Change. Investigative Ophthalmology and Visual 
Science, 53(11), 6939-6946. 
Meyer, D., Leventhal, H., & Gutmann, M. (1985). Common-sense models of illness: the 
example of hypertension. Health Psychology, 115-135. 
Middelweerd, A., Mollee, J. S., van der Wal, N., Brug, J., & te Velde, S. J. (2014). Apps to 
promote physical activity in adults: a review and content analysis. International 
Journal of Behavioural Nutrition and Physical Activity, 11(1), 97. 
Mills, A. J., Durepos, G., & Wiebe, E. (2010). Reflexivity. In Encyclopedia of Case Study 
Research. Thousand Oaks, CA: SAGE Publications. Retrieved from 
https://methods.sagepub.com/reference/encyc-of-case-study-research/n290.xml 
Mira, J. J., Orozco-Beltran, D., Perez-Jover, V., Martinez-Jimeno, L., Gil-Guillen, V. F., & 
Carratala-Munuera, C. (2013). Physician patient communication failure facilitates 
medication errors in older polymedicated patients with multiple comorbidities. 
Family Practice, 30(1), 56-63. doi:https://doi.org/10.1093/fampra/cms046 
Mirzaei, M., Aspin, C., Essue, B., Jeon, Y., Dugdale, P., Usherwood, T., & Leeder, S. (2013). A 
patient-centred approach to health service delivery: improving health outcomes for 
people with chronic illness. BMC Health Services Research, 13(1), 251. 
Mitchell, J., & Bradley, C. (2006). Quality of life in age-related macular degeneration: a 
review of the literature. Health and Quality of Life Outcomes, 97. 
Mok, E., Chan, F., Chan, V., & Yeung, E. (2013). Perception of empowerment by family 
caregivers of patients with a terminal illness in Hong Kong. International Journal of 
Palliative Nursing, 8(3), 137-145. 
Mor, N., & Winquist, J. (2002). Self-focused attention and negative affect: a meta-analysis,. 
Psychological Bulletin, 128(4), 638-662. 
Moss-Morris, R., Weinman, J., Petrie, K., Horne, R., Cameron, L., & Buick, D. (2002). The 
Revised Illness Perception Questionnaire (IPQ-R). Psychology and Health, 17(1), 1-
16. 
Mudie, L. I., LaBarre, S., Varadaraj, V., Karakus, S., Onnela, J., Munoz, B., & Friedman, D. S. 
(2016). The Icare HOME (TA022) Study: Performance of an Intraocular Pressure 




National Institute for Health and Care Excellence. (2017). Glaucoma: diagnosis and 
management.  
Nelson, P., Aspinall, P., Papasouliotis, O., Worton, B., & O'Brien, C. (2003). Quality of Life in 
glaucoma and its relationship with visual function. Journal of Glaucoma, 139-150. 
Newman-Casey, P. A., Robin, A. L., Blachley, T., Farris, K., Heisler, M., Resnicow, K., & Lee, P. 
P. (2015). Most Common Barriers to Glaucoma Medication Adherence: A Cross-
Sectional Survey. Ophthalmology, 122(7), 1308-1316. 
Newman-Casey, P. A., Weizer, J. S., Heisler, M., Lee, P. P., & Stein, J. D. (2013). Systematic 
Review of Educational Interventions to Improve Glaucoma Medication Adherence. 
Seminars in Opthalmology, 191-201. 
Nordmann, J., Auzanneau, N., Ricard, S., & Berdeaux, G. (2003). Vision related quality of life 
and topical glaucoma treatment side effects. Health and Quality of Life Outcomes, 75. 
Northouse, L. L., Katapodi, M. C., Schafenecker, A. M., & Weiss, D. (2012). The Impact of 
Caregiving on the Psychological Wellbeing of Family Caregivers and Cancer Patients. 
Seminars in Oncology Nursing, 28(4), 236-245. 
Nyman, S. R., Dibb, B., Victor, C. R., & Gosney, M. A. (2012). Emotional wellbeing and 
adjustment to vision loss in later life: a meta-synthesis of qualitative studies. 
Disability and Rehabilition, 34(12), 971-981. 
Odberg, T., Jakobsen, J. E., Hultgren, S. J., & Halseide, R. (2001). The impact of glaucoma on 
the quality of life of patients in Norway. I. Results from a self-administered 
questionnaire. Acta Ophthalmologica Scandinavica, 79(2), 116-120. 
Olthoff, C. M., Schouten, J. S., van de Borne, B. W., & Webers, C. A. (2005). Noncompliance 
with ocular hypotensive treatment in patients with glaucoma or ocular 
hypertension an evidence-based review. Ophthalmology, 112(6), 953-961. 
Parrish, R. K., Gedde, S. J., Scott, I. U., Feuer, W. J., Schiffmann, J. C., Mangione, C. M., & 
Montenegro-Pinniella. (1997). Visual function and quality of life among patients 
with glaucoma. Archives of Ophthalmology, 115. 
Pesut, D. P., Bursuc, B. N., & Bulajic, M. V. (2014). Illness perceptions in tuberculosis by 
implementation of the Brief Illness Perception Questionnaire – A TBNET Study. 
SpringerPlus, 3, 664. 
Peters , D., Heijl, A., Brenner, L., & Bengtsson, B. (2015). Visual impairment and vision 
related quality of life in the early manigest glaucoma trial after 20 years of follow up. 
Acta Ophthalmologica, 93(8), 745-752. 
Peters, M., Jenkinson, C., Doll, H., Playford, D., & Fitzpatrick, R. (2013). Carer quality of life 
and experiences of health services: a cross-sectional survey across three 
neurological conditions . Health and Quality of Life Outcomes, 11, 103. 
Peterson-Sweeney, K., McMullen, A., Lorrie Yoos, H., Kitzmann, H., Halterman, J. S., Sidora 
Arcoleo, K., & Anson, E. (2007). Impact of asthma education received from health 
194 
 
care providers on parental illness representation in childhood asthma. Research in 
Nursing and Health, 30(2), 203-212. 
Petrie, K. J., & Weinman, J. (2006). Why illness perceptions matter. Clinical Medicine, 536-
539. 
Petrie, K., Jago, L. A., & Devcich, D. A. (2007). The role of illness perceptions in patients with 
medical conditions. Current opinion in psychiatry, 20, 163-167. 
Pierce, J. L., Kostova, T., & Dirks, K. (2003). The state of psychological ownership: Integrating 
and extending a century of research. Review of General Psychology, 7(1), 84-107. 
Piette, J. D., Farris, K. B., Newman, S., An, L., Sussman, J., & Singh, S. (2015). The potential 
impact of intelligent systems for mobile health self-management support: Monte 
Carlo simulations of text message support for medication adherence. Annals of 
Behavioral Medicine, 49(1), 84-94. 
Pozarowska, D., & Pozarowski, P. (2016). The era of anti-vascular endothelial growth factor 
(VEGF) drugs in ophthalmology, VEGF and anti-VEGF therapy. Central European 
Journal of Immunology, 41(3), 311-316. 
Quigley , H. A., Dunkelberger, G. R., & Green, W. R. (1989). Retinal Ganglion Cell Atrophy 
Correlated With Automated Perimetry in Human Eyes With Glaucoma. American 
Journal of Ophthalmology, 107(5), 453-464. 
Quigley, H. A. (1996). Number of people with glaucoma worldwide. British Journal of 
Ophthalmology, 80, 389-393. 
Quigley, H. A., & Broman, A. T. (2006). The number of people with glaucoma worldwide in 
2010 and 2020. British Journal of Ophthalmology, 90(3), 262-267. 
Rainie, L., & Fox, S. (2000). The Online Health Care Revolution. Washington, DC, USA: Pew 
Research Center. 
Ramirez, A. J., Westcombe, A. M., Burgess, C. C., Sutton, S., Littlejohns, P., & Richards, M. A. 
(1999). Factors predicting delayed presentation of symptomatic breast cancer: a 
systematic review. Lancet, 353(9159), 1127-1131. 
Ramulu, P. (2009). Glaucoma and Disability: Which tasks are affected, and at what stage of 
disease? Current Opinion in Ophthalmology, 92-98. 
Ramulu, P. Y., Hochberg, C., Maul, E. A., Chan, E. S., Ferrucci, L., & Friedman, D. S. (2014). 
Glaucomatous visual field loss associated with less travel from home. Optometry and 
Vision Science, 187-193. 
Ramulu, P. Y., Maul, E., Hochberg, C., Chan, E. S., Ferrucci, L., & Friedman, D. S. (2012). Real-
World Assessment of Physical Activity in Glaucoma Using an Accelerometer. 
Ophthalmology, 1159-1166. 
Read, S., Waterman, H., Morgan, J. E., Harper, R. A., Spencer, A. F., & Stanford, P. (2018). 
Glaucoma, dementia, and the "precipice of care": transitions between states of 
medication adherence. Patient Prefer Adherence, 12, 1315-1325. 
195 
 
Reblin, M., & Uchino, B. N. (2008). Social and emotional support and its implications for 
health. Current Opinion in Psychiatry, 201-205. 
Rees, G., Chong, X., Cheung, X. Y., Aung, T., Friedman, D. S., Crowston, J. G., & Lamoureux, E. L. 
(2014). Beliefs and Adherence to Glaucoma Treatment: A Comparison of Patients 
From Diverse Cultures. Journal of Glaucoma, 293-298. 
Rees, G., Leong, O., Crowston, J. G., & Lamoureux, E. L. (2010). Intentional and unintentional 
nonadherence to ocular hypotensive treatment in patients with glaucoma. 
Ophthalmology, 117, 903-908. 
Richardson, A. E., Morton, R., & Broadbent, E. (2015). Caregivers' Illness Perceptions 
Contribute to Quality of Life in Head and Neck Cancer Patients at Diagnosis. Journal 
of Psychosocial Oncology, 33(4), 414-432. 
Richardson, C., Brunton, L., Olleveant, N., Henson, D. B., Pilling, M., Mottershead, J., . . . 
Waterman, H. (2013). A study to assess the feasibility of undertaking a randomized 
controlled trial of adherence with eye drops in glaucoma patients. Patient Preference 
and Adherence, 7, 1025-1039. 
Richman, J., Lorenzana, L. L., & Lankaranian, D. (2010). Importance of Visual Acuity and 
Contrast Sensitivity in Patients With Glaucoma. Archives of Ophthalmology, 1576-
1582. 
Ross, S., Walker, J., & MacLoed, M. J. (2004). Patient compliance in hypertension: The role of 
illness perceptions and treatment beliefs. Journal of Human Hypertension, 18, 607-
613. 
Royal College of General Practitioners. (2012). Matters of life and death: helping people to 
live well until they die. (Royal College of General Practitioners and Royal College of 
Nursing) Retrieved December 2016, from http://www.rcgp.org.uk/clinical-and-
research/toolkits/~/media/Files/CIRC/Matters%20of%20Life%20and%20Death
%20FINAL.ashx 
Safran, A. B., & Landis, T. (1999). From cortical plasticity to unawareness of visual field 
defects. Journal of Neuro-Ophthalmology, 19(2), 84=88. 
Salmon, N. J., Terry, H. P., Farmery, A. D., & Salmon, J. F. (2007). An analysis of patients 
discharged from a hospital‐based glaucoma case‐finding clinic over a 3‐year period. 
Ophthalmic and Physiological Optics, 27(4), 399-403. 
Sambhara, D., & Aref, A. A. (2014). Glaucoma management: relative value and place in 
therapy of available drug treatments. Therapeutic Advancements in Chronic Disease, 
5(1), 30-43. 
Sarkar, U., Fisher, L., & Schillinger, D. (2006). Is self-efficacy associated with diabetes self-
management across race/ethnicity and health literacy? Diabetes Care, 823-829. 
Saunders, L. J., Medeiros, F. A., Weinreb, R. N., & Zangwill, L. M. (2016). What rates of 




Saunders, L. J., Russell, R. A., & Crabb, D. P. (2012). Practical landmarks for visual field 
disability in glaucoma. British Journal of Ophthalmology, 96(9), 1185-1189. 
Saunders, L. J., Russell, R. A., & Kirwan, J. F. (2014). Examining visual fields loss in patients in 
glaucoma clinics during their predicted remaining lifetime. Investigative 
Ophthalmology and Visual Science, 55, 102-109. 
Saw, S. M., Gazzard, G., & Friedman , D. S. (2003). Awareness of glaucoma, and health-related 
beliefs of patients suffering primary acute angle closure. British Journal of 
Ophthalmology, 87, 446-449. 
Sawyer, A. T., Harris, S. L., & Koening, H. G. (2019). Illness perception and high readmission 
health outcomes. Health Psychology Open, 6(1). 
doi:https://dx.doi.org/10.1177%2F2055102919844504 
Sayera, S. L., Riegel, B., Pawlowski, S., Coyne, J. C., & Samaha, F. F. (2008). Social support and 
self-care of patients with heart failure. Annals of Behavioral Medicine, 35(1), 70-79. 
Scharloo, M., Kaptein, A. A., Weinman, J. A., Hazes, J. M., Breedveld, F. C., & Rooijmams, H. G. 
(1999). Predicting functional status in patients with rheumatoid arthritis. Journal of 
Rheumatology, 1686-1693. 
Scharloo, M., Kaptein, A. A., Weinman, J., Hazes, J. M., Willems, L. N., Bergman, W., & 
Roojimans, H. G. (1998). Illness perceptions, coping and functioning in patients with 
rheumatoid arthritis, chronic obstructive pulmonary disease and psoriasis. Journal 
of Psychosomatic Research, 44(5), 573-585. 
Schmier, J. K., Halpern, M. T., Covert, D., Delgado, J., & Sharma, S. (2006). Impact of visual 
impairment on use of caregiving by individuals with Age-Related Macular 
Degeneraton. Retina, 26(9), 1056-1062. 
Schrag, A., Selai, C., Jahanshahi, M., & Quinn, N. P. (2000). The EQ-5D—a generic quality of 
life measure—is a useful instrument to measure quality of life in patients with 
Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry, 69(1), 67-73. 
Schwartz, G. F., & Quigley, H. A. (2008). Adherence and persistence with glaucoma therapy. 
Survey of Ophthalmology, 53, 57-68. 
Seamark, D. A., Blake, S. D., & Seamark, C. J. (2004). Living with severe chronic obstructive 
pulmonary disease (COPD): perceptions of patients and their carers. An 
interpretative phenomenological analysis. Palliative Medicine, 18(7). 
Shtein, R. M., Newman-Casey, P. A., Herndon, L., Coleman, A. L., & Lee, P. P. (2016). Assessing 
the Role of the Family/Support System Perspective in Patients With Glaucoma. 
Journal of Glaucoma, e676-e680. 
Skalicky, S. E., Lamoureux, E. L., Crabb, D. P., & Ramulu, P. Y. (2019). Patient-reported 
Outcomes, Functional Assessment, and Utility Values in Glaucoma. Journal of 
Glaucoma, 28(2), 89-96. 




Smith, J. A., & Osborn, M. (2012). Interpretative Phenomenological Analysis. In J. A. Smith, 
Qualitative Psychology (pp. 53-80). California, USA: SAGE. 
Smith, J. A., & Osborn, M. (2015). Interpretative phenomenological analysis as a useful 
methodology for research on the lived experience of pain. British Journal of Pain, 
9(1), 41-42. 
Smith, N. D., Crabb, D. P., & Garway-Heath, D. F. (2011). An exploratory study of visual 
search performance in glaucoma. Ophthalmic and Physiological Optics, 225-232. 
Stablein, T., Hall, J., Pervis, C., & Anthony, D. (2015). Negotiating stigma in health care: 
disclosure and the role of electronic health records. Health Sociology Review, 24(3), 
227-241. 
Stamper, R. L., Wigginton, S. A., & Higginbotham, E. J. (2002). Primary Drug Treatment for 
Glaucoma: Beta-Blockers Versus Other Medications. Survey of Ophthalmology, 47(1), 
63-67. 
Stanford, P., Waterman, H., Russell, W. B., & Harper, R. A. (2009) Psychosocial adjustment in 
age related macular degeneration. The British Journal of Visual Impairment, 27(2), 
129-146, 
Taylor, S. E., & Aspinwall, L. G. (1996). Psychosocial aspects of chronic illness. In P. T. Costa, 
& G. R. VandenBos, Psychological aspects of serious illness: chronic conditions, fatal 
diseases, and clinical care (pp. 7-60). Washington. DC, USA: American Psychological 
Association. 
Tejeria, L., Harper, R. A., Artes, P. H., & Dickinson, C. M. (2002). Face recognition in age 
related macular degeneration: perceived disability, measured disability, and 
performance with a bioptic device. British Journal of Ophthalmology, 1019-1026. 
Thompson, R. J., Mata, J., Jaeggi, S. M., Buschkuehl, M., Jonides, J., & Gotlib, I. H. (2010). 
Maladaptive Coping, Adaptive Coping, and Depressive Symptoms: Variations across 
Age and Depressive State. Behavioural Research and Therapy, 48(6), 459-466. 
Thornton, M., & Travis, S. S. (2003). Analysis of the reliability of the modified caregiver 
strain index. J Gerontol B Psychol Sci Soc Sci., 58(2), S127-S13. 
Timmins, N. (2008). NHS goes to the PROMS. British Medical Journal, 336, 1464-1465. 
Tsai, J. (2005, June 15). How to Evaluate the Suspicious Optic Disc. (Review of 
Ophthalmology) Retrieved April 17, 2018, from 
https://www.reviewofophthalmology.com/article/how-to-evaluate-the-suspicious-
optic-disc 
Tsai, J. C., McClure, C. A., Ramos, S. E., & Schlundt, D. G. (2003). Compliance barriers in 
glaucoma: a systematic classification. Journal of Glaucoma, 12, 393-398. 
Turano, K. A., Rubin, G. S., & Quigley, H. A. (1999). Mobility performance in glaucoma. 
Investigative Ophthalmology and Visual Science, 2803-2809. 
198 
 
Turner, J., & Kelly, B. (2000). Emotional dimensions of chronic disease. Western Journal of 
Medicine, 172(2), 124-128. 
Turnquist, D. C., Harvey, J. H., & Andersen, B. L. (1988). Attributions and adjustment to life-
threatening illness. British Journal of Clinical Psychology, 27, 55-65. 
Van den Burg, B., Al, M., Van Exel, J., Koopmanschap, M., & Brouwer, W. (2008). Economic 
valuation of informal care: conjoint analysis applied in a heterogeneous population 
of informal caregivers. Value in Health, 11(7), 1041-1050. 
Van den Heuvel, E., de Witte, L., Schure, L., Sanderman, R., & Meyboom-de Jong, B. (2001). 
Risk-factors for burn-out in caregivers for stroke patients, and possibilities for 
intevention. Clinical Rehabilition, 40(2), 669-667. 
van der Hiele, K., van Gorp, D. A., Heerings, M. A., Jongen, P., van der Klink, J. J., Frequin, S. T., . 
. . Visser, L. H. (2019). Caregiver strain among life partners of persons with mild 
disability due to relapsing-remitting multiple sclerosis. Multiple Sclerosis and 
Related Disorders, 31, 5-11. 
van Hout, B., & Janssen, M. F. (2012). Interim scoring for the EQ-5D-5L: Mapping the EQ-5D-
5L to EQ-5D-3L value sets. . Value in Health, 15(5), 708-715. 
Van Nispen, R. M., de Boer, M. R., & Hoeijmakers, J. G. (2009). Co-morbidity and visual acuity 
are risk factors for health-related quality of life decline: five-month follow-up EQ-5D 
of visually impaired older patients. Health and Quality of Life Outcomes, 7, 7-18. 
Vickerstaff, V., Ambler, G., Bunce, C., Xing, W., & Gazzard, G. (2015). Statistical analysis plan 
for the Laser-1st versus Drops-1st for Glaucoma and Ocular Hypertension Trial 
(LiGHT): a multi-centre randomised controlled trial. . Trials, 16. 
Vogeli, C., Shields, A. E., Lee, T. A., Gibson, T. B., Marder, W. D., Weiss, K. B., & Blumenthal, D. 
(2007). Multiple Chronic Conditions: Prevalence, Health Consequences, and 
Implications for Quality, Care Management, and Costs. Journal of General Internal 
Medicine, 22(3), 391-395. 
von Korff, M., Gruman, J., Schaefer, J., Curry, S. J., & Wagner, E. H. (1997). Collaborative 
management of chronic illness. Annals of Internal Medicine, 127(12), 1097-1102. 
Vukicevic, M., Heraghty, J., Cummins, R., Gopinath, B., & Mitchell, P. (2016). Caregiver 
perceptions about the impact of caring for patients with wet age-related macular 
degeneration. Eye (Lond), 30(3), 413-421. 
Waisbourd, M., Dhami, H., Zhou, C., Hsieh, M., Abichandani, P., Pro, M. J., . . . Myers, J. S. 
(2016). The Wills Eye Glaucoma App: Interest of Patients and Their Caregivers in a 
Smartphone-based and Tablet-based Glaucoma Application. Journal of Glaucoma, 
787-791. 
Waterman, H., Brunton, L., Fenerty, C., Mottershead, J., Richardson, C., & Spencer, F. (2013). 
Adherence to ocular hypotensive therapy: patient health education needs and views 
on group education. Patient Preference and Adherence, 7, 55-63. 
Weinreb, R. B., & Khaw, P. T. (2004). Primary open-angle glaucoma. The Lancet, 1711-1720. 
199 
 
Weiss, D., & Lang, F. R. (2012). “They” are old but “I” feel younger: Age-group dissociation as 
a self-protective strategy in old age. Psychology and Aging, 27(1), 153-163. 
White, M. H., & Dorman, S. M. (2000). Online support for caregivers. Analysis of an Internet 
Alzheimer mailgroup. Computers in Nursing, 18(4), 168-176. 
White, M. H., & Dorman, S. M. (2001). Receiving social support online: implications for 
health education. Health Education Research, 16(6), 693-707. 
Wiebe, D., & Korbel, C. (2003). Defensive denial, affect, and the self-regulation of health 
threats. In L. D. Cameron, & H. Leventhal, The self-regulation of health and illness 
behaviour (pp. 184-203). New York, USA: Routledge. 
Wilensky, J. T., & Chen, T. C. (1996). Long-term results of trabeculectomy in eyes that were 
initially successful. Transactions of the American Ophthalmological Society, 94, 147-
164. 
Williams, L., O'Connor, R. C., Grubb, N. R., & O'Carroll, R. E. (2011). Type D personality and 
illness perceptions in myocardial infarction patients. Journal of Psychosomatic 
Research, 70(2), 141-144. 
Wolfram, C., Stahlberg, E., & Pfeiffer, N. (2019). Patient-Reported Nonadherence with 
Glaucoma Therapy. Journal of Ocular Pharmacology and Therapeutics, 35(4), 223-
228. 
Wood, A. M., Froh, J. J., & Geraghty, A. W. (2010). Gratitude and wellbeing: A review and 
theoretical integration. Clinical Psychology Review, 16. 
Wood, J. M., Black, A. A., Mallon, K., Thomas, R., & Owsley, C. (2016). Glaucoma and driving: 
on-road driving characteristics. PLOS One, 1371. 
Wright, H. R., & Diamond, J. P. (2014). ervice innovation in glaucoma management: using a 
web-based electronic patient record to facilitate virtual specialist supervision of a 
shared care glaucoma programme,. British Journal of Ophthalmology, 99(3), 313-
317. 
Wu, P., Xi, S., Xia, H., Lu, H., & Guo, W. (2014). Survey on Vision-related Quality of Life and 
Self-management Among Patients With Glaucoma. Journal of Glaucoma, 23(2), 75-
80. 
Yaqub, M. (2012). Visual fields interpretation in glaucoma: a focus on static automated 
perimetry. Community Eye Health, 25(79-80), 1-8. 
Yee, J., & Schulz, R. (2000). Gender differences in psychiatric morbidity among family 
caregivers: a review and analysis. The Gerontologist, 36, 147-164. 
York Cornwell, E., & Waite, L. J. (2009). Social Disconnectedness, Perceived Isolation, and 
Health among Older Adults. Journal of Health and Social Behaviour, 50(1), 31-48. 
doi:https://doi.org/10.1177%2F002214650905000103 
Zelber-Sagi, S., Bord, S., Dror-Lavi, G., Smith, M. L., Towne, S. D., Buch, A., . . . Shibolet, O. 
(2017). Role of illness perception and self-efficacy in lifestyle modification among 
200 
 







Appendix 1 – Research protocol (Chapter Four and Five) 
 
Taking the strain? Impact of glaucoma on patient’s informal caregivers 
Date and version number:  Version 2.0. 08/05/2017. 
Study Team 
Principal Investigator   Professor David Crabb (City, University of 
London) 
Co-Investigator  Ms Lydia Chang (Hinchingbrooke Hospital NHS Trust)  
Researcher/Lead author Ms Leanne McDonald (City, University of London) 
Research co-ordinators Ms Paula Turnbull (Hinchingbrooke Hospital NHS 
Trust)  
Ms Manjo Doug (Hinchingbrooke Hospital NHS Trust) 
Abstract 
Glaucoma is a chronic condition characterised by progressive optic nerve head 
damage, potentially resulting in irreversible visual impairment in some patients. It 
does not get better on its own and cannot be cured completely. Fortunately, only a 
minority of treated patients become significantly visually impaired in their lifetime. 
Nevertheless, studies have demonstrated patient’s quality of life to be affected 
before significant sight loss occurs; these studies focus exclusively on changes in 
patients. Little attention has been given to the impact of glaucoma on the lives of 
patient’s partners or informal caregivers.  Research has been undertaken in 
caregiver-strain in life threatening conditions like cancer and more recently, in 
chronic conditions such as multiple sclerosis, Parkinson’s and Alzheimer’s disease. 
This has led to established methodology for assessing well-being in informal 
caregivers for these conditions. We plan to use this methodology to estimate, for the 
first time, the position of glaucoma on the spectrum of conditions that impact on the 
well-being of partners and informal-carers. This will be done using a cross-sectional 
postal survey of 300 patients with moderate to advanced stage glaucoma using a 
standardised 13 item questionnaire. We anticipate glaucoma may have an effect not 
captured by the established methodology. So we therefore also aim to conduct 
interviews (focus groups – qualitative work) to tease out these themes; for example, 
the responsibilities of a partner supporting adherence to treatment, the burden on 
the carer when the patient experiences giving up activities, loss of driving licence, 
loss of self-confidence and fear of blindness. The outcomes of this research, 
conducted over a 15 month period, will be disseminated via an article in an open-
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access journal and will be presented at academic meeting such as the UK and Eire 
Glaucoma Society meeting in December 2017 and the Association for Research in 
Vision and Ophthalmology (ARVO) meeting in May 2018
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List of abbreviations  
COREQ Consolidated Criteria for Reporting Qualitative Research 
CP Caregiver Participant 
EPR Electronic Patient Record 
EQ-5D EuroQol Group’s 5 dimension health status questionnaire   
FG  Focus Group 
MCSI Modified Carer Strain Index 
MD Mean Deviation 
NICE National Institute for Health and Clinical Excellence 
PD Parkinson’s Disease 
PP Patient Participant 
SD Standard Deviation  






Physical, psychological and emotional change due to caring for someone with an 
illness can be termed caregiver strain [1]. An informal caregiver can be defined as 
someone (spouse, partner, close friend or family member) who helps to care for a 
person with an illness but not in a formal capacity. Informal caregivers 
demonstrating significant caregiver strain can, for example, experience exhaustion, 
problems with wellbeing and reduced level of self-esteem [2].  
Caregiver strain is most likely to affect women and those who do not have adequate 
social support themselves [3-5]. Conversely, informal caregivers who are 
psychologically well adjusted, have good social support and implement proactive 
coping strategies are less likely to suffer from caregiver strain [1]. Informal 
caregivers often do not report their caregiver status to healthcare professionals and 
as such may not receive appropriate support [6]. Research into informal caregiver 
burden in eye disease may provide a platform for improving voluntary care and 
ultimately patient outcomes. 
Caregiver strain is well studied in conditions, like cancer, where the burden of care 
is clearly significant. More recently, caregiver stain in ‘silent’ long-term conditions 
has received attention; many of these chronic conditions are age-related and are 
becoming more prevalent because of changing demographics. Caregiver strain has 
recently been investigated in age related macular degeneration [7, 8]. There has been 
no significant investigation into caregiver strain in glaucoma and this is the main 
idea of this proposed programme of work. Comparing the caregiver strain 
associated with glaucoma against a spectrum of other common age-related chronic 
conditions would be useful new knowledge. 
We have recently published results from a qualitative study of functional 
implications and coping behaviours in people living with glaucoma. The patient 
interviews were revealing on many levels. Interestingly some patients reported 
reliance on practical support from family members/friends and others described a 
fear of becoming a burden to their informal caregiver [9].  We think a similar study in 
informal caregivers of people with glaucoma might reveal subtle burdens that are 
unique to glaucoma.  
Aims 
To estimate informal caregiver strain in people with glaucoma using a standardised 
instrument and compare estimates to other chronic conditions. 
To assess factors affecting development of caregiver strain in a sample of informal 
caregivers to those with glaucoma. 
Plan of Investigation - Overview 
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Both quantitative and qualitative methodology (mixed methods) will be used in 
order to investigate the study aims.  
The quantitative element of the research (part 1) will be a cross-sectional study 
focussing on estimating the level of standardised caregiver strain using the modified 
carer strain index (MCSI) [12]; this instrument tests whether aspects of the 
caregivers’ lives, such as sleep, finances and normal routine have been affected by 
their caring role, and whether this has placed a physical and mental strain upon 
them. The MCSI is short (13 items) and has been widely validated (cited 122 times) 
[12]. The MCSI has been applied to a variety of chronic diseases [1, 13, 14]; it has the 
advantage of not being disease-specific, and is therefore easily applied to other 
populations. MCSI is scored to create an aggregate (0-26) with a higher score 
indicating higher burden. MCSI will therefore be the main outcome measure for this 
study and will allow us to place glaucoma on the spectrum of chronic diseases that 
carry significant carer burden. In this study we plan to consider that population of 
patients with visual field damage in both eyes; we will specifically test the 
hypothesis that these patients will have a different average MCSI compared to 
neurological conditions, for example, Parkinson’s disease. 
The qualitative element of the research (Part 2) will also be a cross-sectional study 
to investigate the specific roles that informal caregivers have in glaucoma care. We 
anticipate MCSI will not necessarily capture glaucoma specific problems faced by 
informal care givers in glaucoma. We speculate these unique informal caregiver 
strains might include, for example, care-giver help with adherence to treatment; 
giving up joint activities; dependence to help with everyday tasks; threat of losing a 
driving licence, worries about falls/mobility and the psychological burden fear of 
sight loss. We will test the idea that these subtle factors might accumulate into 
caregiver strain specific to those with glaucoma.  
Quantitative study (Study 1) - Details 
A cross-sectional postal survey will be used for this study. Participants are defined 
as a Patient Participant (PP) or Caregiver Participant (CP). All participants must be 
over the age of 18 years old, but there is no upper age limit on participation. PPs will 
be identified using the electronic patient record (EPR) from glaucoma clinics. 
Inclusion criteria, ascertained from the EPR, for PPs will be: 
 
A clinical diagnosis of primary open angle glaucoma 
No other significant ocular comorbidity. (PPs will not be excluded if they have had 
cataract extraction and intraocular lens implantation.) 
Advanced visual field loss in both eyes (Using most recent Humphrey Visual Field 
with mean deviation (MD) worse than -12dB in the better eye, where the better eye 
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is defined as having the better MD) or a trabeculectomy procedure since January 
2015. 
 
PPs will then be contacted by post to be invited into the study. The posted invitation 
pack will include a patient information document and questionnaire. PP’s will be 
asked to identify a CP, if they have one.  
 
We will post questionnaire materials to 300 potential participants. We expect a 
response rate of around 30%, similar to Peters et al. [1] aiming to recruit 75 pairs of 
participants (150 participants in total).  A thank you/reminder letter will be sent 
two weeks after the initial survey materials in order to attempt to maximise 
response rate. We will record invited PPs’ date of diagnosis, current best corrected 
visual acuity, most recent visual field results, age and co-morbidities (visual and 
otherwise) from the EPR. 
 
The study invitation letter will ask PP’s to identify somebody that they feel provides 
support with their glaucoma; 
 
“Can you identify someone who is an informal caregiver for your glaucoma? This 
might be a spouse, a partner, a relative or friend who helps you with any aspect 
related to your glaucoma.” Yes/No 
 
If PPs do not have an informal caregiver, they will be asked to select ‘No’, we will ask 
if they can record their demographic details (sex, age, ethnicity and education level) 
and complete the EQ-5D and to post back to the researcher.  
 
Inclusion criteria for CP are as follows; 
The informal caregiver cannot be a professional or belong to a formal patient 
support network. If the PP selects ‘yes’, the CP will be asked to agree with the 
following question to check their eligibility; 
 
“Are you a person who voluntarily helps a patient with aspects related to their 




CPs will be invited to self-identify any diagnosis of a cognitive impairment, example, 
dementia;  
 
‘Have you ever been diagnosed with a physical or mental illness (for example, 
dementia) that may affect your ability to fill in the questionnaires?’  
 
Participants with a self-reported diagnosis of cognitive impairment will be excluded. 
CPs will be asked to record the type of relationship between themselves and the 
patient (e.g. spouse, relative [type], friend or other). CPs will be asked to record 
their sex, age, ethnicity and education level. 
 
CPs and PPs will be asked to read a participant information document, sign the 
attached consent form and then invited into the study. Due to the postal nature of 
the survey, participants will be asked to agree to the following statement; 
 
‘I understand that, by returning the questionnaire materials, I agree to take part in the 
research study described in this information sheet’. 
 
This therefore represents “implied consent”. We will state in the guidance letter that 
if they send the questionnaire back, we will assume both CP and PP have consented. 
In order to ensure that responses remain private, we will send two stamped, 
addressed envelopes, marked yellow and green to correspond with the different 
coloured paper on the questionnaire packs. 
Both CPs and PPs will be asked to complete the EQ-5D [15], which is a five item 
measure used to assess general health.  
 
Main outcome measure: Modified Caregiver Strain Index (MCSI) score. 
Proposed sample size 
Results will be compared to those reported in the Peters et al study (2013) [1]. Here, 
for example, mean (95% confidence interval) MCSI was 11.9 (11.4-12.4) in their 
sample of n=571 participants for Parkinson’s disease (PD).  
From these figures the SD of the MCSI score is derived to be approximately ~6. 
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That is (0.5/2)*sqrt [571]. Therefore a sample-size calculation for a one-sample t-
test aiming to demonstrate a mean difference of 2 (~ 7.5% difference on the 0-26 
scale) between an average MCSI score for glaucoma compared to an average MCSI 
score for PD as described in Peters et al (2013) (power [beta] and alpha set at 0.80 
and 0.05 respectively) yields a sample size of at least 73 participants required 
(Minitab 17 Statistical Software (2010). (www.minitab.com)).  
A planned sample of 75 pairs of participants for part 1 of the study is sufficient in 
order to test the main hypothesis that mean MCSI scores from glaucoma are 
different to those from other neurological conditions.  
Data management and planned statistical analysis  
The questionnaire data will be computerised and stored in the secure data store in 
the Crabb Lab at City, University of London. Only researchers associated with the 
project will have access to the data. All quantitative data will be analysed by Leanne 
McDonald, PhD student, under the supervision of Professor David Crabb using SPSS 
V.23. We will calculate average MCSI and compare to previously reported values for 
other chronic conditions (one sample t-test).  We will also conduct a series of 
secondary analyses, such as associations between the outcome of interest (MCSI) 
and age, severity of vision loss and other factors using multiple regression analysis. 
We will compare demographic and EQ-5D data for patients with a caregiver and 
patients without a caregiver. Qualitative data (from the focus groups) will be 
analysed using thematic analysis.  
Qualitative Study (Part 2) – Details  
Participants indicating interest in taking part in future research in Part 1 will be 
invited by postal invitation to take part in a focus group. Two focus groups (FGs) 
will be conducted. The FGs will be run on a separate day and participant travel 
expenses will be made available. We expect each FG to last one and a half hours.   
Recommended number of individuals per FG is 6-8 [16] and so each FG will each 
consist of 4 pairs of PPs and CPs.  
FGs are less formal than interviews and are led primarily by the participants 
involved, with the researcher acting as a facilitator. The FGs in this study will be run 
by Ms Leanne McDonald, a PhD researcher at City University London, who has 
training and experience in facilitating FGs. FGs enable participants to share ideas 
and experiences with each other, creating a more impulsive dialogue. Group 
interaction encourages participants to explore shared perspectives and supports the 
participation of people who may be reluctant to contribute their views [17]. 
Significantly our research team has published expertise using FGs [18]. A pilot topic 
guide will be devised in conjunction with two patients (Ms Carol Bronze and Ms 
Julia Brazier) who have been strategically involved in our research lab’s PPI 
activities previously. All dialogue from the FGs will be audio-recorded (with 
209 
 
permission from the participants) transcribed and reviewed by the investigators in 
accordance with the Consolidated Criteria for Reporting Qualitative Research 
(COREQ) for FGs [19] . Framework analysis, using the qualitative software package 
NVIVO 10.2 (QSR International, Cambridge, Massachusetts) will be used to organise, 
refine and condense themes for exploration [20]. Themes and sub-themes will be 
reported and summarised using a coding tree. 
Outcomes and dissemination 
We plan to report results from our study in an article submitted to an open-access 
journal. We also plan to disseminate results at the UK and Eire Glaucoma Society 
Meeting in 2017 and at the Association for Research in Vision and Ophthalmology in 
2018. We will also ask the International Glaucoma Association if we can disseminate 
findings in their patient publications. 
Currently there is an unmet need, highlighted by the NICE guidelines [11], for 
information for ‘families and carers’ of people newly diagnosed with glaucoma. At a 
later stage, the research team may use the results of the study (part 2 FG work) to 
provide some evidence based information for this unmet need. The results from this 
research may give us the opportunity to take advantage of our expertise and 
experience in developing award winning patient information. 
(http://www.city.ac.uk/news/2015/september/new-app-demystifies-glaucoma). 
After the project we will interact with the IGA in order to see how these can be 
publicised and made available. 
The National Institute for Health and Care Excellence (NICE, 2009) guidelines for 
glaucoma care recommend support groups for patients [11]. The NICE guidelines also 
state that ‘families and carers should also be given the information and support that 
they need’, however there is currently no formal support available for caregivers. 
This research may provide groundwork for creating a support groups for informal 
caregivers. If health services (ophthalmologists, nurses, community optometrists) 
and social care services (social workers, charity groups) were able to routinely 
identify caregivers who may be having problems, it may be possible to improve 
services. For example, carer support groups, and lead to better understanding and 
positive outcomes. This work might lead to an application (by us or others) to the 
National Institute for Health Research to study the health service delivery 
implications of our findings. With permission, the results of this study may, in future 
work, be translated into materials aimed at supporting patients and caregivers with 
their glaucoma journey. 
Ethical considerations  
The research being proposed will be of a sensitive nature due to the subject material 
being discussed, however, there is a low risk of participant harm. 
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Participants will be asked not to take part in the study if they feel that the subject 
matter may be distressing to them. Participants will be told their data will be 
anonymised and will only be accessed by the researchers affiliated with this project 
– who the participants will have contact details for.  
It is important that the distinction between an ‘informal caregiver’ and ‘formal 
carer’ is made to participants. Some participants may not feel that the help they 
provide should be classified as ‘care’ and definitions of the word ‘carer’ differ among 
individuals. This will also help to minimise any distress that patients may 
experience by having their care needs identified. 
During the focus group sessions, the researchers will record participants’ voices so 
that they may be transcribed later. Participants taking part in the focus group will be 
required to sign a separate consent form giving permission to have their voices 
recorded and listened to later by the researchers. Both the qualitative and 
quantitative data will be stored on a secure computer at City University London, 
which only the researchers will have access to. The data will be destroyed after the 
University statutory period, which is 10 years. 
Patient benefit 
To our knowledge this research will be the first of its kind to be conducted with 
glaucoma patients and their caregivers. By identifying risk factors (predictors) for 
informal caregiver strain in glaucoma caregivers, it may be possible to develop 
resources and support systems in the future to monitor patients and caregivers. 
Educating patients and caregivers in this way and providing support is particularly 
relevant as the prevalence of glaucoma is expected to rise significantly due to the 
ageing population, so the number of patients and informal caregivers will rise. 
Similar research in other caregiver groups has generated interest from the medical 
and psychological communities. 
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Appendix 2 – Participant Information Sheet (Chapter Four) 
 
PARTICIPANT INFORMATION SHEET 
 
Date and version: 08/05/2017_v2.0 
 
Study Team 
Principal Investigator   Professor David Crabb 1 
Clinical Investigator  Ms Lydia Chang 2  
Research Team   Ms Leanne McDonald 1 
 Ms Paula Turnbull 2 
 Ms Manjo Doug 2 
1. City, University of London  2. North West Anglia NHS Foundation Trust 
 
1. Study title 
Taking the strain? Impact of glaucoma on patient’s informal caregivers. 
 
2. Invitation  
We invite you to take part in a research study. Before you decide if you want to 
take part, we would like you to understand why the research is being done and 
what it will involve. Please take time to read the following information carefully.  
Please discuss this information with your family and friends if you wish. 
Participation is voluntary; it is entirely up to you if you want to take part in the 
study. Not taking part in this study will not affect your care in the clinic.  
 
3. What is the purpose of the study? 
We want to know more about the informal care you receive as a person with 
glaucoma. This informal (unpaid for) care could be given to you by a spouse, 




4. Do I have to take part? 
No. Whatever you decide to do will not affect your care within the NHS. If you 
do decide to take part, you will be asked to send back the questionnaire 
materials as an indicator of your consent. 
 
5. What will happen to me if I take part? 
You will be asked to complete the attached short questionnaire pack. It 
should take only 10-20 minutes to complete. The questionnaire pack 
contains: 
 
• Questions about you – your age, education level and marital status. 
• A few questions about your general health. 
 
Your clinical team may also take a look at your medical records for more 
information about your health; this will be collected by your clinical team 
and stored securely. 
 
If you have somebody that informally helps you with your glaucoma:  
You will be asked to give a copy of the questionnaire materials to this person. 
This could be a spouse, a partner, a relative or friend who helps you with any 
aspect related to your glaucoma. This person will have a separate 
information sheet and consent form to sign and some additional 
questionnaires to fill in. You will then be asked to send back both 
questionnaires to us. 
 
If you do not have somebody that helps you with your glaucoma 
You will be asked to send just your questionnaire, plus the additional 
materials, back to us.  
 
6. What do I have to do? 
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Once you have read this participant information sheet, you can fill in your 
questionnaire pack. This pack comes with a stamped addressed envelope to 
send the materials back to the researchers. By posting your materials back to 
us, you will be consenting to take part in the study. If you do not send your 
materials back, we will assume that you do not wish to take part in the study. 
 
7. Are there any possible disadvantages/risks of taking part? 
No – although some people may feel that the subject material is of a sensitive 
nature and discussing the subject of care may upset you. If you feel upset, you 
can contact the researchers to discuss this. 
 
8. What are the possible benefits of taking part? 
Participants will receive no direct benefit from taking part. However, it is 
hoped that the results of the study will be used to inform better support for 
patients and caregivers in the future.  
 
9. What if there is a problem? 
If you wish to make a complaint, you should contact the research team 
immediately.  
• Paula Turnbull: North West Anglia NHS Foundation Trust.  
• Tel: 01480 363880 or email: paula.turnbull@nhs.net 
Usual NHS complaint mechanisms are also available to you: 
• Patient Advice and Liaison Service (PALS) Tel: 01480 428964  
Open from 9am-4.30pm Mon to Fri or email: hch-tr.pals@nhs.net 
 
10. Will my taking part in the study be kept confidential? 
All information collected throughout the course of the study will be 
processed and stored securely using password protected systems. Your 
personal information will be coded and only other researchers who are part 
of the study will be able to identify you. When the study is over, copies of 
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your questionnaire results will be retained for the minimum period of ten 
years but will be anonymised. All data storage procedures in this study are 
compliant with the Data Protection Act 1998. 
 
11. What will happen to the results of the research study? 
The outcomes of this research will be published in an article in an open-
access journal and will be presented at research meetings. Identities of 
participating volunteers will not be revealed in any published materials.  
 
12. Who is organising and funding the study? 
The study is being organised by North West Anglia NHS Foundation Trust 
and The Crabb Lab at City, University of London. The study is funded by an 
unrestricted grant from Santen UK Ltd, but Santen UK Ltd will have no access 
to the data from the study. 
 
13. Who has reviewed the study? 
The East of Scotland Research Ethics Service REC 2, which has responsibility 
for scrutinising all proposals for research on humans, has examined the 
proposal and has raised no objections from the point of view of research 
ethics.  It is a requirement that your records in this research, together with 
any relevant medical records, be made available for scrutiny by monitors 
from North West Anglia NHS Foundation Trust, whose role is to check that 




Thank you for your interest in taking part in the study. You may keep this 




Appendix 3 – Questionnaire packs (Chapter Four) 
 
Dear sir/madam 
You are a very important person; you meet the criteria for our research because you 
have a diagnosis of primary open angle glaucoma and are seen by doctors at North 
West Anglia NHS Foundation trust.  
We are a team of researchers at City, University of London and North West Anglia 
NHS Foundation trust working with Miss Lydia Chang, Consultant Ophthalmic 
Surgeon. We are interested in the health and needs of glaucoma patients and their 
family/friends. We invite you to take part in a research study. We have included a 
detailed information sheet about the research with this letter. 
We aim to find out how glaucoma patients and their families/friends cope outside of 
a hospital environment. We hope to use the information from the study to improve 
resources for the loved ones of people with glaucoma.  
If you choose to take part in the research, you will be asked to fill in some 
questionnaires and to give some questionnaires to a person who you feel helps you 
with your glaucoma. This person can be a spouse, partner, friend or any other 
person who is not a paid professional. The person might, for example, help 
you with things such as attending appointments, putting in eye drops or 
anything else to do with your glaucoma. You should give this person the green 
booklet. 
If you do not feel that you have anybody who acts as an informal caregiver, you can 
still take part in the research. Simply complete the yellow booklet and send it back 
to us on the return address above. 
Please note that we do not have access to your name and contact details, this letter 
has been sent on our behalf.  
Thank you for considering taking part in our study. 
Yours sincerely, 






Thank you for choosing to take part in our research study. Please tick one of the 
options below: 
I have given the sheet marked ‘caregiver’ to somebody who helps me with 
my glaucoma. Please indicate your relationship to the person below.  
 ___________________________________. 






Section 1.  
We would like to ask you some questions about yourself, please tick the circle that 
applies to you for each question.  
Gender  
 





















Your education level 
No School Education 
































For this section, we would like you to fill in some questions about your health. Show 
us how you feel by ticking an option below. 
 
1. Mobility 
I have no problems in walking about 
 
I have slight problems in walking about 
 
I have moderate problems in walking about 
 
I have severe problems in walking about 
 
I am unable to walk about 
 
 
2. Self-care  
I have no problems washing/dressing myself 
 
I have slight problems washing/dressing myself 
 
I have moderate problems washing/dressing myself 
 
I have severe problems washing/dressing myself 
 
I am unable to wash/dress myself 
 
 
3. Usual activities (e.g. work, study, housework) 
I have no problems with usual activities 
 
I have slight problems with usual activities 
 
I have moderate problems with usual activities 
 
I have severe problems with usual activities 
 




















4. Pain/discomfort  
I have no pain/discomfort 
 
I have slight pain/discomfort 
 
I have moderate pain/discomfort 
 
I have severe pain/discomfort 
 




5. Anxiety/depression   
I am not anxious or depressed 
 
I am slightly anxious or depressed 
 
I am moderately anxious or depressed 
 
I am severely anxious or depressed 
 
I am extremely anxious or depressed 
 
 














Further research invitation 
We are planning to conduct more research in the future. This will involve coming to 
the hospital to take part in a focus group about the material discussed in this 
research. Please indicate below (by ticking an option) whether you would like to be 
contacted about this research. 
Please don’t contact me about further glaucoma caregivers research 
I would like to be contacted about further glaucoma caregivers research  




Telephone number: _________________________________________________ 
 







This is to be given to a person who helps with your glaucoma. Please do not fill 
this section in if you are the person this letter has been addressed to. 
  
Dear sir/madam, 
You are a very important person; you meet the criteria for our research because you 
have a family member or friend with a diagnosis of primary open angle glaucoma 
and are seen by doctors at North West Anglia NHS Foundation trust. You have been 
identified by this person as a suitable person to take part in our research. 
We are a team of researchers from City, University of London and North West Anglia 
NHS Foundation trust. We are interested in the health and needs of glaucoma 
patients and their families/friends and we are contacting you to invite you to take 
part in a research study. 
We aim to find out how glaucoma patients and their families/friends cope outside of 
a hospital environment. We hope to use the information from the study to improve 
resources for the family and friends of people with glaucoma.  
We have included a detailed information sheet about the research with this letter; 
together with the questionnaire materials that we would like you to fill in. 
If you choose to take part in the research, you will be asked to fill in some 
questionnaires and send them back to our research team. If you don’t want to take 
part in the research, please return these materials to us at the return address. 







Thank you for choosing to take part in our research study. You have been identified 
as somebody who voluntarily helps a patient with aspects related to their 
glaucoma (e.g. attending appointments, providing assistance with eye drops).  
Section 1. 
We would like to ask you some questions about yourself, please tick the circle that 
applies to you for each question. 
Gender  
 




















Your education level 
No School Education 


























What is your relationship to the patient? ________________________________ 
                                                          Caregiver 
Section 2. 
 
For this section, we would like you to first complete some questions about your 
general health; not just related to your glaucoma role. Show us how you feel by 
ticking an option below. 
 
1. Mobility 
I have no problems in walking about  
I have slight problems in walking about  
I have moderate problems in walking about  
I have severe problems in walking about  
I am unable to walk about  
 
2. Self-care  
I have no problems washing/dressing myself  
I have slight problems washing/dressing myself  
I have moderate problems washing/dressing myself  
I have severe problems washing/dressing myself  

















3. Usual activities (e.g. work, study, housework) 
I have no problems with usual activities  
I have slight problems with usual activities  
I have moderate problems with usual activities  
I have severe problems with usual activities  
I am unable to complete usual activities  
 
4. Pain/discomfort  
I have no pain/discomfort  
I have slight pain/discomfort  
I have moderate pain/discomfort  
I have severe pain/discomfort  
I have extreme pain/discomfort  
 
5. Anxiety/depression   
I am not anxious or depressed  
I am slightly anxious or depressed  
I am moderately anxious or depressed  
I am severely anxious or depressed  






















Think about the help that you give to your family member or friend for their 
glaucoma.  
We would like you to think about how each statement applies to your caregiving 
for glaucoma.  
Please tick the box that is most appropriate. Remember it applies to your 
caregiving for glaucoma.  





Regularly  Sometimes  Not at all 
 
 





Regularly  Sometimes  Not at all 
 
 





Regularly  Sometimes  Not at all 
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Regularly  Sometimes  Not at all 
 
 










There have been other demands on my time (for example, other family 




   
   
   
   
   
   




Regularly  Sometimes  Not at all 
 
 














Regularly  Sometimes  Not at all 
 
 
It is upsetting to find the person I care for has changed so much from his/her 





Regularly  Sometimes  Not at all 
 
 
There have been work adjustments because of my caregiving 
   
   
   
   
   
   







Regularly  Sometimes  Not at all 
 
 





Regularly  Sometimes  Not at all 
 
 





Regularly  Sometimes  Not at all 
 
 
Thank you for completing this questionnaire.  
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Further research invitation 
We are planning to conduct more research in the future, which involves coming to 
the hospital to take part in a focus group about the material discussed in this 
research. Please indicate below (by ticking an option) whether you would like to be 
contacted about this research. 
Please don’t contact me about further glaucoma caregivers research 
I would like to be contacted about further glaucoma caregivers research  




Telephone number: _________________________________________________ 
 








Appendix 4 – Semi-structured interview schedule (Chapter Five)  
 
The semi-structured interview schedule used in Chapter Five of this thesis. 















I would first like to know what kind of help each of you 
consider as part of the role of a caregiver? 
Probes: If eye drops/hospital appointments/driving not 
mentioned; does anybody consider ________ as part of your 
role? If not, why not? 
 
Has your experience with glaucoma changed the way 
you communicate with your loved one(s) in any way? 
Probes: Tell me more about that. Was this a positive 
experience or a negative experience? Why?  
 
Which areas do you feel that a caregiver/patient may 
need support in? 
Probes: Why do you say that? What do you find 
particularly hard about that? What feelings are associated 









Are you aware of, or do you access, any support 
groups? What are your experiences with these? 
Probes: Why? If not, why not? What makes this successful? 
  
